data_1pun_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pun _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.719 0.295 . . . . 0.44 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.431 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.44 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' THR . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.44 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.652 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.44 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.44 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.44 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.44 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.44 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.44 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.612 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.44 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.44 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.44 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.44 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.44 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.44 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.44 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 105' ' ' MET . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.44 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 1.7 tmm_? . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.895 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.44 110.959 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.44 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.44 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.44 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.44 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.44 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.44 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.44 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.563 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.44 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.44 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.44 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.582 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.44 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.44 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.44 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.44 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.44 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.44 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.44 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.44 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.44 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.44 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.44 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.44 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.44 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.44 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.537 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.44 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.44 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.616 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.44 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.44 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.44 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.44 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.44 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.44 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.44 109.328 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.44 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.44 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.44 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.44 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.44 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.44 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.44 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.04 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.419 ' CE1' HG22 ' A' ' 81' ' ' THR . 4.1 t-80 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.44 110.954 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.44 109.792 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.44 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 71' ' ' LEU . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.44 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.44 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.44 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.44 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.658 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.44 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.44 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.44 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.44 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.44 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.44 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.44 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.44 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.571 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.44 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.44 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.44 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.44 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.44 111.479 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.44 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.44 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.44 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.44 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.457 ' HG2' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.44 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.432 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.44 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.484 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.44 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.44 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.44 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.44 110.753 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.44 112.345 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.44 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.44 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.44 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.44 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.44 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.44 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.44 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.44 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.44 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.44 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.44 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.44 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.44 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.44 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.44 110.568 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.814 0.34 . . . . 0.44 110.743 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.36 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.44 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.44 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.44 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.44 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.44 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.673 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.44 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.627 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.44 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.44 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.532 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.44 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.44 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.44 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.44 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.44 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.44 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.44 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.44 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.44 111.668 -178.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.44 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.832 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.44 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.482 ' CE1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.44 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.44 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.44 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.44 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.44 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.44 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.44 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.44 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.44 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.44 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.606 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.44 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.44 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.44 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.44 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.44 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.44 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.44 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.44 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.44 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.44 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.644 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.44 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.44 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.49 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.44 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.44 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.646 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.44 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.44 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.597 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.44 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.44 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.44 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.44 109.459 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.44 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.44 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.44 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.44 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.44 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.44 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.44 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.44 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.44 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.44 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.44 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.44 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.44 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.44 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.44 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.44 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.44 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.646 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.44 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.44 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.44 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.44 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.516 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.44 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.644 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.44 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.44 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.44 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.44 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 28.0 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.44 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.44 112.165 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.44 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.44 110.374 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.44 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.44 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.44 110.966 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.434 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.44 111.837 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.44 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 111' ' ' ASN . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.44 110.64 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.768 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.44 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.44 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.832 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.44 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.44 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.44 111.439 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.439 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.44 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.44 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.44 111.415 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.44 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.44 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.44 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.44 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.44 111.432 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.664 0.269 . . . . 0.44 110.752 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.44 110.302 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.41 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.44 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.717 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.44 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.44 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.44 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.44 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.44 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.44 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.44 113.504 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.44 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.44 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.44 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.44 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.44 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.646 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.44 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.44 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.44 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.44 111.904 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.775 0.321 . . . . 0.44 110.971 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.44 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.44 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.44 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.717 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.44 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.44 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.44 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.44 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.44 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.44 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.44 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.44 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.44 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.44 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.44 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.44 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.44 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 40' ' ' ILE . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.44 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.44 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.44 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.44 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.44 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.44 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.64 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.44 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.44 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.44 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.44 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.64 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.44 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.44 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.44 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.44 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.595 ' HG ' ' HB2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.44 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.44 111.145 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.4 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.44 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.44 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.44 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.44 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.44 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.44 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.44 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.44 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.44 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.44 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.44 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.44 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.44 114.056 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.44 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.44 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.44 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.44 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.44 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.64 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.44 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.44 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.44 111.05 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.44 113.216 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.44 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.44 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.44 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.44 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.44 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.237 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.566 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.44 112.238 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.44 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.44 110.93 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.44 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.44 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.44 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.598 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.44 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.44 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.44 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.44 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.44 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.44 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.595 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.44 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.44 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.531 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.44 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.44 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.44 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.44 111.265 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.44 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.44 111.413 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.44 110.909 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.296 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.44 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.44 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.702 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.44 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.44 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.44 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.44 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.661 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.44 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.531 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.44 113.021 -179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.44 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.44 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.44 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.44 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.44 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.44 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.44 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.44 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.538 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.691 0.281 . . . . 0.44 111.071 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.44 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.44 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.44 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.44 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.44 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.44 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.44 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.44 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.44 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.44 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.44 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.44 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.6 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.44 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.6 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.44 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.44 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.44 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.44 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.44 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.44 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.44 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.44 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.44 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.44 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.44 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.616 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.44 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.44 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.44 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.44 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.44 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.44 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.44 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.44 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.44 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.44 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.515 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.44 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.44 111.305 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.44 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.44 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.44 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.44 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.44 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.44 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.8 m170 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.44 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.44 109.122 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.44 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.44 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.44 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.44 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.44 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.44 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.44 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.44 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.44 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.61 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.44 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.44 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.472 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.44 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.44 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.44 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.44 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.44 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.44 112.47 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.44 112.228 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.44 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.44 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.44 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.438 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.44 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.44 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.437 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.44 112.219 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.44 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.44 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.44 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.44 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.44 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.44 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.542 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.44 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.44 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.44 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.44 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.44 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.44 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.44 110.773 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 123' ' ' ILE . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.44 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.44 111.398 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.726 0.298 . . . . 0.44 110.76 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.44 110.833 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.44 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.44 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.44 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.44 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.44 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.44 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.44 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.44 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.601 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.44 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.44 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.44 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.44 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.44 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.44 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.44 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.44 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.44 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.44 111.025 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.696 0.284 . . . . 0.44 111.05 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.44 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.44 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.44 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.44 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.44 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.44 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.44 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.44 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.592 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.44 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.44 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.44 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.44 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.44 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.44 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.44 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.44 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.44 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 54' ' ' LEU . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.44 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.44 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.44 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.44 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.44 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.44 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.44 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.586 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.44 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.44 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.505 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.44 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.44 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.594 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.44 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.491 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.44 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.538 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.44 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.44 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.44 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.44 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.44 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.44 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.44 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.44 110.853 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.44 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.44 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.44 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.44 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.44 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.44 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.44 109.449 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.44 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.44 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.44 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.44 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.44 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.44 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.44 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.44 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.601 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.44 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.44 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.44 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.44 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.44 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.44 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.44 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.44 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.44 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.44 112.012 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.44 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.44 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.44 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.44 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 18' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 18' ' ' ILE . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.44 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.44 112.451 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.44 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 123' ' ' ILE . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.44 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.44 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.44 111.026 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.44 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.44 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.44 112.367 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.44 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.44 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.44 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.44 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.44 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.44 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.44 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.44 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.44 111.88 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.44 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.44 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.44 111.372 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.44 110.728 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.44 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.44 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.44 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.44 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.44 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.734 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.44 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.44 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.44 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.44 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.44 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.44 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.44 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.44 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.44 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.44 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.44 108.809 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.702 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.44 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.44 111.503 -179.072 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.793 0.33 . . . . 0.44 111.01 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.44 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.44 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.44 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.44 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.44 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.44 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.44 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.44 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.44 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.44 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.602 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.44 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.44 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.44 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.44 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.44 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.44 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.44 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.44 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.44 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.44 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.44 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.44 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.521 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.44 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.44 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.632 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.44 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.44 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.44 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HA ' HG12 ' A' ' 87' ' ' VAL . 2.7 t-160 -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.44 110.111 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.44 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.44 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.44 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.44 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.44 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.44 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.44 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.44 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.44 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.44 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.44 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.44 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.44 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.44 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.44 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.44 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.44 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.734 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.44 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.44 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.44 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.44 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.44 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.44 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.44 110.637 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.44 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.44 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.44 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.44 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.44 110.702 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.44 113.687 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.411 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.44 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.44 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.44 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.44 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.44 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.44 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.44 110.691 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' CD2' ' CD1' ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.44 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.44 112.007 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.44 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.44 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.44 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.789 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.44 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.44 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.44 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.44 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.44 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.44 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.44 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.44 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.44 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.44 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.44 111.196 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 123' ' ' ILE . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.44 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.44 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.44 111.414 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.69 0.281 . . . . 0.44 110.792 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.302 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.44 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.44 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.44 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.44 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.44 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.44 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.851 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.44 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.44 109.97 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.44 113.472 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.44 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.44 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.44 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.44 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.851 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.44 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.44 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.44 109.097 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.764 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.44 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.44 111.359 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.566 0.222 . . . . 0.44 111.426 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.44 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.764 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.44 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.44 112.081 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.492 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.44 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.44 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.44 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.44 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.44 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.44 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.44 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.44 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.44 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.44 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.604 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.44 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.604 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.44 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.44 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.44 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.44 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.44 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.44 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.44 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.44 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.44 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.639 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.44 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.44 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.57 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.44 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.44 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.648 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.44 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.44 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.44 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.44 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.44 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.44 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.44 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.44 109.925 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.44 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.44 111.753 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.44 110.501 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.44 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.44 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.44 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.44 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.44 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.44 110.046 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.44 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.44 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.44 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.44 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.44 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.696 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.44 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.44 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.44 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.648 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.44 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.44 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.44 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.44 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.55 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.44 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.639 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.44 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.44 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.364 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.44 113.188 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.44 111.865 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.44 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.44 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.44 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.44 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.44 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.385 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.44 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.44 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.44 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.44 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.44 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.44 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.44 112.705 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.44 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.519 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.44 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.44 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.44 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.44 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.44 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.44 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.44 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.44 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.44 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.44 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.44 111.429 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.754 0.312 . . . . 0.44 110.765 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.278 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.44 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.44 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.44 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.44 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.44 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.44 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.44 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.44 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.579 HD22 ' HG2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.44 111.693 178.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.44 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.44 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.44 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.579 ' HG2' HD22 ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.44 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.44 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.44 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.44 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.44 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.44 111.916 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.707 0.289 . . . . 0.44 111.07 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.44 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.44 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE2' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.44 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.44 111.765 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.44 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.44 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.44 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.44 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.44 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.44 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.44 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.578 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.44 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.44 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.44 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.44 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.44 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.44 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.44 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.44 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.44 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.44 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.44 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.44 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.606 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.44 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.44 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.44 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.44 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.576 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.44 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.44 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.44 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.44 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.44 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.901 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.44 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.44 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.44 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.44 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HB2' HG23 ' A' ' 122' ' ' VAL . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.44 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.44 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.44 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.44 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.44 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.44 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.44 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.44 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.44 109.63 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.44 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.44 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.44 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.44 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.901 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.44 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.44 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.44 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.44 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.44 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.44 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.44 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.44 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.44 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.44 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.606 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.44 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.44 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.44 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.44 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.44 112.254 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.44 112.504 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.44 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.44 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.44 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.48 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.4 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' HG23 ' A' ' 18' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.44 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.44 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.44 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.45 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.44 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.44 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.44 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.25 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.44 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.44 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.44 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.44 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.511 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.44 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.44 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.44 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.44 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.44 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.44 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' LEU . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.44 111.317 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 123' ' ' ILE . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.44 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.44 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.454 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.703 0.287 . . . . 0.44 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.44 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 6' ' ' ILE . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.44 108.08 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.44 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.44 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.44 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.44 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.745 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.44 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.44 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.44 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.44 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.44 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.44 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.44 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.44 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.44 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.44 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.44 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 57.8 ttp180 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.44 111.511 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.724 0.297 . . . . 0.44 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.44 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' O ' ' CG2' ' A' ' 21' ' ' THR . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.44 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.44 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.44 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.44 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.44 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.44 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.44 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.44 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.44 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.44 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.62 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.44 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.62 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.44 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.44 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.44 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.44 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.44 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.44 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.44 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.44 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.44 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.604 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.44 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.44 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.44 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.44 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.44 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.44 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.44 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.44 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.44 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.44 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.44 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.44 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.44 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.44 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.44 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.44 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.44 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.44 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.44 110.93 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 80' ' ' ILE . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.44 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.44 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.44 109.974 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.44 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.44 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.44 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.44 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.44 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.44 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.44 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.44 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.667 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.44 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.44 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.44 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.44 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.44 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.604 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.44 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.44 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.909 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.44 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.44 111.987 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.44 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.44 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.44 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.44 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.475 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.44 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.404 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.44 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.44 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.44 110.739 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.44 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.44 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.44 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.44 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.44 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.549 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.44 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.44 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.44 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.44 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.44 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.44 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.44 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.44 111.014 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.434 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.44 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.32 179.402 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.744 0.307 . . . . 0.44 110.741 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.425 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.44 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.44 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.649 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.44 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.44 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.44 113.753 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.68 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.44 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.44 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.44 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.44 113.021 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.44 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.44 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.44 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.44 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.44 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.44 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.44 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 8.9 ttp85 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.44 111.676 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.458 0.171 . . . . 0.44 111.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.44 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.44 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.44 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.44 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.44 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.44 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.44 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.44 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.44 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.44 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.44 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.44 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.584 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.44 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.44 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.44 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.44 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.44 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.44 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.44 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.44 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.472 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.44 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.44 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.556 ' CG1' HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.44 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.44 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.556 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.44 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.44 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.44 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.44 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.569 ' HA ' HG13 ' A' ' 87' ' ' VAL . 2.7 t-160 -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.44 110.364 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.44 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.44 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.44 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 121' ' ' PRO . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.44 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.44 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.44 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.44 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.44 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.44 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.44 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.44 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.44 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.44 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.44 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.44 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.44 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.44 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.877 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.44 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.44 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.44 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.4 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.44 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.44 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.678 ' CE3' HG21 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.44 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.44 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.44 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.44 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.44 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.44 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.44 110.452 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.44 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.404 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.44 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.44 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.44 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.44 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.44 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.44 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.44 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.44 110.804 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.44 111.903 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.44 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.225 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.44 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.44 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.44 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.567 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.44 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.44 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.44 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.44 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.44 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.44 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.44 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.44 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.44 111.376 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.561 0.22 . . . . 0.44 110.791 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.44 110.764 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.44 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.44 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.44 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.44 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.44 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.44 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.44 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.44 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.599 ' OD1' ' HB3' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.44 111.81 178.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.44 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 33.8 t-20 -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.44 113.263 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.44 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.44 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.44 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.44 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG13 ' CG ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.44 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.44 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.44 111.397 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.705 0.288 . . . . 0.44 111.166 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.44 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.44 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.44 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.44 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.44 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.44 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.44 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.44 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.667 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.44 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.667 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.44 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.44 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.44 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.44 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.626 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.44 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.44 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.44 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.44 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.44 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.44 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.44 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.44 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.44 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.44 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.783 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.44 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.639 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.44 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.44 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.44 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.44 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.44 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.44 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.58 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.44 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.44 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.793 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.44 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.44 109.19 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.512 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.44 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.44 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.44 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.44 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.44 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.44 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.44 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.44 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.44 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.44 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CZ3' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.44 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.793 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.44 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.701 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.44 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.44 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.44 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.44 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.44 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.44 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.44 110.763 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.44 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.44 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.639 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.44 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.44 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.44 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.44 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.44 112.115 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.44 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.44 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.44 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.599 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.44 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.512 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.44 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.44 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.44 112.182 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.44 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.44 110.727 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.44 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.44 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.44 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.201 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.44 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.44 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.44 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.532 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.44 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.44 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.44 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.44 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.44 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.44 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.44 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.44 111.264 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.44 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.44 111.389 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.476 -0.194 . . . . 0.44 110.476 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.443 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.44 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.44 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 4' ' ' LEU . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.44 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.44 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.44 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.44 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.44 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.496 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.44 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.44 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.44 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.44 111.655 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.44 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.44 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.542 HG21 ' C ' ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.44 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.44 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.44 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.44 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' CB ' HD11 ' A' ' 33' ' ' LEU . 6.7 tmm_? . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.44 111.253 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.751 0.31 . . . . 0.44 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.44 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.44 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.44 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.44 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.44 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.44 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.44 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.44 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.61 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.44 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.44 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.44 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.44 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.44 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.44 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.44 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.44 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.44 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.44 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.44 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.44 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.594 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.44 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.44 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.573 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.44 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.44 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.44 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.44 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.553 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.44 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.44 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.44 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.44 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.44 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.44 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.44 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.44 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.44 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.44 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.44 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.44 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.44 109.59 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.44 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.44 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.465 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.44 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.44 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.876 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.44 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.44 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.44 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.44 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.44 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.62 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.44 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.44 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.44 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.44 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.44 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.44 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.44 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.44 110.496 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.44 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.44 112.079 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.44 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.44 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.44 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.44 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.44 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.44 111.25 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.81 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.44 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 ' CD1' ' CD2' ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.44 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.44 112.209 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.44 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.729 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.44 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.44 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.44 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.44 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.519 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.44 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.44 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.44 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.44 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.44 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.44 110.985 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.44 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.44 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.44 111.38 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.641 0.257 . . . . 0.44 110.715 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 6' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.44 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.44 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.44 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.44 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.44 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.44 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.755 ' HB ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.44 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.889 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.44 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.44 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.44 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.44 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.44 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.44 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.44 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.889 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.44 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.44 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.44 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.44 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.44 110.829 -179.713 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.44 111.228 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.44 111.519 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.678 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.44 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' CG ' ' CG ' ' A' ' 116' ' ' PRO . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.44 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.44 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.44 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.44 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.44 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.44 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.727 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.44 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.44 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.44 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.44 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.44 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.44 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.44 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.44 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.44 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.727 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.44 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.44 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.44 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.47 HD13 ' CE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.44 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.44 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.44 111.076 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.44 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.627 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.44 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.44 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.44 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.44 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.598 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.44 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.44 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.571 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.2 t-160 -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.44 110.69 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.44 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.44 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.44 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.44 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.44 111.011 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.44 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.44 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.44 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.44 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.44 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.44 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.44 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.44 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.44 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.44 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.655 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.729 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.44 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.44 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.44 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.44 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.44 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.598 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.44 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.44 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.44 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.44 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.546 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.44 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.44 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.44 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.44 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.44 112.001 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.44 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.44 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.44 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.458 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.44 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.273 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.44 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.44 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.44 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.44 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.355 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.44 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.44 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.44 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.44 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.053 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.44 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.511 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.44 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.44 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.536 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.44 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.44 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.44 111.558 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.44 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.44 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.44 111.523 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.701 0.286 . . . . 0.44 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 80' ' ' ILE . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.44 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.44 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.44 107.965 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.44 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.44 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.44 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.44 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.44 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.44 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.44 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.44 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.44 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.44 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.44 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.44 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.44 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.44 109.06 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.44 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.44 111.56 -178.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.582 0.23 . . . . 0.44 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.44 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.78 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.44 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.44 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.44 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.44 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.44 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.44 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.44 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.44 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.44 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.44 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.44 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.44 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.44 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.44 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.44 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.44 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.44 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.44 111.213 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.44 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.44 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.44 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.44 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.44 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.44 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.44 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.44 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.44 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.44 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.44 104.993 175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.44 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.44 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.44 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.44 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.44 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.44 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.44 109.746 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.44 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.44 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.44 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.44 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.44 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.44 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.44 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.659 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.44 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.44 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.44 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.44 110.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.44 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.439 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.44 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.44 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.44 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.44 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.44 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.44 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.44 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.44 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HB3' HG21 ' A' ' 61' ' ' THR . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.44 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.44 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.44 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.44 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.44 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.44 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.44 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.261 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.288 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.44 111.811 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.44 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.44 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.44 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.44 110.483 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.44 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.44 110.89 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.44 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.44 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.44 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.44 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.44 113.106 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.44 112.11 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.44 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.535 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.44 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.44 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.44 110.563 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.44 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.44 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.44 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.44 111.611 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.44 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.44 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.44 111.35 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.699 0.285 . . . . 0.44 110.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.44 110.349 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.44 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.44 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.44 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.44 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.44 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.673 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.44 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.679 ' C ' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.44 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' O ' ' CE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.44 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.664 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.44 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.44 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.44 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.44 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.44 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.679 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.44 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.44 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.44 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.44 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.073 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.44 111.793 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.44 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.44 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.44 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.44 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.44 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.44 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.44 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.44 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.44 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.44 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.44 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.44 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.631 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.44 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.631 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.44 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.44 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.44 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.44 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.44 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.44 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.44 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.44 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.44 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.44 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.44 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.44 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.44 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.44 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.44 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.644 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.44 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.44 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.44 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.44 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.44 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.44 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.44 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.44 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.44 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.44 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.44 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.44 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.44 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.908 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.44 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.44 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.44 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.639 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.44 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.44 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.44 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.44 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.44 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.664 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.44 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.44 110.778 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.44 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.583 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.44 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.44 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.44 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.44 111.396 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.44 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.44 112.223 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.44 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.44 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.44 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.596 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.44 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.44 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 110' ' ' LEU . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.44 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' CD2' HD13 ' A' ' 123' ' ' ILE . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.44 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.44 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.44 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.44 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.44 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.44 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.44 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.44 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.44 111.277 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.44 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.44 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.44 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.44 111.579 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.44 111.434 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.775 0.322 . . . . 0.44 110.862 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.459 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.44 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HB ' ' CD2' ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.44 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.44 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.44 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.71 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.44 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.576 ' O ' ' CB ' ' A' ' 18' ' ' ILE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.44 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.44 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.44 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.499 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.44 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.44 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.44 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.44 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.576 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.44 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.44 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' HG2' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.44 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.44 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 11.1 ttm105 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.44 111.502 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.52 0.2 . . . . 0.44 111.37 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.44 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.44 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.44 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.44 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.44 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.44 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.44 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.44 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.44 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.44 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.44 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.44 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.617 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.44 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.44 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.44 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.44 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.44 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.44 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.44 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.44 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.44 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.44 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.633 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.44 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.44 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.44 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.44 108.945 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.44 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.44 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.4 t-160 -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.44 109.545 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.44 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.81 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.44 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.799 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.44 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.44 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.44 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.44 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.44 110.823 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.44 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.44 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.44 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.44 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.44 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.44 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' CD2' ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.44 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.488 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.44 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.44 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.81 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.44 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.44 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.44 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.44 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.44 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.674 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.44 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.44 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.44 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.495 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.44 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.44 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.633 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.44 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.44 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.018 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.44 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.44 111.67 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.44 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.44 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.44 110.647 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.44 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.44 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.44 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.44 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.44 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.44 110.312 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.44 112.704 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.44 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.44 111.342 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.44 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.44 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.44 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.44 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.35 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.44 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.44 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.435 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.44 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.44 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.44 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.44 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.44 110.777 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.44 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.44 111.403 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.716 0.293 . . . . 0.44 110.737 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.44 110.494 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.44 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.44 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.44 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.44 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.44 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.663 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.44 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.496 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.44 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.44 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.566 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.44 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.44 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.44 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.44 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.44 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.663 HG12 HG12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.44 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.44 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.44 111.583 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.698 0.285 . . . . 0.44 111.282 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.44 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.785 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.44 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.44 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.44 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.44 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.44 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.44 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.44 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.58 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.44 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.44 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.44 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.44 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.44 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.584 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.44 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.44 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.44 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.44 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.44 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.44 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.44 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.44 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' CG1' HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.44 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.567 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.44 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.44 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.609 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.44 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.44 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.598 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.44 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.44 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.44 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.44 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.44 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.44 109.809 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.44 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.44 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.44 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.44 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.44 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.44 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.44 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.44 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.44 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.44 109.615 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.44 110.674 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.44 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.44 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.44 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.44 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.44 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.44 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.44 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.609 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.44 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.44 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.44 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.44 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.44 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.44 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.44 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.44 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.44 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 47.0 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.44 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.44 112.901 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.44 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.44 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.44 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.489 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.44 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.122 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.44 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.44 112.159 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.44 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.44 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.44 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.44 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.44 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.44 111.55 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.785 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.44 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.44 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.44 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.44 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.44 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.44 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.44 111.174 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.44 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.44 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 129' ' ' LEU . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.44 111.313 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.44 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.44 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.44 111.527 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.699 0.285 . . . . 0.44 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.44 110.316 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.44 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.44 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.44 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.593 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.44 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.44 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.723 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.44 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.895 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.44 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.539 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.44 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.44 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.44 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.44 108.792 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.895 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.44 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.44 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.476 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.44 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.44 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.472 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.643 0.259 . . . . 0.44 111.171 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.44 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.44 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.476 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.44 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.44 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.44 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.44 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.44 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.44 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.589 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.44 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.44 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.44 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.44 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.596 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.44 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.596 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.44 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.44 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' C ' ' HB ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.44 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG12 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.44 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.44 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.44 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.44 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.44 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.44 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.618 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.44 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.44 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.44 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.44 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.44 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.44 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.63 ' HA ' HG12 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.44 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.44 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.44 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.95 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.44 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.44 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.44 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.44 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.44 111.612 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.44 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.44 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.44 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.44 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.44 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.44 110.829 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.44 109.115 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.44 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.44 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.44 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.44 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.95 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.44 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.44 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.44 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.44 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.44 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.44 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.44 110.717 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.44 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.44 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.618 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.44 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.44 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.44 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.44 112.068 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.44 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.44 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.44 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.416 ' CG ' HG13 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.44 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.44 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.44 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.44 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.44 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.44 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.465 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.44 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.44 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.44 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.44 112.453 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.44 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 115' ' ' PHE . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.44 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.44 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.44 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.359 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 127' ' ' LYS . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.44 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.44 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.44 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.44 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.44 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.44 111.502 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.688 0.28 . . . . 0.44 110.747 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.44 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.44 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.44 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.44 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.44 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.44 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.764 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.44 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.772 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.44 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.44 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.685 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.44 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.44 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.44 112.786 -178.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.44 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.44 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.772 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.44 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.44 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.516 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.44 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.44 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.44 111.487 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.729 0.3 . . . . 0.44 111.058 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.44 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' LYS . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.44 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.516 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.44 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.44 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.44 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.44 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.44 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.517 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.44 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.604 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.44 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.604 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.44 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.44 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.44 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.44 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.44 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.44 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.44 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.44 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.44 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.665 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.44 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.44 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.668 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.44 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.44 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.44 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 13.0 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.44 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.605 ' HA ' HG13 ' A' ' 87' ' ' VAL . 2.2 t-160 -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.44 109.869 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.44 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.44 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' LEU . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.44 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.44 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.44 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.44 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.44 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.44 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.44 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 9.8 m-70 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.44 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.44 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.44 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.44 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.44 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.44 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.44 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.764 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.44 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.44 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.44 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.44 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.44 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.44 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.44 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.546 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.44 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.665 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.44 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.44 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.44 110.878 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.44 113.842 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' O ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.44 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.44 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.44 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.44 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.44 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.448 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.44 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 111.282 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 110' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.44 112.43 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.44 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.44 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.44 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.44 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.44 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.44 111.132 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.7 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.44 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.44 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.44 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.44 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.107 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.44 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.44 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.44 112.009 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.44 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.44 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.44 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.44 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.44 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.44 111.436 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.444 -0.206 . . . . 0.44 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.45 HD13 ' CG1' ' A' ' 80' ' ' ILE . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.44 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.44 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.44 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.44 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.44 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.44 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.44 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.44 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.44 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.44 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.44 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.44 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.44 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.765 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.44 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.44 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.44 109.1 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.44 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.44 110.856 -179.8 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.693 0.282 . . . . 0.44 111.142 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.44 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' THR . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.44 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.44 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.44 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.712 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.44 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.44 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.44 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.44 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.44 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.44 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.44 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.44 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.44 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.627 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.44 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.44 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.44 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.44 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' C ' ' HB ' ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.44 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.44 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.44 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.44 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.524 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.44 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.44 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.44 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.44 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.56 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.44 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.44 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.595 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.44 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.44 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.44 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.6 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.44 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.44 112.133 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.44 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.952 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.44 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.44 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.693 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.44 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.44 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.44 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.44 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.44 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.44 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.44 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.44 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.44 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.8 m170 -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.44 110.753 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.44 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.44 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.44 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.44 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.952 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.44 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG21 ' CD2' ' A' ' 64' ' ' HIS . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.44 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.44 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.44 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.44 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' CB ' HG23 ' A' ' 61' ' ' THR . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.44 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.44 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.44 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.44 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.44 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.44 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.44 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.44 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.44 111.755 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.44 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.44 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.44 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.44 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.44 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 110' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.44 112.297 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.44 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.44 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.44 112.886 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.44 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.44 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.44 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.44 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.44 112.471 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.44 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.536 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.44 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.44 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.44 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.44 110.913 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.584 HG13 ' CE2' ' A' ' 115' ' ' PHE . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.44 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.44 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.44 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.44 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.44 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.44 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.478 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.44 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.04 140.43 44.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -136.2 158.09 45.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.44 110.783 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.431 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.44 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG12 " O3'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.44 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.652 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.44 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.44 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.44 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.44 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.44 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.44 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.612 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.44 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.44 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.44 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.44 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.44 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.44 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.44 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 105' ' ' MET . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.44 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 1.7 tmm_? -146.62 146.96 30.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.895 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 5.7 mtm180 51.21 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.561 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 82.51 36.94 0.06 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.291 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.35 82.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.377 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.49 88.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.111 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.44 -165.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.988 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -56.12 -57.08 13.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.44 111.021 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.4 mtt -145.41 135.4 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.0 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -8.98 58.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.437 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -95.11 31.13 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.306 . . . . 0.44 110.959 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.44 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.44 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.44 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.44 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.44 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.44 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.44 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.563 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.44 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.44 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.44 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.582 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.44 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.44 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.44 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.44 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.44 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.44 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.44 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.44 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.44 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.44 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.44 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.44 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.44 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.44 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.44 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.44 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.616 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.44 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.44 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.44 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.44 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.44 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.44 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.44 109.328 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.44 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.44 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.44 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.44 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.44 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.44 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.44 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.04 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.419 ' CE1' HG22 ' A' ' 81' ' ' THR . 4.1 t-80 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.44 110.954 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.44 109.792 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.44 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 71' ' ' LEU . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.44 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.44 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.44 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.44 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.658 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.44 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.44 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.44 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.44 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.44 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.44 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.44 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.44 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.571 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.44 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.44 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.44 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.44 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.44 111.479 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.44 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.44 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.44 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.44 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.457 ' HG2' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.44 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.432 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.44 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.484 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.44 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.44 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.44 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.44 110.753 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.44 112.345 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.515 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.44 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.44 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.44 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.44 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.44 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.44 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.44 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.44 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.44 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.44 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.44 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.44 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.44 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.44 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.44 110.568 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.411 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5013 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5014 ' ' HOH . . . . . 0.539 ' H1 ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.772 0.32 . . . . 0.44 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 116.64 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.845 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 133.23 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.743 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' CD2' " H2'" ' A' ' 131' ' ' 8OG . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.36 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.44 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.44 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.44 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.44 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.44 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.44 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.627 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.44 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.44 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.532 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.44 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.44 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.44 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.44 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.44 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.44 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.44 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.44 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -134.0 131.55 39.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.44 111.668 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 25.6 mtm105 56.13 16.31 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.44 112.045 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.28 -163.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.701 0.286 . . . . 0.44 111.443 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' CB ' ' HG2' ' A' ' 101' ' ' PRO . . . -118.43 -37.5 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.915 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.78 117.08 9.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.808 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 67.33 -159.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.042 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 68.87 173.14 0.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.44 110.981 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.5 146.59 34.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.44 111.137 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -87.14 -22.0 25.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.429 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -93.44 31.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.44 111.17 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.832 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.44 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.482 ' CE1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.44 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.44 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.44 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.44 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.644 ' HD2' ' H2 ' ' A' 5026 ' ' HOH . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.44 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.44 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.44 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.44 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.44 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.44 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.606 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.44 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.44 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.44 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.44 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.44 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.44 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.44 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.44 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.44 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.44 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.644 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.44 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.44 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.49 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.44 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.44 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.646 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.44 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.44 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.597 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.44 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.44 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.44 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.44 109.459 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.44 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.44 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.44 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.44 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.44 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.44 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.44 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.44 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.44 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.44 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.44 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.44 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.44 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.44 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.44 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.44 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.44 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.646 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.44 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.44 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.44 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.44 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.516 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.44 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.644 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.44 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.44 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.44 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.44 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 28.0 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.44 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.44 112.165 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.44 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.44 110.374 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.44 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.44 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.44 110.966 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.434 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.44 111.837 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.44 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 111' ' ' ASN . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.44 110.64 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.768 -179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.44 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.44 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.832 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.44 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.44 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.44 111.439 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.439 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.44 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.44 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.44 111.415 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.44 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.44 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.44 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.44 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.44 111.432 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.424 " H2'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5025 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5026 ' ' HOH . . . . . 0.644 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.806 0.336 . . . . 0.44 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.22 107.08 13.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.44 110.884 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.21 139.02 35.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.44 110.752 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' CD1' " H2'" ' A' ' 131' ' ' 8OG . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.44 110.302 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.41 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.44 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.717 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.44 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.44 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.44 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.44 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.44 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.44 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.44 113.504 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.44 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.44 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.44 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.44 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.44 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.646 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.44 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.44 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.44 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -132.4 138.73 47.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.44 111.904 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 39.92 30.94 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.677 -0.692 . . . . 0.44 111.903 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.98 -166.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 0.44 111.329 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.06 -29.94 62.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.001 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.74 -54.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.44 111.062 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.78 108.86 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.311 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -179.35 77.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.44 110.751 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.0 tpt 64.11 108.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.924 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.39 -20.76 36.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.391 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.62 31.1 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.44 110.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.44 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.44 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.44 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.717 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.44 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.44 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.656 ' HD2' ' H2 ' ' A' 5037 ' ' HOH . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.44 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.44 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.44 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.44 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.44 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.44 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.44 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.44 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.44 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.44 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.44 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 40' ' ' ILE . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.44 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.44 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.44 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.44 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.44 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.44 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.64 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.44 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.53 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.44 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.44 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.44 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.64 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.44 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.44 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.44 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.44 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.595 ' HG ' ' HB2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.44 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.44 111.145 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.4 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.44 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.44 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.44 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.44 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.44 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.44 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.44 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.44 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.44 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.44 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.44 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.44 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.44 114.056 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.44 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.44 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.44 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.44 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.44 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.64 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.44 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.44 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.44 111.05 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.44 113.216 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.44 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.44 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.44 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.44 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.44 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.237 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.566 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.44 112.238 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.44 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.44 110.93 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.44 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.44 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.44 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.598 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.735 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.44 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.44 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.44 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.44 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.44 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.44 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.595 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.44 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.44 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.531 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.44 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.44 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.44 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.44 111.265 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.44 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.44 111.413 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.466 " O3'" ' CD1' ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5037 ' ' HOH . . . . . 0.656 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5038 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.756 0.312 . . . . 0.44 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.74 137.95 44.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.879 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 158.0 44.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.44 110.909 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.296 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.44 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.44 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.702 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.44 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.44 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.44 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.44 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.661 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.44 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.44 113.021 -179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.44 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.44 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.44 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.44 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.44 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.44 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG21 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.44 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.44 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 -129.38 136.88 50.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.538 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.34 30.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.802 -0.635 . . . . 0.44 111.981 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . . . 48.94 -168.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.44 111.444 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.54 -30.88 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.44 111.107 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.42 23.52 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.44 111.154 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.5 76.42 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.387 -0.37 . . . . 0.44 111.237 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.03 -70.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.836 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.7 ttt -113.55 100.03 8.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.15 -18.45 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.44 111.399 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.34 31.01 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.49 -0.323 . . . . 0.44 111.071 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.44 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.44 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.44 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.44 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.44 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.44 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' CB ' ' H2 ' ' A' 5049 ' ' HOH . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.44 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.44 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.44 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.44 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.44 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.44 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.6 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.44 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.6 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.44 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.44 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.44 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.44 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.44 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.44 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.44 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.44 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.44 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.44 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.44 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.616 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.44 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.44 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.44 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.44 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.44 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.44 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.44 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.44 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.44 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.44 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.515 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.44 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.44 111.305 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.44 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.44 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.44 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.44 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.44 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.44 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.8 m170 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.44 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.44 109.122 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.44 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.44 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.44 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.44 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.44 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.44 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.44 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.44 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.44 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.61 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.44 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.44 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.472 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.44 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.44 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.44 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.44 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.44 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.44 112.47 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.44 112.228 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.44 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.44 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.44 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.438 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.432 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.44 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.44 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.437 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.44 112.219 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.44 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.44 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.44 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.44 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.44 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.44 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.542 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.44 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.44 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.44 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.44 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.44 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.44 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.44 110.773 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 123' ' ' ILE . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.44 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.44 111.398 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5049 ' ' HOH . . . . . 0.671 ' H2 ' ' CB ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5050 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.44 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.0 120.57 42.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.955 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.25 134.15 30.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.76 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.44 110.833 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.44 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.44 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.44 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.44 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.44 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.44 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.44 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.44 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.601 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.44 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.44 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.44 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.44 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.44 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.44 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.44 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.44 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.44 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -117.19 88.98 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.44 111.025 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 57.01 21.58 6.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.163 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.35 -81.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.44 111.337 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.24 -69.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.44 111.12 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.23 143.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.44 111.008 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.36 36.84 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.131 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -134.47 -167.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.44 110.948 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 89.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.929 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.63 -16.13 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.445 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.24 28.53 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.46 -0.337 . . . . 0.44 111.05 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.44 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.44 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.44 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.44 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.44 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.44 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.44 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.669 ' HD2' ' H2 ' ' A' 5061 ' ' HOH . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.44 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.592 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.44 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.44 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.44 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.44 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.44 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.44 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.44 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.44 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.44 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 54' ' ' LEU . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.44 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.44 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.44 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.44 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.44 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.44 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.44 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.586 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.44 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.44 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.505 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.44 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.44 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.594 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.44 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.491 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.44 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.538 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.44 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.44 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.44 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.44 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.44 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.44 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.44 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.44 110.853 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.44 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.44 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.44 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.44 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.44 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.44 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.44 109.449 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.44 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.44 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.44 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.44 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.44 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.44 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.44 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.44 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.601 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.44 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.44 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.44 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.44 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.44 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.44 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.44 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.44 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.44 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.44 112.012 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.44 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.44 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.44 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.44 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 18' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 18' ' ' ILE . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.44 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.44 112.451 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.44 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 123' ' ' ILE . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.44 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.44 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.44 111.026 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.44 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.44 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.44 112.367 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.44 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.44 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.44 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.44 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.44 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.44 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.44 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.44 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.44 111.88 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.44 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.44 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.44 111.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.42 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5061 ' ' HOH . . . . . 0.669 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5062 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.44 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 125.07 52.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.867 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? -137.94 153.21 49.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.728 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' HB2' ' N7 ' ' A' ' 131' ' ' 8OG . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.44 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.44 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.44 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.44 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.44 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.734 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.44 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.44 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.44 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.44 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.44 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.44 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.44 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.44 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.44 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.44 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.44 108.809 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.702 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.44 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -126.9 136.51 52.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.44 111.503 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ALA . 19.3 mtt180 51.73 22.94 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.916 -0.583 . . . . 0.44 111.627 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.36 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.588 -0.278 . . . . 0.44 111.633 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -149.24 71.14 1.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.844 0.354 . . . . 0.44 110.904 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.56 126.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.923 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.78 -168.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.44 111.091 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 64.46 -172.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.915 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.17 101.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.332 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.15 -8.96 56.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.666 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.71 31.19 2.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.44 111.01 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.44 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.44 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.44 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.44 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.44 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.692 ' HD2' ' H2 ' ' A' 5074 ' ' HOH . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.44 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.44 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.44 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.44 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.44 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.602 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.44 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.44 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.44 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.44 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.44 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.44 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.44 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.44 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.44 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.44 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.44 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.44 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.521 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.44 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.44 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.632 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.44 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.44 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.44 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HA ' HG12 ' A' ' 87' ' ' VAL . 2.7 t-160 -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.44 110.111 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.44 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.44 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.705 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.44 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.44 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.44 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.44 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.44 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.44 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.44 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.44 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.44 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.44 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.44 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.44 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.44 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.44 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.44 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.44 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.734 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.44 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.44 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.44 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.44 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.44 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.44 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.44 110.637 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.44 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.44 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.44 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.44 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.44 110.702 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.44 113.687 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.411 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.44 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.44 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.44 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.44 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.44 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.44 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.44 110.691 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' CD2' ' CD1' ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.44 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.44 112.007 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.44 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.44 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.44 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.789 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.44 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.44 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.44 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.44 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.44 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.44 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.44 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.44 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.44 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.44 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.44 111.196 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 123' ' ' ILE . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.44 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.44 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.44 111.414 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.473 ' N7 ' ' HB2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5073 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5074 ' ' HOH . . . . . 0.692 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.893 0.378 . . . . 0.44 111.237 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.36 114.05 21.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.926 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.18 139.47 35.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.792 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.302 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.479 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.44 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.44 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.663 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.44 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.44 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.44 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.696 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.44 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.851 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.44 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.44 109.97 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.44 113.472 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.44 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.44 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.44 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.44 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.851 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.44 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.44 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.44 109.097 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.764 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.44 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -148.3 128.03 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.44 111.359 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' ALA . 1.5 mtt-85 42.72 28.59 0.13 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.44 111.613 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' A' ' 100' ' ' GLN . . . 54.29 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.438 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -165.8 31.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.44 111.171 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.6 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.978 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 178.94 112.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.073 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.82 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.819 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mmt -92.55 51.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.44 110.864 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.3 66.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.44 111.377 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.46 13.49 15.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.44 111.426 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.44 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.764 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.44 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.44 112.081 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.492 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.44 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.44 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.44 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.44 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' HD2' ' H2 ' ' A' 5085 ' ' HOH . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.44 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.44 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.44 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.44 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.44 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.44 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.44 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.604 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.44 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.44 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.44 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.44 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.44 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.44 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.44 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.44 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.44 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.639 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.44 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.44 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.57 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.44 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.44 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.648 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.44 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.44 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.44 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.44 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.44 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.44 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.44 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.44 109.925 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.44 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.44 111.753 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.44 110.501 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.44 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.44 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.44 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.44 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.44 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.44 110.046 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.44 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.44 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.44 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.44 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.44 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.696 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.44 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.44 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.44 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.648 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.44 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.44 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.44 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.44 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.55 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.44 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.44 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.44 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.364 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.44 113.188 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 24' ' ' ALA . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.44 111.865 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.44 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.44 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.44 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.44 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.44 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.385 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.44 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.44 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.44 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.44 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.44 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.44 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.44 112.705 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.44 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.519 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.44 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.44 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.44 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.44 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.44 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.44 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.44 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.44 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.44 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.44 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.44 111.429 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5085 ' ' HOH . . . . . 0.57 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5086 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.844 0.354 . . . . 0.44 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 147.25 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.95 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.43 155.2 50.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.44 110.765 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.278 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.44 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.44 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.44 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.44 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.44 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.44 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.44 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.44 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.579 HD22 ' HG2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.44 111.693 178.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.44 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.44 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.44 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.579 ' HG2' HD22 ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.44 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.44 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.44 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.44 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.44 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 -120.92 133.74 55.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.44 111.916 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 36.07 34.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.608 -0.724 . . . . 0.44 112.064 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.63 -164.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.44 111.118 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.63 29.07 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.44 111.103 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.06 -76.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.44 110.97 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.42 132.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.099 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.16 -65.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.797 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 mmt -133.14 92.02 2.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.44 110.648 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -62.43 -26.14 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.51 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -96.76 30.83 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.346 . . . . 0.44 111.07 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.44 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.44 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE2' HG21 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.44 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.44 111.765 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.44 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.44 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.44 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.44 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.44 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.44 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.44 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.578 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.44 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.44 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.44 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.44 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.44 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.44 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.44 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.44 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.44 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.44 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.44 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.44 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.606 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.44 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.44 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.44 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.44 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.576 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.44 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.44 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.44 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.44 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.44 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.901 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.44 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.44 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.44 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.44 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HB2' HG23 ' A' ' 122' ' ' VAL . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.44 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.44 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.44 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.44 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.44 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.44 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.44 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.44 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.44 109.63 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.44 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.44 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.44 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.44 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.901 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.44 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.44 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.44 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.44 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.44 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.576 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.44 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.44 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.44 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.44 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.44 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.606 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.44 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.44 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.44 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.44 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.44 112.254 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.44 112.504 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.44 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.44 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.44 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.48 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.4 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' HG23 ' A' ' 18' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.44 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.44 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.44 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.44 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.44 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.44 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.25 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.44 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.44 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.44 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.44 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.511 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.44 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.44 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.44 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.44 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.44 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.44 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' LEU . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.44 111.317 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 123' ' ' ILE . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.44 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.44 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.454 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.4 " H3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5097 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5098 ' ' HOH . . . . . 0.516 ' H2 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.821 0.343 . . . . 0.44 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 122.43 46.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.887 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt -139.38 152.22 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.884 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.44 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.44 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 6' ' ' ILE . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.44 108.08 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.44 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.44 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.44 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.44 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.745 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.44 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.44 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.44 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.44 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.44 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.44 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.44 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.44 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.44 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.44 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.44 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 57.8 ttp180 -148.17 147.63 29.66 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.44 111.511 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 36.1 mtp180 41.96 28.68 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.44 112.185 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' CB ' ' CG ' ' A' ' 100' ' ' GLN . . . 46.49 28.99 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.844 0.354 . . . . 0.44 111.422 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.28 29.55 19.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.44 110.975 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.05 -68.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.974 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.72 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.219 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -49.38 127.4 15.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.159 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.6 mtt 59.31 63.52 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.848 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -64.21 -19.86 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.359 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -95.5 31.28 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.423 -0.353 . . . . 0.44 111.086 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.44 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' O ' ' CG2' ' A' ' 21' ' ' THR . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.44 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.44 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.44 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.44 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.44 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.44 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.44 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.44 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.44 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.44 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.62 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.44 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.62 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.44 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.44 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.44 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.44 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.44 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.44 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.44 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.44 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.44 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.604 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.44 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.44 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.44 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.44 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.44 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.44 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.44 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.44 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.44 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.44 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.44 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.44 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.44 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.44 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.44 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.44 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.44 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.44 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.44 110.93 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 80' ' ' ILE . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.44 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.44 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.44 109.974 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.44 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.44 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.44 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.44 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.44 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.44 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.44 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.44 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.667 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.44 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.44 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.44 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.44 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.44 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.604 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.44 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.44 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.909 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.44 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' CG ' ' CB ' ' A' ' 24' ' ' ALA . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.44 111.987 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.44 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.44 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.44 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.44 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.475 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.44 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.404 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.44 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.44 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.44 110.739 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.44 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.44 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.44 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.44 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.44 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.549 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.44 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.44 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.44 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.44 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.44 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.44 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.44 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.44 111.014 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.434 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.44 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.32 179.402 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.704 ' OP3' " O4'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5109 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5110 ' ' HOH . . . . . 0.497 ' H2 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.84 0.352 . . . . 0.44 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 79' ' ' HIS . 8.7 ttpt -109.84 139.15 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.904 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.5 132.8 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.44 110.741 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.425 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.44 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.44 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.44 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.44 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.44 113.753 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.68 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.44 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.711 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.44 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.44 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.44 113.021 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.44 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.44 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.44 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.44 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.44 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.44 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.44 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 8.9 ttp85 -129.71 142.34 50.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.44 111.676 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 59.96 13.46 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.791 -0.64 . . . . 0.44 112.078 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . 45.75 25.06 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.002 0.371 . . . . 0.44 112.002 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 162.61 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.381 . . . . 0.44 110.943 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -45.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.038 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.45 104.54 1.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.44 111.151 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.65 -68.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.44 110.852 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.08 63.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.847 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.31 52.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.347 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 1.56 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.44 111.452 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.44 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.44 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.44 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.44 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.44 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.44 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.44 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.44 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.44 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.44 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.44 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.44 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.584 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.44 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.44 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.44 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.44 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.44 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.44 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.44 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.44 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.472 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.44 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.44 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.556 ' CG1' HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.44 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.44 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.556 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.44 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.44 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.44 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.44 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.569 ' HA ' HG13 ' A' ' 87' ' ' VAL . 2.7 t-160 -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.44 110.364 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.44 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.44 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.44 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 121' ' ' PRO . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.44 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.44 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.44 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.44 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.44 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.44 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.44 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.44 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.44 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.44 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.44 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.44 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.46 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.44 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.44 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.877 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.44 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.44 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.44 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.4 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.44 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.44 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.678 ' CE3' HG21 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.44 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.44 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.44 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.44 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.44 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.44 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.44 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.44 110.452 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.44 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HG3' ' CB ' ' A' ' 24' ' ' ALA . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.44 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.44 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.44 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.44 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.44 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.44 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.44 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.44 110.804 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.44 111.903 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.44 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.44 111.225 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.44 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.44 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.44 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.567 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.44 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.44 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.44 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.44 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.44 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.44 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.44 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.44 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.44 111.376 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.409 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5121 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5122 ' ' HOH . . . . . 0.505 ' H1 ' ' CB ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.853 0.358 . . . . 0.44 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.67 127.05 53.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.738 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.14 139.16 35.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.44 110.791 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 HD13 " C3'" ' A' ' 131' ' ' 8OG . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.44 110.764 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.44 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.44 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.44 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.44 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.44 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.666 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.44 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.44 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.44 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.599 ' OD1' ' HB3' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.44 111.81 178.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.44 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 33.8 t-20 -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.44 113.263 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.44 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.44 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.44 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.44 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG13 ' CG ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.44 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.44 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.1 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.44 111.397 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 47.56 25.73 0.7 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.259 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 100' ' ' GLN . . . 54.84 20.47 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.663 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.13 29.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.55 -0.295 . . . . 0.44 111.699 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.96 -83.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.532 -0.304 . . . . 0.44 111.074 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 171.86 40.58 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.44 111.131 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -173.56 164.69 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.44 111.035 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 tpp 57.9 43.97 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.704 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.66 -16.79 61.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.44 111.6 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.18 25.45 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.44 111.166 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.44 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.44 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.44 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.44 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.44 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.44 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.44 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.44 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.667 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.44 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.667 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.44 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.44 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.44 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.44 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.626 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.44 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.44 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.44 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.44 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.44 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.44 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.44 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.44 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.44 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.44 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.783 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CG ' ' H1 ' ' A' 5134 ' ' HOH . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.44 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.639 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.44 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.44 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.44 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.44 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.44 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.44 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.58 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.44 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.44 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.793 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.44 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.44 109.19 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.512 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.44 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.44 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.44 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.44 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.44 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.44 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.44 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.44 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.44 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.44 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CZ3' ' CD1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.44 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.793 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.44 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.701 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.44 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.44 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.44 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.44 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.44 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.44 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.44 110.763 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.44 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.44 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.44 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.44 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.44 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.44 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.44 112.115 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.44 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.44 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.44 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.599 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.44 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.512 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.44 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.44 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.44 112.182 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.44 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.44 110.727 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.44 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.44 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.44 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.201 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.44 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.44 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.44 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.532 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.44 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.44 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.44 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.44 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.44 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.44 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.44 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' LEU . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.44 111.264 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.44 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.44 111.389 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.406 " C3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5133 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5134 ' ' HOH . . . . . 0.591 ' H2 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.82 0.343 . . . . 0.44 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.0 111.02 22.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.972 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.42 158.33 44.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.44 110.476 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.443 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.44 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.44 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 4' ' ' LEU . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.44 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 37' ' ' GLY . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.44 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.44 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.44 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.44 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.496 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.44 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.44 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.44 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.44 111.655 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.44 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.44 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.542 HG21 ' C ' ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.44 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.44 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.44 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.44 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' CB ' HD11 ' A' ' 33' ' ' LEU . 6.7 tmm_? -120.42 118.08 29.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.44 111.253 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 48.44 26.8 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.44 111.447 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 50.76 27.03 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.44 111.406 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 82.16 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.29 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.64 130.27 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.44 110.93 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.5 -164.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.085 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.17 -173.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.908 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -58.06 110.21 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.948 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.33 62.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.44 111.337 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.95 31.24 2.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.424 -0.353 . . . . 0.44 111.017 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.44 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.44 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.44 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.44 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.44 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.44 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.44 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.44 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.61 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.44 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.61 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.44 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.44 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.44 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.44 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.44 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.44 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.44 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.44 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.44 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.44 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.44 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.594 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.44 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.44 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.573 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.44 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.44 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.44 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.44 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.553 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.44 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.44 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.44 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.44 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.44 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.44 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.44 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.44 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.44 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.44 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.44 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.44 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.44 109.59 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.44 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.44 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.465 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.44 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.44 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.876 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.44 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.44 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.44 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.44 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.44 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.62 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.44 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.44 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.44 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.44 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.44 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.44 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.44 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.44 110.496 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.44 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.428 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.44 112.079 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.44 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.44 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.44 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.44 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.44 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.44 111.25 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.81 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.44 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 ' CD1' ' CD2' ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.44 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.44 112.209 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.44 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.729 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.44 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.44 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.44 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.44 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.519 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.44 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.44 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.44 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.44 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.44 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.44 110.985 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.44 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.44 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.44 111.38 179.271 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5145 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5146 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.769 0.319 . . . . 0.44 111.276 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -110.04 134.84 51.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.417 . . . . 0.44 110.842 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.74 140.18 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.44 110.715 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 6' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.44 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.44 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.44 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.44 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.44 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.44 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.755 ' HB ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.44 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.889 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.44 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.44 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.44 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.44 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.44 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.44 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.44 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.889 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.44 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.44 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.44 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.44 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -105.25 83.94 2.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.44 110.829 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 25' ' ' ALA . 2.4 mtt180 54.59 22.05 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.44 111.166 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.83 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.493 -0.321 . . . . 0.44 111.15 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -125.83 -60.79 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.37 -0.377 . . . . 0.44 110.853 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.78 178.15 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.44 110.924 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.55 102.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.414 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.06 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.355 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.5 mtp 58.75 29.95 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.44 110.979 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.81 -21.22 34.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.526 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 27.18 4.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.537 -0.301 . . . . 0.44 111.228 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.44 111.519 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.678 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.44 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' CG ' ' CG ' ' A' ' 116' ' ' PRO . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.44 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.44 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.44 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.44 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.44 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.691 ' HD2' ' H2 ' ' A' 5158 ' ' HOH . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.44 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.727 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.44 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.44 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.44 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.44 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.573 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.44 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.44 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.44 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.44 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.44 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.727 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.44 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.44 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.44 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.47 HD13 ' CE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.44 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.44 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.44 111.076 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.44 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.627 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.44 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.44 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.44 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.44 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.44 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.44 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.571 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.2 t-160 -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.44 110.69 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.44 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.44 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.44 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.44 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.44 111.011 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.44 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.44 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.44 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.44 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.44 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.44 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.44 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.44 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.44 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.44 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.655 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.729 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.44 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.44 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.44 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.44 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.44 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.598 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.44 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.44 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.44 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.44 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.546 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.44 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.44 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.44 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.44 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.44 112.001 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.44 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.44 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.44 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.458 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.44 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.273 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.44 112.298 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.44 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.44 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.44 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.44 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.355 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.44 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.44 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.44 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.44 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.053 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.44 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.511 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.44 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.44 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.536 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.44 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.44 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.44 111.558 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.44 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.44 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.44 111.523 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5157 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5158 ' ' HOH . . . . . 0.691 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.872 0.368 . . . . 0.44 111.19 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -95.34 102.77 14.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.44 110.94 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -79.24 158.45 27.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.508 . . . . 0.44 110.633 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 80' ' ' ILE . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.44 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.44 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 HG12 " O3'" ' A' ' 131' ' ' 8OG . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.44 107.965 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.44 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.44 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.44 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.44 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.44 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.44 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.44 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.44 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.44 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.44 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.44 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.44 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.44 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.44 109.06 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.44 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -133.33 124.88 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.44 111.56 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' ALA . 7.6 mtt180 60.86 14.11 4.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.44 111.763 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 45.99 -89.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.774 0.287 . . . . 0.44 111.774 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.99 -52.74 0.47 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.847 0.356 . . . . 0.44 110.93 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.1 129.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.974 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.29 39.91 21.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.44 111.154 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -131.28 -176.47 4.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.803 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 mtm -51.14 94.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.44 110.992 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -86.47 -27.12 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.44 111.364 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.46 17.23 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.333 . . . . 0.44 111.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.44 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.78 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.44 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.44 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.44 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.44 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.44 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.44 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.44 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.44 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.44 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.44 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.44 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.44 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.44 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.44 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.44 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.44 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.44 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.44 111.213 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.44 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.44 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.44 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.44 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.44 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.44 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.44 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.44 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.44 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.44 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.44 104.993 175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.44 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.44 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.44 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.44 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.44 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.44 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.44 109.746 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.44 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.44 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.44 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.44 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.44 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.44 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.44 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.659 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.44 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.44 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.44 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.44 110.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.44 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.439 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.44 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.44 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.44 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.44 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.44 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.44 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.44 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.44 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HB3' HG21 ' A' ' 61' ' ' THR . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.44 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.44 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.44 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.44 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.44 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.44 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.44 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.261 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.288 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.44 111.811 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.44 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.44 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.44 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.44 110.483 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.44 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.44 110.89 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.44 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.44 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.44 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.44 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.44 113.106 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.44 112.11 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.44 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.535 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.44 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.44 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.44 110.563 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.44 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.44 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.44 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.44 111.611 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.44 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.44 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.44 111.35 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.408 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5169 ' ' HOH . . . . . 0.507 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5170 ' ' HOH . . . . . 0.481 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.44 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -102.88 117.11 33.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.44 110.996 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -140.4 134.48 30.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.865 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.44 110.349 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.44 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.44 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.44 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.44 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.44 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.44 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.679 ' C ' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.44 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' O ' ' CE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.44 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.664 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.44 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.44 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.44 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.44 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.44 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.679 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.44 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.44 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.44 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.44 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -129.11 146.91 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.073 -179.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 3.8 ptp85 35.98 -106.82 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.814 -0.63 . . . . 0.44 110.997 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 159.43 47.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.937 0.398 . . . . 0.44 110.376 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 72.5 24.83 2.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.44 111.014 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.74 141.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.44 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.62 -158.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.44 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.73 -61.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.44 111.097 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 16.8 mtm -96.95 37.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.44 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -8.87 27.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.44 111.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.39 22.36 2.19 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.44 111.793 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.44 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.44 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.44 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.44 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.44 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.44 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.44 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.44 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.44 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.44 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.44 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.44 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.631 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.44 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.631 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.44 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.44 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.44 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.44 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.44 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.44 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.44 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.44 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.44 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.44 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.44 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.44 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.44 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.44 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.44 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.644 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.44 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.44 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.44 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.44 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.44 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.44 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.44 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.44 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.44 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.44 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.44 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.44 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.44 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.44 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.908 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.44 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.44 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.44 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.44 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.639 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.44 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.44 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.44 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.44 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.44 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.664 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.44 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.44 110.778 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.44 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.583 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.44 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.44 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.44 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.44 111.396 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.44 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.44 112.223 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.44 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.44 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.44 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.596 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.44 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.44 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 110' ' ' LEU . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.44 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' CD2' HD13 ' A' ' 123' ' ' ILE . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.44 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.44 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.44 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.44 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.44 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.44 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.44 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.44 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.44 111.277 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.44 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.44 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.44 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 129' ' ' LEU . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.44 111.579 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 123' ' ' ILE . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.44 111.434 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.401 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5181 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5182 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.876 0.37 . . . . 0.44 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -74.01 113.32 11.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.842 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.27 134.96 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.44 110.862 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.44 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HB ' ' CD2' ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.44 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.44 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.44 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.71 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.44 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.576 ' O ' ' CB ' ' A' ' 18' ' ' ILE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.44 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.44 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.44 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.499 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.44 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.44 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.44 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.44 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.576 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.44 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.44 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' HG2' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.44 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.44 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 11.1 ttm105 -134.02 150.53 51.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.44 111.502 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -102.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.706 -0.679 . . . . 0.44 111.778 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 173.19 46.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.44 110.967 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 70.24 16.29 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.568 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.98 -86.55 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.657 -0.247 . . . . 0.44 110.855 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 177.68 38.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.792 0.33 . . . . 0.44 111.102 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.72 129.87 54.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.976 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mtm 67.93 47.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.955 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -17.34 62.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.05 -0.523 . . . . 0.44 111.399 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -6.38 45.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.44 111.37 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.44 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.44 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.44 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.44 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.44 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.44 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.44 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.704 ' CD ' ' H1 ' ' A' 5193 ' ' HOH . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.44 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.586 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.44 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.44 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.44 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.44 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.617 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.44 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.44 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.44 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.44 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.44 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.44 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.44 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.44 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.44 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.44 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.633 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.44 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.44 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.44 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.44 108.945 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.44 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.44 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.4 t-160 -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.44 109.545 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.44 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.81 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.44 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.799 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.44 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.44 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.44 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.44 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.44 110.823 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.44 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.44 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.44 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.44 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.44 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.44 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' CD2' ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.44 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.488 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.44 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.44 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.81 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.44 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.44 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.44 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.44 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.44 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.674 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.44 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.44 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.44 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.495 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.44 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.44 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.633 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.44 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.44 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.018 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.44 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.44 111.67 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.44 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.44 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.44 110.647 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.44 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' HG13 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.44 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.44 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.44 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.44 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.44 110.312 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.44 112.704 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.44 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.44 111.342 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.44 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.44 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.44 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.44 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.35 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.44 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.44 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.435 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.44 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' LYS . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.44 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.44 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.44 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.44 110.777 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.44 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.44 111.403 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.41 " H2'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5193 ' ' HOH . . . . . 0.704 ' H1 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5194 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.806 0.336 . . . . 0.44 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.09 130.12 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.975 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -137.09 158.12 45.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.737 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.44 110.494 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.547 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.44 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.44 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.44 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.44 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.44 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.663 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.44 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.496 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.44 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.44 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.566 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.44 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.44 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.44 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.44 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.44 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.663 HG12 HG12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.44 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.44 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.44 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.32 141.42 50.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.44 111.583 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 60.08 12.93 3.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.793 -0.64 . . . . 0.44 111.35 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' CB ' ' CE1' ' A' ' 28' ' ' HIS . . . 63.37 -66.65 0.1 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.773 0.32 . . . . 0.44 111.62 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . 75.05 29.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.682 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.21 -73.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.009 -0.541 . . . . 0.44 110.837 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.51 36.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.582 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' CE1' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -137.42 -176.33 4.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.954 0.406 . . . . 0.44 111.111 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.56 155.71 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 0.44 111.625 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.16 -8.78 56.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.44 111.496 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.55 31.47 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.542 -0.299 . . . . 0.44 111.282 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.44 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.785 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.44 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.44 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.44 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.44 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.44 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.44 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.44 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.58 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.44 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.44 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.44 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.44 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.44 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.584 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.44 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.44 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.44 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.44 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.44 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.44 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.44 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.44 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' CG1' HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.44 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.567 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.44 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.44 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.609 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.44 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.44 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.44 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.44 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.44 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.44 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.44 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.44 109.809 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.44 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.44 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.44 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.44 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.44 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.44 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.44 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.44 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.44 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.44 109.615 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.44 110.674 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.44 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.44 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.44 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.44 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.44 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.44 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.44 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.609 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.44 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.44 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.44 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.44 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.44 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.44 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.44 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.44 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.44 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 47.0 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.44 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.44 112.901 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.44 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.44 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.44 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.489 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.44 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.122 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.44 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.44 112.159 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.44 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.44 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.44 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.44 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.44 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.44 111.55 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.785 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.44 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.44 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.44 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.44 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.44 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.44 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.44 111.174 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.44 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.44 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.44 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 129' ' ' LEU . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.44 111.313 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.44 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.44 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.44 111.527 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5205 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5206 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.81 0.338 . . . . 0.44 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -110.07 129.88 55.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.44 110.961 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 158.0 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.44 110.615 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.44 110.316 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.44 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.44 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.44 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.593 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.44 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.44 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.723 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.44 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.895 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.44 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.539 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.44 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.44 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.44 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.44 108.792 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.895 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.44 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.44 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.44 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.44 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 -124.7 126.71 46.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.472 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 43.75 26.7 0.14 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.849 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 100' ' ' GLN . . . 47.1 28.48 0.94 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.726 0.298 . . . . 0.44 111.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.96 27.03 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.44 111.03 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -165.47 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.837 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.76 95.53 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -144.46 -78.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.744 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -139.18 101.94 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.44 110.713 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.63 -12.7 61.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.44 111.789 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.56 25.22 5.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.643 0.259 . . . . 0.44 111.171 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.44 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.44 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.44 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.44 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.44 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.44 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.44 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.44 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.589 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.44 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.44 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.44 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.44 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.596 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.44 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.596 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.44 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.44 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' C ' ' HB ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.44 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG12 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.44 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.44 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.44 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.44 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.44 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.44 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.618 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.44 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.44 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.44 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.44 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.44 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.44 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.63 ' HA ' HG12 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.44 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.44 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.44 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.95 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.44 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.44 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.44 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.44 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.44 111.612 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.44 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.44 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.44 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.44 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.44 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.44 110.829 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.44 109.115 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.44 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.44 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.44 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.44 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.95 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.44 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.44 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.44 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.44 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.44 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.44 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.44 110.717 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.44 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.44 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.618 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.44 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.44 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.44 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.44 112.068 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.44 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.44 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.44 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.416 ' CG ' HG13 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.44 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.497 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.44 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.44 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.44 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.44 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.44 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.465 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.44 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.44 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.44 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.44 112.453 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.44 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 115' ' ' PHE . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.44 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.44 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.44 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.359 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 127' ' ' LYS . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.44 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.44 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.44 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.44 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.44 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.44 111.502 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5217 ' ' HOH . . . . . 0.467 ' H2 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 5218 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.44 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.13 102.8 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.44 110.855 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.26 138.23 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.747 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.44 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.44 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 HD12 " O3'" ' A' ' 131' ' ' 8OG . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.44 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.44 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.44 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.44 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.764 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.44 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.772 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.44 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.44 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.685 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.44 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.44 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.44 112.786 -178.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.44 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.44 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.772 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.44 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD2' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.44 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.516 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.44 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.44 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.22 95.61 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.44 111.487 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 63.83 9.78 4.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.44 112.008 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HA ' ' CB ' ' A' ' 100' ' ' GLN . . . 63.28 11.13 5.17 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.105 0.409 . . . . 0.44 112.105 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.26 30.22 0.28 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.683 0.253 . . . . 0.44 111.683 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.99 13.21 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.44 111.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.88 98.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.44 111.288 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -175.2 -68.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.893 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 tpp -118.11 87.43 2.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.947 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.25 -20.02 64.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.44 111.27 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.52 31.2 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.058 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.44 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' LYS . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.44 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.516 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.44 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.44 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.44 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.44 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.44 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.517 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.44 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.44 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.604 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.44 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.44 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.44 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.44 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.44 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.44 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.44 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.44 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.44 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.665 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.44 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.44 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.668 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.44 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.44 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.44 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 13.0 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.44 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.605 ' HA ' HG13 ' A' ' 87' ' ' VAL . 2.2 t-160 -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.44 109.869 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.44 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.44 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 82' ' ' LEU . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.44 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.44 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.44 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.44 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.44 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.44 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.44 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 9.8 m-70 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.44 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.44 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.44 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.44 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.44 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.44 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.44 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.764 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.44 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.44 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.44 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.44 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.44 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.44 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.44 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.546 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.44 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.665 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.44 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.44 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.44 110.878 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.44 113.842 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' O ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.44 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.44 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.44 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.44 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.44 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.448 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.44 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 111.282 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 110' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.44 112.43 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.44 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.44 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.44 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.44 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.44 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.44 111.132 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.7 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.44 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.44 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.44 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.44 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.44 111.107 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.44 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.44 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.44 112.009 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.44 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.44 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.44 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.44 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.44 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.44 111.436 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.412 " O3'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5229 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5230 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.842 0.353 . . . . 0.44 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.0 117.62 34.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.942 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -140.12 158.32 44.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.502 . . . . 0.44 110.444 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.44 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.44 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.44 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.44 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.44 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.44 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.44 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.44 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.44 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.44 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.44 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.44 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.44 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.765 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.44 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.44 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.44 109.1 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.44 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -121.95 117.56 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.44 110.856 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.01 28.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.107 -0.497 . . . . 0.44 111.339 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 50.52 -167.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.44 111.23 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.89 -30.51 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.44 111.054 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.08 42.83 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.006 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.1 140.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.44 111.268 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.49 -75.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.101 -0.5 . . . . 0.44 110.684 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.32 102.42 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.849 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.29 -24.2 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.44 111.432 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.63 27.99 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.142 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.44 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' THR . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.44 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.44 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.44 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.712 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.44 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.44 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.44 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.44 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.604 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.44 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.44 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.44 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.44 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.44 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.627 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.44 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.44 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.44 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.44 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' C ' ' HB ' ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.44 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.44 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.44 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.44 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.524 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.44 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.44 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.44 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.44 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.56 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.44 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.44 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.595 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.44 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.488 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.44 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.44 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.6 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.44 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.44 112.133 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.44 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.952 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.44 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.44 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.693 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.44 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.44 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.44 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.44 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.44 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.44 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.44 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.44 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.44 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.8 m170 -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.44 110.753 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.44 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.44 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.44 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.44 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.952 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.44 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG21 ' CD2' ' A' ' 64' ' ' HIS . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.44 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.44 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.44 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.44 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' CB ' HG23 ' A' ' 61' ' ' THR . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.44 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.44 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.44 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.469 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.44 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.44 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.44 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.44 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.44 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.44 111.755 -179.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.44 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.44 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.44 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.44 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.44 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 110' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.44 112.297 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.44 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.44 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.44 112.886 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.44 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.44 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.44 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.44 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.44 112.471 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.44 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.536 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.44 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.44 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.44 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.44 110.913 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.584 HG13 ' CE2' ' A' ' 115' ' ' PHE . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.44 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.44 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.44 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.44 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 123' ' ' ILE . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.44 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.44 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.478 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.451 " O3'" ' CD1' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5241 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5242 ' ' HOH . . . . . 0.517 ' H2 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.719 0.295 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.431 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.633 ' CG2' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.0 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.0 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.717 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.622 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.0 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.0 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.063 HG23 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' HG3' ' A' ' 98' ' ' GLU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB2' HD13 ' A' ' 33' ' ' LEU . 1.7 tmm_? . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.0 110.959 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 20' ' ' ILE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.0 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.0 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.0 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.0 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.0 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.592 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.0 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.0 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.0 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.0 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.921 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.048 HG12 HG13 ' A' ' 60' ' ' ILE . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.0 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.048 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.0 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.87 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.0 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.921 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HB2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.822 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.0 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.0 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.04 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.792 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.0 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD23 ' CG2' ' A' ' 6' ' ' ILE . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.0 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.452 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' CE2' HG11 ' A' ' 50' ' ' VAL . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.753 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.0 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.717 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.579 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.589 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 21' ' ' THR . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.0 111.479 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.0 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.727 ' CG ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.0 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.451 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.063 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.809 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.1 m-20 -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.531 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.0 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.686 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.0 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.71 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.814 0.34 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.0 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.0 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.808 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.737 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.0 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.0 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HD2' HD12 ' A' ' 33' ' ' LEU . 1.1 ttp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.0 111.668 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.847 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.0 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HG3' HD11 ' A' ' 11' ' ' ILE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.0 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.0 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.0 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.0 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.0 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.0 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.0 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.704 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.0 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.911 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.0 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.666 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.0 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.83 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.789 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.0 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.712 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.0 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.0 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.685 HD13 ' OD1' ' A' ' 119' ' ' ASN . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.0 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.0 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.0 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.737 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.0 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.0 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.646 ' HE1' HG23 ' A' ' 60' ' ' ILE . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.0 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.0 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 9.9 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.0 112.165 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.0 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.615 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.966 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.434 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.837 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.768 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.847 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 34' ' ' GLU . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.0 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.0 111.439 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.685 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.0 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.0 111.415 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.432 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.664 0.269 . . . . 0.0 110.752 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.0 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 7.2 t30 -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.0 113.504 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.0 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.029 HD11 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.0 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.646 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 111.904 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.775 0.321 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.0 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.0 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.0 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.0 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.0 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.0 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.0 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.0 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.843 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.926 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.926 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.662 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.0 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.843 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.0 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' N ' HD22 ' A' ' 71' ' ' LEU . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.145 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.0 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.0 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 4' ' ' LEU . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.811 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 86' ' ' LEU . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.0 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.0 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.721 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.0 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.0 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.542 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.662 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.0 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.0 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.0 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.891 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.566 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 107' ' ' LEU . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.93 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.598 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.767 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.0 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.0 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.0 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.0 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.0 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.0 111.265 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.413 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 78' ' ' ARG . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.0 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.803 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.004 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.0 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.781 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.8 t30 -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.0 113.021 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.0 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.0 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.76 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.538 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.691 0.281 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.0 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 20' ' ' ILE . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' THR . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.659 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.0 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.0 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.0 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.004 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.0 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.0 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.958 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.958 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.0 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.865 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.0 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.182 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.0 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.0 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.904 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.0 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.182 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.0 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.614 ' N ' HD22 ' A' ' 71' ' ' LEU . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.305 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.0 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HD3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.3 m-70 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 HD11 ' A' ' 4' ' ' LEU . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.0 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 71' ' ' LEU . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.0 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.873 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.0 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.0 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.635 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.0 112.228 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.459 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.953 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.4 m-20 -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.219 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.0 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.0 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.693 ' OD1' HD22 ' A' ' 82' ' ' LEU . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.567 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.0 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.788 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.0 110.773 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.398 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.726 0.298 . . . . 0.0 110.76 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.682 ' O ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.833 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.0 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.14 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.0 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.0 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.807 HG22 ' CE2' ' A' ' 35' ' ' PHE . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.805 HD12 ' CE2' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.634 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.0 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.0 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.0 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.805 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 113' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.783 ' HG3' HD11 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.0 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.0 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.0 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.14 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.0 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.0 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.0 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.841 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.868 HD11 ' NE2' ' A' ' 64' ' ' HIS . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.89 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.0 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.89 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.605 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.0 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.0 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.636 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.853 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.0 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.0 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.0 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 ' OD1' ' A' ' 119' ' ' ASN . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.841 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.0 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.0 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.735 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.0 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.0 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.603 ' O ' HG22 ' A' ' 21' ' ' THR . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 112.012 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.0 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.427 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD13 HD22 ' A' ' 107' ' ' LEU . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.026 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.0 112.367 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.0 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.772 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.834 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.0 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.0 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.88 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.62 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.372 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.77 HD23 ' CD ' ' A' ' 78' ' ' ARG . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.0 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.983 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 119' ' ' ASN . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.858 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.0 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.0 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.005 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.0 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.743 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.809 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -179.072 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.0 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' HD11 ' A' ' 11' ' ' ILE . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.0 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.0 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.0 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.983 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.0 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.942 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.769 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.127 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 60' ' ' ILE . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.0 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.0 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.127 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.111 -176.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' HD11 ' A' ' 67' ' ' LEU . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.0 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.0 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.0 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.77 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.65 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.801 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.0 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.742 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.0 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.0 110.637 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.706 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.0 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.702 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.687 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.0 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.0 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.61 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.691 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD21 HD13 ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.576 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.818 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.0 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.0 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 8' ' ' VAL . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.642 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.0 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.0 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.576 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.414 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.302 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.482 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.0 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.93 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.875 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.97 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 8.1 t30 -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.0 113.472 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.0 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.359 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.0 112.081 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.0 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.0 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.0 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.017 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.0 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.0 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.978 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.978 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.0 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.976 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.0 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.95 HG12 HG13 ' A' ' 60' ' ' ILE . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.0 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.0 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.95 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.835 ' HG3' HG11 ' A' ' 58' ' ' VAL . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.0 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.748 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.925 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.844 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.0 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.753 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 80' ' ' ILE . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.501 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.0 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.765 HD12 HD11 ' A' ' 4' ' ' LEU . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.0 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.908 HD23 ' CG2' ' A' ' 122' ' ' VAL . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.0 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.822 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 10' ' ' ILE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.0 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.678 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.0 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.0 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.364 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 21' ' ' THR . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.0 111.865 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.0 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.0 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.0 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.867 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.0 112.705 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.0 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.54 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.0 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.908 ' CG2' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.0 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.0 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.429 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.754 0.312 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.278 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.603 ' C ' HD12 ' A' ' 6' ' ' ILE . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.0 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.611 ' CG2' HD23 ' A' ' 82' ' ' LEU . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.0 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.798 HD21 ' HH2' ' A' ' 90' ' ' TRP . 14.2 p30 -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.0 111.693 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.66 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.707 0.289 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.0 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.0 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HG3' HD11 ' A' ' 11' ' ' ILE . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.0 111.765 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.0 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.0 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.0 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.019 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.0 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.0 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.951 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.0 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.939 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.0 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.162 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.0 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.909 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.0 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.0 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.162 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.0 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 HD12 ' A' ' 82' ' ' LEU . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.0 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.0 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.0 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 4' ' ' LEU . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.63 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.763 HD12 HD23 ' A' ' 71' ' ' LEU . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.924 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.0 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.0 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.798 ' HH2' HD21 ' A' ' 13' ' ' ASN . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.0 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.0 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.626 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 112.254 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.0 112.504 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.748 ' HB3' HD22 ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.555 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 10' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.967 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.0 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.967 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.0 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.0 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.533 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.594 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.0 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.0 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 110' ' ' LEU . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.0 111.317 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.454 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.703 0.287 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 80' ' ' ILE . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.988 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.0 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.709 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.779 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.0 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.706 ' HD3' HD22 ' A' ' 33' ' ' LEU . 57.8 ttp180 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.0 111.511 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.724 0.297 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD22 ' HD3' ' A' ' 22' ' ' ARG . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.714 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.0 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.0 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.0 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.988 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.0 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.0 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.0 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.0 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.0 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.0 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.021 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.021 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.0 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.954 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.0 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.029 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.888 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.0 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.0 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.562 ' NE2' HG23 ' A' ' 81' ' ' THR . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.562 HG23 ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.0 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.029 HG22 ' ND1' ' A' ' 64' ' ' HIS . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.0 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.0 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.621 ' NE1' HG23 ' A' ' 60' ' ' ILE . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.987 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.0 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.0 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.496 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 123' ' ' ILE . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.0 110.739 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.817 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.0 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.557 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.576 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.742 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.577 ' HB2' HD22 ' A' ' 71' ' ' LEU . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.0 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.817 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.0 111.014 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.806 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.32 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.744 0.307 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.879 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.556 ' C ' HD12 ' A' ' 6' ' ' ILE . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.0 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.753 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.97 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.0 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.021 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.807 HG21 HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.726 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.776 ' HB2' HD13 ' A' ' 33' ' ' LEU . 8.9 ttp85 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.458 0.171 . . . . 0.0 111.452 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 22' ' ' ARG . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.0 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.0 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.0 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.0 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.94 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.0 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.0 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 40' ' ' ILE . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.023 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.0 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.0 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.0 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.897 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.0 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.023 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.364 -176.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 82' ' ' LEU . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.0 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 71' ' ' LEU . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.0 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.582 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.809 HG22 ' CE1' ' A' ' 64' ' ' HIS . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.0 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.686 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.452 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.0 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.97 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' A' ' 107' ' ' LEU . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.0 110.804 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.903 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.649 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.0 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.225 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.0 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.587 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.0 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.0 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.649 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.561 0.22 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.673 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.965 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.0 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.0 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.671 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.0 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.775 ' ND2' ' HB3' ' A' ' 104' ' ' TRP . 6.7 p30 -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.0 111.81 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.263 -178.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.0 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.726 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.787 HD11 HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.705 0.288 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 20' ' ' ILE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.0 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.0 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.0 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.0 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.0 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.965 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.0 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.693 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.0 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.0 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.0 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.0 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.0 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.955 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 60' ' ' ILE . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.0 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.913 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.0 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.0 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.955 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HB3' HD11 ' A' ' 67' ' ' LEU . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.0 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.643 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.0 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.707 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.0 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.796 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.94 ' CE2' HG11 ' A' ' 50' ' ' VAL . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.76 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.0 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.765 ' HH2' HD21 ' A' ' 13' ' ' ASN . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.0 110.763 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.0 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.0 112.115 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.0 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.775 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.0 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 107' ' ' LEU . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.727 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.0 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.0 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 112' ' ' ALA . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.0 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 111.264 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.389 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 80' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' ILE . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.0 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 5' ' ' GLN . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.0 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.0 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.0 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.779 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.0 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 18' ' ' ILE . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.0 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.0 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG21 HG22 ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.776 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.708 ' HG3' HD13 ' A' ' 33' ' ' LEU . 6.7 tmm_? . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 20' ' ' ILE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' THR . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.0 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.0 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.0 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.0 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.96 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.96 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.0 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.85 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.0 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 60' ' ' ILE . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.0 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.818 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.0 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.0 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.85 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.0 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.0 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.0 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.0 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 4' ' ' LEU . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.614 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.913 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.0 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.0 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.0 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.0 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.0 112.079 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.0 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.773 ' HG2' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.644 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.25 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.867 HD23 HD13 ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.867 HD13 HD23 ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.0 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.0 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.0 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.0 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.0 110.985 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.575 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.38 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.641 0.257 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 80' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.865 ' CB ' HG21 ' A' ' 40' ' ' ILE . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.0 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.0 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.018 HG22 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.914 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.0 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.0 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.934 HG22 ' O ' ' A' ' 34' ' ' GLU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.829 -179.713 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.519 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HG22 ' A' ' 21' ' ' THR . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.0 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.0 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.0 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.0 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.865 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.0 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.0 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.892 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.892 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.966 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.0 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.686 ' CB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.675 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.0 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.076 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 60' ' ' ILE . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.0 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.0 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.813 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.69 -175.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.0 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.011 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.0 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.705 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.0 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 4' ' ' LEU . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.0 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 71' ' ' LEU . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.0 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.0 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.0 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.745 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.0 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.0 112.001 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.0 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.0 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.664 ' HB2' HG12 ' A' ' 108' ' ' VAL . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.921 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.355 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.67 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.0 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.0 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.647 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.0 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 71' ' ' LEU . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.752 ' HE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.558 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 125' ' ' LYS . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.64 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.523 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.701 0.286 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.0 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.0 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.728 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.0 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.927 HD11 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.0 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.927 HG23 HD11 ' A' ' 18' ' ' ILE . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HG3' HD12 ' A' ' 33' ' ' LEU . 18.9 ttt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.0 111.56 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.582 0.23 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.0 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HD2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.0 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.0 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.0 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.0 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.213 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.0 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.0 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.867 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.0 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.0 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 70' ' ' LYS . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.0 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.0 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.0 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.0 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.733 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.0 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 60' ' ' ILE . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.0 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.607 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.261 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.288 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.811 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.0 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.0 110.483 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD13 HD22 ' A' ' 107' ' ' LEU . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.0 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 113.106 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.0 112.11 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.558 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 71' ' ' LEU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.0 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.0 110.563 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 126' ' ' LEU . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.0 111.611 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.588 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.35 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 79' ' ' HIS . 9.3 ptpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.699 0.285 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 6' ' ' ILE . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.349 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.0 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.93 HD11 HD12 ' A' ' 4' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.0 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.781 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.672 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.0 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.85 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.073 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.0 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.0 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.781 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.0 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.0 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.0 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.053 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.0 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.955 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.955 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.0 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.937 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.0 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.177 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG12 HG13 ' A' ' 60' ' ' ILE . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.0 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.043 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.918 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.0 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.177 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.0 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.0 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.0 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.0 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.908 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.0 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.846 HD12 HD23 ' A' ' 71' ' ' LEU . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.0 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.753 ' CE2' HG11 ' A' ' 50' ' ' VAL . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.0 110.778 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.0 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.396 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 21' ' ' THR . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.0 112.223 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.0 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.0 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.611 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.667 ' CD1' HD13 ' A' ' 110' ' ' LEU . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 107' ' ' LEU . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.671 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.0 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.0 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.495 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HB2' HD22 ' A' ' 71' ' ' LEU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.0 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.0 111.277 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.0 111.579 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.577 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.434 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.775 0.322 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' O ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.0 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.884 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.116 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.0 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.701 HD12 ' CE2' ' A' ' 19' ' ' PHE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.517 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.0 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.99 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.0 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.871 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.799 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.1 ttm105 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.0 111.502 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.52 0.2 . . . . 0.0 111.37 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 22' ' ' ARG . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.0 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.0 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.0 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.0 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.116 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.0 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.0 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.953 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.0 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.756 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.879 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.0 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.903 HG11 ' HG3' ' A' ' 62' ' ' PRO . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.0 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.483 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.0 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.837 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.545 -176.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.817 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.802 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.0 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.808 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.0 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.823 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.0 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD23 ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.681 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.879 ' CE2' HG11 ' A' ' 50' ' ' VAL . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.0 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.837 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.0 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.0 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.651 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.799 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.018 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.0 111.67 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.0 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.0 110.647 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.0 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.871 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.807 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.342 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.0 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.0 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.588 HD22 HG11 ' A' ' 8' ' ' VAL . 1.4 m-20 -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.35 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.572 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.0 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.808 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.0 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 110.777 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.765 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.403 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.613 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.494 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.0 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.067 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.0 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.892 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.0 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.0 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.951 HD11 HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.0 111.583 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.698 0.285 . . . . 0.0 111.282 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.0 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.0 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.067 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.0 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.935 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.935 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.0 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.0 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.961 HG12 HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.617 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.961 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.0 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.0 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 70' ' ' LYS . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.841 ' HD2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.0 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.0 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.0 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.615 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.0 110.674 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 ' OD1' ' A' ' 119' ' ' ASN . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.789 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.892 HG11 HG23 ' A' ' 11' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.0 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.0 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.643 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.0 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.671 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 26.3 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.0 112.901 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.74 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.0 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.772 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.0 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.994 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.55 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.0 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.0 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.66 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.813 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.0 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.0 111.174 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.694 ' CG2' HD11 ' A' ' 110' ' ' LEU . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.313 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.527 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.699 0.285 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.594 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.316 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.0 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.718 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.06 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.0 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.639 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.0 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.833 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.915 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.543 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.0 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.915 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.472 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.0 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.833 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.0 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.0 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.0 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.0 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.06 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.0 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.616 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.0 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.0 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.967 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.967 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.0 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.965 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.0 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.714 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.108 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.0 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.908 ' HG3' HG11 ' A' ' 58' ' ' VAL . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.0 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.108 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.0 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.981 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.0 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.0 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.606 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.612 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.0 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 71' ' ' LEU . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.981 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 68' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.857 HG22 ' CG ' ' A' ' 64' ' ' HIS . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.0 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.0 110.717 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.0 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 112.068 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.0 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.0 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.427 ' SD ' HD12 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.804 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.0 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.0 112.453 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.609 HD21 HG11 ' A' ' 8' ' ' VAL . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.0 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.359 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.804 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.502 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.688 0.28 . . . . 0.0 110.747 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.753 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.0 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.0 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.949 HG22 ' CE2' ' A' ' 35' ' ' PHE . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.8 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.693 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 7.2 t-20 -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.0 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.8 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.787 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 34' ' ' GLU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.487 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 21' ' ' THR . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.949 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.0 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.0 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.0 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.0 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.918 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.918 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.0 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.944 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.0 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.0 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.0 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.815 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.869 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.803 HD21 ' HD3' ' A' ' 70' ' ' LYS . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.803 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.829 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.0 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.0 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.0 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 21.9 m80 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.0 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.76 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.944 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.0 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.815 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.0 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.0 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.0 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.0 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' OE2' HG22 ' A' ' 21' ' ' THR . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.842 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.662 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.0 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.787 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.0 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.597 ' OG ' HG12 ' A' ' 108' ' ' VAL . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.282 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.597 HG12 ' OG ' ' A' ' 106' ' ' SER . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.0 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.639 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.733 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.0 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.499 HD21 HG11 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.107 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.0 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 112.009 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.436 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 80' ' ' ILE . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.018 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.0 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.814 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.0 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.777 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.0 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.777 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.0 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 33' ' ' LEU . 3.9 ptt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.693 0.282 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 33' ' ' LEU . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.834 ' CE2' HD13 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.0 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.018 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.626 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.0 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.0 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.0 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.572 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.013 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.98 HG12 HG13 ' A' ' 60' ' ' ILE . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.98 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.0 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.0 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.0 112.133 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.702 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.934 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.0 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.0 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.0 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.753 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.702 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.982 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 11' ' ' ILE . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.0 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.69 ' O ' HG21 ' A' ' 60' ' ' ILE . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.0 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.0 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.0 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 21' ' ' THR . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.0 111.755 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.0 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.0 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 108' ' ' VAL . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.756 HD13 ' CD2' ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.0 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.0 112.471 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.561 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.0 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.0 110.913 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.844 HG22 ' HB2' ' A' ' 112' ' ' ALA . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.0 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.0 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.755 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.478 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.04 140.43 44.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -136.2 158.09 45.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.431 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.633 ' CG2' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.0 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.0 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.717 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.622 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.0 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.0 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.063 HG23 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' HG3' ' A' ' 98' ' ' GLU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB2' HD13 ' A' ' 33' ' ' LEU . 1.7 tmm_? -146.62 146.96 30.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 5.7 mtm180 51.21 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.561 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 82.51 36.94 0.06 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.291 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.35 82.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.377 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.49 88.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.44 -165.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -56.12 -57.08 13.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.4 mtt -145.41 135.4 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -8.98 58.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.437 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -95.11 31.13 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.959 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 20' ' ' ILE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.0 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.0 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.0 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.0 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.0 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.592 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.0 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.0 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.0 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.0 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.921 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.048 HG12 HG13 ' A' ' 60' ' ' ILE . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.0 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.048 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.0 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.87 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.0 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.921 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HB2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.822 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.0 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.0 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.04 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 110.954 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.792 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.0 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD23 ' CG2' ' A' ' 6' ' ' ILE . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.0 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.452 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' CE2' HG11 ' A' ' 50' ' ' VAL . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.753 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.0 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.717 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.579 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.589 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 21' ' ' THR . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.0 111.479 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.0 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.727 ' CG ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.0 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.451 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.063 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.809 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.1 m-20 -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.531 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.0 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.686 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.0 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.71 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.411 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.772 0.32 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 116.64 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 133.23 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.729 HD22 H2'' ' A' ' 131' ' ' 8OG . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.0 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 " O3'" ' A' ' 131' ' ' 8OG . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.0 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.808 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.737 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.0 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.0 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HD2' HD12 ' A' ' 33' ' ' LEU . 1.1 ttp180 -134.0 131.55 39.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.0 111.668 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 25.6 mtm105 56.13 16.31 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.045 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.28 -163.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.701 0.286 . . . . 0.0 111.443 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' A' ' 101' ' ' PRO . . . -118.43 -37.5 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.915 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -143.78 117.08 9.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 67.33 -159.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 68.87 173.14 0.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.981 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.5 146.59 34.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -87.14 -22.0 25.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.429 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -93.44 31.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.847 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.0 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HG3' HD11 ' A' ' 11' ' ' ILE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.0 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.0 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.0 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.0 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.0 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.0 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.0 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.704 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.0 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.911 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.0 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.666 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.0 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.83 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.789 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.0 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.712 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.0 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.0 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.685 HD13 ' OD1' ' A' ' 119' ' ' ASN . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.0 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.0 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.0 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.737 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.0 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.0 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.646 ' HE1' HG23 ' A' ' 60' ' ' ILE . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.0 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.0 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 9.9 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.0 112.165 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.0 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.615 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.966 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.434 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.837 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.768 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.847 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 34' ' ' GLU . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.0 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.0 111.439 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.685 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.0 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.0 111.415 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.432 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.764 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.22 107.08 13.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.21 139.02 35.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.908 HD11 " O3'" ' A' ' 131' ' ' 8OG . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.0 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 7.2 t30 -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.0 113.504 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.0 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.029 HD11 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.0 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.646 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -132.4 138.73 47.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 111.904 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 39.92 30.94 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.903 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . . . 49.98 -166.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.06 -29.94 62.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.001 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.74 -54.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.78 108.86 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -179.35 77.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.751 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.0 tpt 64.11 108.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.39 -20.76 36.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.391 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.62 31.1 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.0 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.0 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.0 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.0 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.0 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.0 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.0 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.0 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.843 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.926 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.926 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.0 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.843 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.0 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' N ' HD22 ' A' ' 71' ' ' LEU . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.145 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.0 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.0 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 4' ' ' LEU . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.811 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 86' ' ' LEU . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.0 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.0 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.721 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.0 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.0 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.542 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.662 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.0 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.0 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.0 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.891 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.566 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 107' ' ' LEU . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.93 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.598 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.767 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.0 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.0 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.0 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.0 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.0 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.0 111.265 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.413 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.908 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.756 0.312 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.74 137.95 44.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 158.0 44.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 78' ' ' ARG . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.0 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.803 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.004 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.0 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.781 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 10.8 t30 -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.0 113.021 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.0 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.0 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.76 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 -129.38 136.88 50.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.538 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.34 30.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.981 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 48.94 -168.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.444 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -96.54 -30.88 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.42 23.52 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.5 76.42 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.03 -70.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.7 ttt -113.55 100.03 8.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.15 -18.45 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.34 31.01 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.0 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 20' ' ' ILE . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' THR . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.659 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.0 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.0 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.0 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.004 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.0 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.0 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.958 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.958 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.0 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.865 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.0 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.182 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.0 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.0 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.904 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.0 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.182 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.0 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.614 ' N ' HD22 ' A' ' 71' ' ' LEU . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.305 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.0 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HD3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.3 m-70 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 HD11 ' A' ' 4' ' ' LEU . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.0 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 71' ' ' LEU . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.0 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.873 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.0 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.0 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.635 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.687 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.0 112.228 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.459 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 108' ' ' VAL . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.953 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.4 m-20 -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.219 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.0 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.0 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.693 ' OD1' HD22 ' A' ' 82' ' ' LEU . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.567 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.0 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.788 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.0 110.773 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.398 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.419 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.0 120.57 42.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.25 134.15 30.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.76 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.682 ' O ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.833 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.0 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.621 HD11 H2'' ' A' ' 131' ' ' 8OG . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.14 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.0 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.0 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.807 HG22 ' CE2' ' A' ' 35' ' ' PHE . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.805 HD12 ' CE2' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.634 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.0 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.0 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.0 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.805 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -117.19 88.98 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 30' ' ' ALA . 0.5 OUTLIER 57.01 21.58 6.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.163 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.35 -81.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.337 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.24 -69.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.23 143.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.008 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.36 36.84 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -134.47 -167.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 89.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 23' ' ' ARG . . . -72.63 -16.13 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 113' ' ' ASP . 0.9 OUTLIER -95.24 28.53 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.05 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.783 ' HG3' HD11 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.0 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.0 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.0 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.14 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.0 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.0 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.0 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.841 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.868 HD11 ' NE2' ' A' ' 64' ' ' HIS . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.89 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.0 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.89 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.605 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.0 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.0 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.636 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.853 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.0 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.0 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.0 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 ' OD1' ' A' ' 119' ' ' ASN . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.841 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.0 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.0 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.735 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.0 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.0 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.603 ' O ' HG22 ' A' ' 21' ' ' THR . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 112.012 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.0 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.427 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD13 HD22 ' A' ' 107' ' ' LEU . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.026 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.0 112.367 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.0 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.772 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.834 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.0 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.0 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.88 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.62 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.372 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.621 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 125.07 52.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? -137.94 153.21 49.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.77 HD23 ' CD ' ' A' ' 78' ' ' ARG . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.0 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.983 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 119' ' ' ASN . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.858 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.0 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.0 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.005 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.0 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.743 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.809 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -126.9 136.51 52.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ALA . 19.3 mtt180 51.73 22.94 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.627 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.36 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.633 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -149.24 71.14 1.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.844 0.354 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.56 126.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.78 -168.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 64.46 -172.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.17 101.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.332 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -87.15 -8.96 56.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.71 31.19 2.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.0 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' HD11 ' A' ' 11' ' ' ILE . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.0 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.0 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.0 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.983 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.0 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.942 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.769 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.127 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 60' ' ' ILE . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.0 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.0 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.127 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.111 -176.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' HD11 ' A' ' 67' ' ' LEU . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.0 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.0 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.0 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.77 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.65 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.801 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.0 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.742 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.0 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.0 110.637 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.706 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.0 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.702 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.687 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.0 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.0 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.61 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.691 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD21 HD13 ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.576 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.818 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.0 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.0 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 8' ' ' VAL . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.642 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.0 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.0 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.576 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.414 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.485 ' N7 ' ' HB2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.36 114.05 21.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.18 139.47 35.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.302 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.482 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.0 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.93 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.875 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.97 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 8.1 t30 -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.0 113.472 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.0 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -148.3 128.03 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.359 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' ALA . 1.5 mtt-85 42.72 28.59 0.13 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.613 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . . . 54.29 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.438 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -165.8 31.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.6 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 178.94 112.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.82 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mmt -92.55 51.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 110.864 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.3 66.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.46 13.49 15.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.426 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.0 112.081 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.0 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.0 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.0 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.017 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.0 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.0 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.978 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.978 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.0 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.976 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.0 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.95 HG12 HG13 ' A' ' 60' ' ' ILE . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.0 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.0 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.95 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.835 ' HG3' HG11 ' A' ' 58' ' ' VAL . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.0 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.748 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.925 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.844 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.0 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.753 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 80' ' ' ILE . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.501 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.0 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.765 HD12 HD11 ' A' ' 4' ' ' LEU . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.0 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.908 HD23 ' CG2' ' A' ' 122' ' ' VAL . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.0 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.822 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 10' ' ' ILE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.0 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.678 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.0 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.0 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.364 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 21' ' ' THR . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.0 111.865 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.0 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.0 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.0 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.867 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.0 112.705 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.0 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.54 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.0 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.908 ' CG2' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.0 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.0 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.429 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.575 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 147.25 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.43 155.2 50.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.765 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.278 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.603 ' C ' HD12 ' A' ' 6' ' ' ILE . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.0 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.689 HD11 H2'' ' A' ' 131' ' ' 8OG . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.0 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.798 HD21 ' HH2' ' A' ' 90' ' ' TRP . 14.2 p30 -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.0 111.693 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.66 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 -120.92 133.74 55.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.916 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 36.07 34.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.064 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 56.63 -164.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 111.118 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -97.63 29.07 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.06 -76.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.42 132.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.16 -65.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 mmt -133.14 92.02 2.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.648 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -62.43 -26.14 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -96.76 30.83 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.07 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.0 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.0 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HG3' HD11 ' A' ' 11' ' ' ILE . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.0 111.765 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.0 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.0 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.0 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.019 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.0 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.0 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.951 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.0 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.939 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.0 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.162 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.0 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.909 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.0 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.0 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.162 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.0 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 HD12 ' A' ' 82' ' ' LEU . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.0 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.0 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.0 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 4' ' ' LEU . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.63 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.763 HD12 HD23 ' A' ' 71' ' ' LEU . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.924 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.0 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.0 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.798 ' HH2' HD21 ' A' ' 13' ' ' ASN . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.0 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.0 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.626 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.0 112.504 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.748 ' HB3' HD22 ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.555 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 10' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.967 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.0 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.967 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.0 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.0 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.533 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.594 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.0 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.0 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 110' ' ' LEU . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.0 111.317 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.454 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.689 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.821 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 122.43 46.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt -139.38 152.22 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 80' ' ' ILE . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 " O5'" ' A' ' 131' ' ' 8OG . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.988 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.0 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.709 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.779 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.0 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.706 ' HD3' HD22 ' A' ' 33' ' ' LEU . 57.8 ttp180 -148.17 147.63 29.66 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.0 111.511 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 36.1 mtp180 41.96 28.68 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.185 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 46.49 28.99 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.844 0.354 . . . . 0.0 111.422 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.28 29.55 19.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.05 -68.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.72 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.219 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -49.38 127.4 15.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.159 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.6 mtt 59.31 63.52 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -64.21 -19.86 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -95.5 31.28 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD22 ' HD3' ' A' ' 22' ' ' ARG . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.714 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.0 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.0 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.0 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.988 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.0 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.0 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.0 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.0 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.0 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.0 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.021 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.021 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.0 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.954 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.0 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.029 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.888 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.0 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.0 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.562 ' NE2' HG23 ' A' ' 81' ' ' THR . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.562 HG23 ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.0 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.029 HG22 ' ND1' ' A' ' 64' ' ' HIS . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.0 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.0 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.621 ' NE1' HG23 ' A' ' 60' ' ' ILE . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.61 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.987 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.0 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.0 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.496 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 123' ' ' ILE . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.0 110.739 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.817 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.0 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.557 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.576 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.742 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.577 ' HB2' HD22 ' A' ' 71' ' ' LEU . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.0 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.817 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.0 111.014 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.806 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.32 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.832 " H3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.84 0.352 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 79' ' ' HIS . 8.7 ttpt -109.84 139.15 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.5 132.8 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.741 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.879 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.556 ' C ' HD12 ' A' ' 6' ' ' ILE . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.0 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.753 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.97 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.0 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.021 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.807 HG21 HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.726 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.776 ' HB2' HD13 ' A' ' 33' ' ' LEU . 8.9 ttp85 -129.71 142.34 50.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 59.96 13.46 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.078 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 45.75 25.06 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 162.61 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.381 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -45.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.45 104.54 1.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.65 -68.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.08 63.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.847 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.31 52.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.347 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -79.97 1.56 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.452 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 22' ' ' ARG . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.0 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.0 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.0 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.0 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.94 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.0 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.0 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 40' ' ' ILE . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.023 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.0 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.0 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.0 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.897 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.0 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.023 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.364 -176.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 82' ' ' LEU . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.0 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 71' ' ' LEU . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.0 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.582 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.809 HG22 ' CE1' ' A' ' 64' ' ' HIS . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.0 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.686 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.643 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.452 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.0 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.97 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' A' ' 107' ' ' LEU . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.0 110.804 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.903 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.649 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.0 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.225 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.0 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.587 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.0 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.0 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.649 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.845 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.67 127.05 53.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.738 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.14 139.16 35.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.791 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.991 HD13 " H3'" ' A' ' 131' ' ' 8OG . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.673 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.965 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.0 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.0 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.671 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.0 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.775 ' ND2' ' HB3' ' A' ' 104' ' ' TRP . 6.7 p30 -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.0 111.81 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.263 -178.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.0 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.726 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.787 HD11 HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.1 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 47.56 25.73 0.7 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 100' ' ' GLN . . . 54.84 20.47 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.663 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.13 29.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.699 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -114.96 -83.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.074 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . 171.86 40.58 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -173.56 164.69 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 tpp 57.9 43.97 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.66 -16.79 61.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.18 25.45 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 111.166 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 20' ' ' ILE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.0 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.0 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.0 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.0 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.0 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.965 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.0 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.0 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.0 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.0 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.0 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.0 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.955 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 60' ' ' ILE . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.0 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.913 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.0 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.0 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.955 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HB3' HD11 ' A' ' 67' ' ' LEU . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.0 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.643 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.0 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.707 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.0 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.796 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.94 ' CE2' HG11 ' A' ' 50' ' ' VAL . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.76 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.0 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.765 ' HH2' HD21 ' A' ' 13' ' ' ASN . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.0 110.763 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.0 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.0 112.115 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.0 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.775 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.0 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 107' ' ' LEU . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.727 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.0 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.0 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 112' ' ' ALA . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.0 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 111.264 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.389 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.991 " H3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.82 0.343 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.0 111.02 22.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.42 158.33 44.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 80' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' ILE . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.0 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 H2'' ' A' ' 131' ' ' 8OG . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.0 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.0 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.0 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.779 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.0 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 18' ' ' ILE . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.0 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.0 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG21 HG22 ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.776 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.708 ' HG3' HD13 ' A' ' 33' ' ' LEU . 6.7 tmm_? -120.42 118.08 29.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.253 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 48.44 26.8 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 50.76 27.03 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.406 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 82.16 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.64 130.27 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.5 -164.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.17 -173.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -58.06 110.21 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.33 62.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.337 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.95 31.24 2.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.017 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 20' ' ' ILE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' THR . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.0 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.0 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.0 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.0 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.96 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.96 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.0 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.85 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.0 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 60' ' ' ILE . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.0 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.818 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.0 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.0 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.85 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.0 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.0 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.0 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.0 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 4' ' ' LEU . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.614 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.913 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.0 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.0 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.0 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.0 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.0 112.079 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.0 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.773 ' HG2' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.644 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.25 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.867 HD23 HD13 ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.867 HD13 HD23 ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.0 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.0 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.0 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.0 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.0 110.985 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.575 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.38 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.788 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.769 0.319 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -110.04 134.84 51.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.74 140.18 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 80' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' CB ' HG21 ' A' ' 40' ' ' ILE . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.0 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.0 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.018 HG22 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.914 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.0 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.0 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.934 HG22 ' O ' ' A' ' 34' ' ' GLU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -105.25 83.94 2.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.829 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HB1' ' A' ' 30' ' ' ALA . 2.4 mtt180 54.59 22.05 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.166 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.626 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . . . 56.83 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -125.83 -60.79 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.78 178.15 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.55 102.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.414 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.06 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.355 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.5 mtp 58.75 29.95 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.979 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.541 ' HB1' ' NE ' ' A' ' 23' ' ' ARG . . . -82.81 -21.22 34.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.526 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 27.18 4.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.228 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.519 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HG22 ' A' ' 21' ' ' THR . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.0 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.0 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.0 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.0 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.865 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.0 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.0 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.892 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.892 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.966 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.0 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.686 ' CB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.675 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.0 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.076 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 60' ' ' ILE . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.0 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.0 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.813 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.69 -175.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.0 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.011 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.0 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.705 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.0 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 4' ' ' LEU . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.0 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 71' ' ' LEU . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.0 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.0 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.0 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.745 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.0 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.0 112.001 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.0 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.0 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.664 ' HB2' HG12 ' A' ' 108' ' ' VAL . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.921 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.355 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.67 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.0 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.0 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.647 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.0 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 71' ' ' LEU . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.752 ' HE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.558 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 125' ' ' LYS . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.64 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.523 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.645 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.872 0.368 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -95.34 102.77 14.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.94 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -79.24 158.45 27.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.0 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.412 HG12 " O3'" ' A' ' 131' ' ' 8OG . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.0 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.728 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.0 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.927 HD11 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.0 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.927 HG23 HD11 ' A' ' 18' ' ' ILE . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HG3' HD12 ' A' ' 33' ' ' LEU . 18.9 ttt180 -133.33 124.88 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.0 111.56 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' ALA . 7.6 mtt180 60.86 14.11 4.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.763 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 45.99 -89.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.99 -52.74 0.47 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.847 0.356 . . . . 0.0 110.93 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.1 129.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.29 39.91 21.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.154 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -131.28 -176.47 4.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 mtm -51.14 94.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -86.47 -27.12 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.46 17.23 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.0 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HD2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.0 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.0 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.0 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.0 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.213 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.0 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.0 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.867 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.0 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.0 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 70' ' ' LYS . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.0 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.0 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.0 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.0 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.733 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.0 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 60' ' ' ILE . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.0 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.607 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.261 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.288 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.811 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.0 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.0 110.483 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD13 HD22 ' A' ' 107' ' ' LEU . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.0 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 113.106 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.0 112.11 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.558 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 71' ' ' LEU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.0 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.0 110.563 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 126' ' ' LEU . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.0 111.611 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.588 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.35 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.412 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -102.88 117.11 33.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 79' ' ' HIS . 9.3 ptpt -140.4 134.48 30.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 6' ' ' ILE . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.349 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.0 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.93 HD11 HD12 ' A' ' 4' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.0 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.781 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.672 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.0 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.85 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -129.11 146.91 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.073 -179.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.8 ptp85 35.98 -106.82 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.997 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 159.43 47.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.937 0.398 . . . . 0.0 110.376 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 72.5 24.83 2.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.74 141.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.62 -158.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.73 -61.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.097 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 16.8 mtm -96.95 37.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -8.87 27.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.39 22.36 2.19 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.0 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.0 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.781 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.0 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.0 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.0 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.053 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.0 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.955 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.955 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.0 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.937 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.0 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.177 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG12 HG13 ' A' ' 60' ' ' ILE . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.0 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.043 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.918 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.0 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.177 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.0 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.0 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.0 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.0 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.908 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.0 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.846 HD12 HD23 ' A' ' 71' ' ' LEU . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.0 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.753 ' CE2' HG11 ' A' ' 50' ' ' VAL . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.0 110.778 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.0 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.396 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 21' ' ' THR . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.0 112.223 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.0 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.0 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.611 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.667 HD13 HG21 ' A' ' 18' ' ' ILE . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 107' ' ' LEU . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.671 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.0 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.0 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.495 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HB2' HD22 ' A' ' 71' ' ' LEU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.0 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.0 111.277 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.0 111.579 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.577 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.434 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.725 ' C8 ' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.876 0.37 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -74.01 113.32 11.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.27 134.96 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.801 HD13 " C2'" ' A' ' 131' ' ' 8OG . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.0 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.884 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.116 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.0 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.701 HD12 ' CE2' ' A' ' 19' ' ' PHE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.517 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.0 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.99 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.0 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.871 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.799 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.1 ttm105 -134.02 150.53 51.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.0 111.502 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 35.05 -102.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.778 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.19 46.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 70.24 16.29 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.568 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -146.98 -86.55 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.855 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . 177.68 38.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.72 129.87 54.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.976 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mtm 67.93 47.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -17.34 62.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.399 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -73.11 -6.38 45.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.37 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 22' ' ' ARG . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.0 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.0 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.0 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.0 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.116 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.0 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.0 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.953 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.0 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.756 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.879 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.0 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.903 HG11 ' HG3' ' A' ' 62' ' ' PRO . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.0 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.483 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.0 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.837 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.545 -176.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.817 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.802 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.0 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.808 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.0 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.823 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.0 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD23 ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.681 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.879 ' CE2' HG11 ' A' ' 50' ' ' VAL . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.0 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.837 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.0 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.0 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.651 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.799 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.018 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.0 111.67 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.0 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.0 110.647 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.0 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.871 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.807 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.342 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.0 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.0 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.588 HD22 HG11 ' A' ' 8' ' ' VAL . 1.4 m-20 -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.35 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.0 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.808 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.0 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 110.777 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.765 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.403 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.801 " C2'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.09 130.12 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.975 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -137.09 158.12 45.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.737 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.613 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.494 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.0 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.067 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.0 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.892 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.0 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.0 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.951 HD11 HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.32 141.42 50.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.0 111.583 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 60.08 12.93 3.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.35 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB1' ' CE1' ' A' ' 28' ' ' HIS . . . 63.37 -66.65 0.1 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.773 0.32 . . . . 0.0 111.62 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.841 ' HB3' ' HB2' ' A' ' 101' ' ' PRO . . . 75.05 29.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.682 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.21 -73.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.51 36.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.582 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.747 ' CE1' ' HB1' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -137.42 -176.33 4.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.954 0.406 . . . . 0.0 111.111 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.56 155.71 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.16 -8.78 56.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.496 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -85.55 31.47 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.282 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.0 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.0 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.067 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.0 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.935 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.935 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.0 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.0 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.961 HG12 HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.617 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.961 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.0 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.0 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 70' ' ' LYS . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.841 ' HD2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.0 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.0 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.0 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.615 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.0 110.674 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 ' OD1' ' A' ' 119' ' ' ASN . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.789 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.892 HG11 HG23 ' A' ' 11' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.0 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.0 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.643 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.0 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.671 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 26.3 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.841 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.0 112.901 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.74 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.0 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.772 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.0 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.994 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.55 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.0 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.0 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.66 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.813 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.0 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.0 111.174 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.694 ' CG2' HD11 ' A' ' 110' ' ' LEU . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.313 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.527 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -110.07 129.88 55.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 158.0 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.594 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.316 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.0 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.718 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.06 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.0 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.639 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.0 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.833 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.915 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.543 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.0 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.915 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 -124.7 126.71 46.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.472 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ALA . 5.0 mtp85 43.75 26.7 0.14 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.849 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' CD ' ' A' ' 100' ' ' GLN . . . 47.1 28.48 0.94 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.726 0.298 . . . . 0.0 111.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.96 27.03 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.03 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -165.47 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.76 95.53 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.141 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -144.46 -78.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -139.18 101.94 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.713 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . . . -67.63 -12.7 61.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.789 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.56 25.22 5.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.0 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.833 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.0 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.0 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.0 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.0 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.06 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.0 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.616 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.0 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.0 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.967 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.967 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.0 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.965 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.0 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.714 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.108 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.0 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.908 ' HG3' HG11 ' A' ' 58' ' ' VAL . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.0 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.108 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.0 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.981 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.0 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.0 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.606 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.612 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.0 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 71' ' ' LEU . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.981 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 68' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.857 HG22 ' CG ' ' A' ' 64' ' ' HIS . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.0 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.0 110.717 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.0 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.681 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 112.068 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.0 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.0 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.427 ' SD ' HD12 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.804 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.0 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.0 112.453 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.609 HD21 HG11 ' A' ' 8' ' ' VAL . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.0 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.359 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.804 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.502 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.439 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.13 102.8 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.26 138.23 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.747 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.753 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.0 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.0 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.949 HG22 ' CE2' ' A' ' 35' ' ' PHE . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.8 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.693 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 7.2 t-20 -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.0 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.8 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.787 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 34' ' ' GLU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.22 95.61 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.487 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 63.83 9.78 4.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.008 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 63.28 11.13 5.17 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.26 30.22 0.28 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.99 13.21 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.88 98.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.288 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -175.2 -68.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 tpp -118.11 87.43 2.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.25 -20.02 64.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.27 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.52 31.2 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 21' ' ' THR . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.949 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.0 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.0 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.0 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.0 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.918 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.918 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.0 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.944 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.0 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.0 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.0 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.815 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.869 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.803 HD21 ' HD3' ' A' ' 70' ' ' LYS . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.803 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.829 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.0 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.0 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.0 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 21.9 m80 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.0 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.76 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.944 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.0 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.815 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.0 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.0 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.0 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.0 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' OE2' HG22 ' A' ' 21' ' ' THR . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.842 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.662 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.0 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.787 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.0 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.597 ' OG ' HG12 ' A' ' 108' ' ' VAL . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.282 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.597 HG12 ' OG ' ' A' ' 106' ' ' SER . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.0 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.639 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.733 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.0 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.499 HD21 HG11 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.107 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.0 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 112.009 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.436 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.653 " C2'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.0 117.62 34.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -140.12 158.32 44.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.444 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.705 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.018 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.0 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.814 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.0 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.777 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.0 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.777 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.0 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 33' ' ' LEU . 3.9 ptt180 -121.95 117.56 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.01 28.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 100' ' ' GLN . . . 50.52 -167.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 111.23 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.89 -30.51 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.054 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.08 42.83 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.1 140.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.268 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.49 -75.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.32 102.42 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.29 -24.2 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.432 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.63 27.99 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.142 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 33' ' ' LEU . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.834 ' CE2' HD13 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.0 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.018 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.626 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.0 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.0 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.0 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.572 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.013 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.98 HG12 HG13 ' A' ' 60' ' ' ILE . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.98 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.0 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.0 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.0 112.133 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.702 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.934 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.0 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.0 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.0 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.753 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.702 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.982 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 11' ' ' ILE . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.0 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.69 ' O ' HG21 ' A' ' 60' ' ' ILE . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.0 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.0 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.0 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 21' ' ' THR . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' CB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.0 111.755 -179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.0 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.0 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 108' ' ' VAL . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.756 HD13 ' CD2' ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.0 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.0 112.471 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.561 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.0 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.0 110.913 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.844 HG22 ' HB2' ' A' ' 112' ' ' ALA . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.0 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.0 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.755 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.478 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.705 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.719 0.295 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.431 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.633 ' CG2' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.0 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.0 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.717 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.622 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.0 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.0 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.063 HG23 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' HG3' ' A' ' 98' ' ' GLU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB2' HD13 ' A' ' 33' ' ' LEU . 1.7 tmm_? . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.0 110.959 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 20' ' ' ILE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.0 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.0 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.0 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.0 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.0 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.592 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.0 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.0 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.0 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.0 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.721 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.048 HG12 HG13 ' A' ' 60' ' ' ILE . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.0 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.048 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.0 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.87 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.0 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.753 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HB2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.822 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.0 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.0 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.04 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.459 ' CE1' HG23 ' A' ' 81' ' ' THR . 4.1 t-80 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.792 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.459 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.0 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD23 ' CG2' ' A' ' 6' ' ' ILE . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.0 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.452 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' CE2' HG11 ' A' ' 50' ' ' VAL . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.753 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.0 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.717 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.579 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.589 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 21' ' ' THR . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.0 111.479 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.0 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.727 ' CG ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.0 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.451 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.063 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.809 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.68 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.531 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.0 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.686 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.0 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.71 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.814 0.34 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.0 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.0 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.808 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.737 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.0 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.0 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HD2' HD12 ' A' ' 33' ' ' LEU . 1.1 ttp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.0 111.668 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.847 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.0 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HG3' HD11 ' A' ' 11' ' ' ILE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.0 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.0 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.0 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.0 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.0 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.0 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.0 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.0 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.911 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.0 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.666 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.0 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.83 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.789 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.0 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.712 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.0 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.0 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 ' ND2' ' A' ' 119' ' ' ASN . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.0 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.0 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.0 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.737 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.0 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.0 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.646 ' HE1' HG23 ' A' ' 60' ' ' ILE . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.0 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.0 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 28.0 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.0 112.165 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.0 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.615 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.966 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.434 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.837 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.768 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.847 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 34' ' ' GLU . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.0 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.0 111.439 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.835 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.0 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.0 111.415 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.595 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.432 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.664 0.269 . . . . 0.0 110.752 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.0 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.0 113.504 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.0 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.029 HD11 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.0 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.646 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 111.904 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.775 0.321 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.0 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.0 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.0 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.0 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.0 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.0 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.0 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.0 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.843 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.926 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.926 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.662 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.0 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.843 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.0 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' N ' HD22 ' A' ' 71' ' ' LEU . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.145 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.0 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.0 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 4' ' ' LEU . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.811 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 86' ' ' LEU . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.0 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.0 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.721 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.0 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.0 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.542 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.662 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.0 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.0 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.0 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.891 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.566 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 107' ' ' LEU . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.93 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.598 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.767 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.0 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.0 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.0 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.0 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.0 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.0 111.265 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.413 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 78' ' ' ARG . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.0 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.803 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.004 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.0 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.781 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.531 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.0 113.021 -179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.0 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.0 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.76 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.538 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.691 0.281 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.0 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 20' ' ' ILE . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' THR . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.659 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.0 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.0 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.0 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.004 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.0 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.0 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.958 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.958 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.0 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.865 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.0 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.982 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.0 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.0 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.904 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.0 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.982 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.0 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.614 ' N ' HD22 ' A' ' 71' ' ' LEU . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.305 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.0 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HD3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.468 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 m170 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 HD11 ' A' ' 4' ' ' LEU . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.0 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 71' ' ' LEU . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.0 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.873 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.0 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.0 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.635 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.0 112.228 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.459 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.953 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.219 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.0 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.0 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.693 ' OD1' HD22 ' A' ' 82' ' ' LEU . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.567 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.0 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.788 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.0 110.773 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.398 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.726 0.298 . . . . 0.0 110.76 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.682 HD12 ' O ' ' A' ' 4' ' ' LEU . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.833 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.0 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.14 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.0 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.0 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.807 HG22 ' CE2' ' A' ' 35' ' ' PHE . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.805 HD12 ' CE2' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.634 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.0 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.0 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.0 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.805 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.783 ' HG3' HD11 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.0 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.0 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.0 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.14 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.0 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.0 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.0 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.841 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.868 HD11 ' NE2' ' A' ' 64' ' ' HIS . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.89 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.0 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.89 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.605 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.0 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.0 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.636 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.853 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.0 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.0 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.0 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 ' OD1' ' A' ' 119' ' ' ASN . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.841 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.0 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.0 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.735 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.0 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.0 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.603 ' O ' HG22 ' A' ' 21' ' ' THR . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 112.012 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.0 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.427 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD13 HD22 ' A' ' 107' ' ' LEU . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.0 112.367 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.0 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.772 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.834 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.0 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.0 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.88 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.62 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.372 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.77 HD23 ' CD ' ' A' ' 78' ' ' ARG . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.0 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.983 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 119' ' ' ASN . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.858 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.0 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.0 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.005 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.0 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.743 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.809 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -179.072 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.0 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' HD11 ' A' ' 11' ' ' ILE . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.0 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.0 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.0 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.983 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.0 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.942 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.769 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.927 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 60' ' ' ILE . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.0 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.0 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.951 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.111 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' HD11 ' A' ' 67' ' ' LEU . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.0 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.0 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.0 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.77 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.65 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' CD2' ' A' ' 64' ' ' HIS . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.0 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.742 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.0 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.0 110.637 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.706 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.0 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.702 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.687 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.0 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.0 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.61 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.691 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD21 HD13 ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.576 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.818 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.0 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.0 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 8' ' ' VAL . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.642 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.0 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.0 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.576 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.414 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.302 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.482 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.0 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.93 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.875 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.97 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.0 113.472 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.0 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.359 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.0 112.081 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.0 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.0 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.0 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.017 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.0 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.0 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.978 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.978 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.0 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.976 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.0 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.95 HG12 HG13 ' A' ' 60' ' ' ILE . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.0 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.0 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.95 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.835 ' HG3' HG11 ' A' ' 58' ' ' VAL . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.0 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.748 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.925 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.844 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.0 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.753 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 80' ' ' ILE . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.501 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.0 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.765 HD12 HD11 ' A' ' 4' ' ' LEU . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.0 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.908 HD23 ' CG2' ' A' ' 122' ' ' VAL . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.0 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.822 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 10' ' ' ILE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.0 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.678 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.0 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.0 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.364 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 21' ' ' THR . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.0 111.865 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.0 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.0 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.0 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.867 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.0 112.705 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.0 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.54 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.0 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.908 ' CG2' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.0 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.0 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.429 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.754 0.312 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.278 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.603 ' C ' HD12 ' A' ' 6' ' ' ILE . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.0 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.611 ' CG2' HD23 ' A' ' 82' ' ' LEU . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.0 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.653 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.0 111.693 178.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.653 ' HG2' HD21 ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.916 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.707 0.289 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.0 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.0 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HG3' HD11 ' A' ' 11' ' ' ILE . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.0 111.765 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.0 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.0 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.0 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.019 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.0 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.0 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.951 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.0 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.939 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.0 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.972 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.0 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.909 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.0 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.0 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.972 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.0 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 HD12 ' A' ' 82' ' ' LEU . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.0 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.0 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.0 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 4' ' ' LEU . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.63 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.763 HD12 HD23 ' A' ' 71' ' ' LEU . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.924 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.0 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.0 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.0 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.0 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.626 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 112.254 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.0 112.504 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.555 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 10' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.967 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.0 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.967 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.0 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.0 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.533 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.594 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.0 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.0 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 110' ' ' LEU . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.0 111.317 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.454 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.703 0.287 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 80' ' ' ILE . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.988 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.0 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.709 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.779 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.0 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.706 ' HD3' HD22 ' A' ' 33' ' ' LEU . 57.8 ttp180 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.0 111.511 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.724 0.297 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD22 ' HD3' ' A' ' 22' ' ' ARG . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.714 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.0 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.0 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.0 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.988 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.0 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.0 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.0 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.0 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.0 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.0 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.021 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.021 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.0 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.954 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.0 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.029 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.888 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.0 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.0 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.562 ' NE2' HG23 ' A' ' 81' ' ' THR . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.562 HG23 ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.0 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.029 HG22 ' ND1' ' A' ' 64' ' ' HIS . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.0 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.0 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.621 ' NE1' HG23 ' A' ' 60' ' ' ILE . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.987 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.0 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.0 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.496 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 123' ' ' ILE . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.0 110.739 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.817 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.0 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.557 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.576 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.742 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.577 ' HB2' HD22 ' A' ' 71' ' ' LEU . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.0 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.817 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.0 111.014 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.806 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.32 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.744 0.307 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.879 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.556 ' C ' HD12 ' A' ' 6' ' ' ILE . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.0 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.753 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.97 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.0 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.021 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.807 HG21 HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.726 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.776 ' HB2' HD13 ' A' ' 33' ' ' LEU . 8.9 ttp85 . . . . . 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.458 0.171 . . . . 0.0 111.452 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 22' ' ' ARG . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.0 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.0 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.0 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.0 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.94 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.0 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.0 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 40' ' ' ILE . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.823 HD11 ' NE2' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.0 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.0 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.0 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.897 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.0 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.364 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 82' ' ' LEU . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.0 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 71' ' ' LEU . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.0 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.582 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.004 HG22 ' CD2' ' A' ' 64' ' ' HIS . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.0 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.686 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.452 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.0 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.97 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' A' ' 107' ' ' LEU . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.0 110.804 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.903 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.649 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.0 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.225 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.0 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.587 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.0 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.0 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.649 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.561 0.22 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.673 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.965 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.0 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.0 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.671 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.0 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.0 111.81 178.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 33.8 t-20 -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.263 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.0 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.787 HD11 HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.705 0.288 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 20' ' ' ILE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.0 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.0 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.0 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.0 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.0 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.965 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.0 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.693 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.0 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.0 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.0 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.0 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.0 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 60' ' ' ILE . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.0 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.913 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.0 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.0 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.76 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HB3' HD11 ' A' ' 67' ' ' LEU . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.0 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.643 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.0 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.707 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.0 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.796 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.94 ' CE2' HG11 ' A' ' 50' ' ' VAL . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.76 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.0 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.0 110.763 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.0 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.0 112.115 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.0 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.625 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.0 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 107' ' ' LEU . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.727 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.0 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.0 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 112' ' ' ALA . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.0 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 111.264 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.389 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 80' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' ILE . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.0 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' C ' ' A' ' 5' ' ' GLN . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.0 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.0 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.0 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.779 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.0 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 18' ' ' ILE . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.0 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.0 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.779 HG21 HG22 ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.776 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.708 ' HG3' HD13 ' A' ' 33' ' ' LEU . 6.7 tmm_? . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.751 0.31 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 20' ' ' ILE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' THR . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.0 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.0 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.0 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.0 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.96 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.96 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.0 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.85 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.0 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 60' ' ' ILE . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.0 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.818 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.0 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.0 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.85 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.0 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.0 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.0 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.0 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 4' ' ' LEU . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.614 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.913 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.0 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.0 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.0 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.0 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.0 112.079 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.0 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.773 ' HG2' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.644 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.25 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.867 HD23 HD13 ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.867 HD13 HD23 ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.0 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.0 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.0 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.0 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.0 110.985 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.575 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.38 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.641 0.257 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 80' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.865 ' CB ' HG21 ' A' ' 40' ' ' ILE . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.0 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.0 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.018 HG22 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.914 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.0 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.0 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.934 HG22 ' O ' ' A' ' 34' ' ' GLU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.829 -179.713 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.519 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HG22 ' A' ' 21' ' ' THR . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.0 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.0 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.0 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.0 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.865 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.0 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.0 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.892 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.892 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.966 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.0 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.686 ' CB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.0 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.076 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 60' ' ' ILE . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.0 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.0 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.2 t-160 -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.69 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.0 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.011 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.0 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.705 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.0 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 4' ' ' LEU . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.0 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 71' ' ' LEU . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.0 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.0 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' CD2' ' A' ' 64' ' ' HIS . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.0 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.745 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.0 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.0 112.001 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.0 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.0 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.664 ' HB2' HG12 ' A' ' 108' ' ' VAL . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.829 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.921 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.355 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.67 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.0 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.0 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.797 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.0 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 71' ' ' LEU . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.752 ' HE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.558 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 125' ' ' LYS . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.64 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.523 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.701 0.286 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.0 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.0 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.728 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.0 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.927 HD11 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.0 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.927 HG23 HD11 ' A' ' 18' ' ' ILE . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HG3' HD12 ' A' ' 33' ' ' LEU . 18.9 ttt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.0 111.56 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.582 0.23 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.0 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HD2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.0 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.0 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.0 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.0 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.213 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.0 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.0 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.867 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.0 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.0 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 70' ' ' LYS . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.0 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.0 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.0 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.0 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.733 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.0 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 60' ' ' ILE . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.0 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.607 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.261 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.288 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.811 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.0 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.0 110.483 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD13 HD22 ' A' ' 107' ' ' LEU . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.0 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 113.106 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.0 112.11 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.558 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 71' ' ' LEU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.0 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.0 110.563 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 126' ' ' LEU . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.0 111.611 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.588 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.35 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 79' ' ' HIS . 9.3 ptpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.699 0.285 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 6' ' ' ILE . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.349 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.0 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.93 HD11 HD12 ' A' ' 4' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.0 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.781 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.672 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.0 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.85 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.073 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.0 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.0 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.781 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.0 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.0 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.0 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.053 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.0 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.955 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.955 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.0 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.937 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.0 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG12 HG13 ' A' ' 60' ' ' ILE . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.0 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.043 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.918 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.0 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.977 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.0 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.0 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.0 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.0 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.908 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.0 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.846 HD12 HD23 ' A' ' 71' ' ' LEU . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.0 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.753 ' CE2' HG11 ' A' ' 50' ' ' VAL . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.0 110.778 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.0 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.396 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 21' ' ' THR . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.0 112.223 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.0 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.0 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.611 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.667 ' CD1' HD13 ' A' ' 110' ' ' LEU . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 107' ' ' LEU . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.671 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.0 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.0 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.495 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HB2' HD22 ' A' ' 71' ' ' LEU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.0 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.0 111.277 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.0 111.579 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.577 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.434 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.775 0.322 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' O ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.0 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.884 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.116 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.0 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.701 HD12 ' CE2' ' A' ' 19' ' ' PHE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.517 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.0 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.99 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.0 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.871 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.799 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.1 ttm105 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.0 111.502 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.52 0.2 . . . . 0.0 111.37 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 22' ' ' ARG . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.0 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.0 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.0 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.0 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.116 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.0 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.0 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.953 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.0 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.756 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.879 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.0 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.903 HG11 ' HG3' ' A' ' 62' ' ' PRO . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.0 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.483 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.0 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.015 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.4 t-160 -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.545 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.817 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.802 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.0 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.808 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.0 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.823 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.0 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD23 ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.681 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.879 ' CE2' HG11 ' A' ' 50' ' ' VAL . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.0 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 64' ' ' HIS . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.0 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.0 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.651 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.799 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.018 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.0 111.67 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.0 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.0 110.647 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.0 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.871 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.807 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.342 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.0 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.0 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.577 ' ND2' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.35 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.572 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.0 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.808 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.0 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 110.777 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.765 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.403 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.613 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.494 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.0 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.067 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.0 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.892 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.0 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.0 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.951 HD11 HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.0 111.583 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.698 0.285 . . . . 0.0 111.282 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.0 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.0 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.067 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.0 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.935 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.935 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.0 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.0 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.961 HG12 HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.617 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.961 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.0 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.0 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 70' ' ' LYS . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.841 ' HD2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.0 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.0 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.0 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.615 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.0 110.674 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.81 HD13 ' ND2' ' A' ' 119' ' ' ASN . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.789 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.892 HG11 HG23 ' A' ' 11' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.0 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.0 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.643 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.0 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.671 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 47.0 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.0 112.901 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.74 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.0 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.772 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.0 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.994 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.55 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.0 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.0 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.81 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.813 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.0 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.0 111.174 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.694 ' CG2' HD11 ' A' ' 110' ' ' LEU . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.313 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.527 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.699 0.285 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.594 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.316 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.0 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.718 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.06 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.0 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.639 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.0 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.833 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.915 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.543 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.0 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.915 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.472 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.0 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.833 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.0 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.0 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.0 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.0 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.06 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.0 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.616 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.0 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.0 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.967 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.967 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.0 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.965 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.0 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.714 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.908 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.0 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.908 ' HG3' HG11 ' A' ' 58' ' ' VAL . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.0 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.908 ' NE2' HD11 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.0 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.981 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.0 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.0 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.606 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.612 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.0 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 71' ' ' LEU . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.981 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 68' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.857 HG22 ' CG ' ' A' ' 64' ' ' HIS . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.0 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.0 110.717 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.0 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 112.068 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.0 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.0 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.427 ' SD ' HD12 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.804 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.0 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.0 112.453 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.609 HD21 HG11 ' A' ' 8' ' ' VAL . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.0 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.359 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.804 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.502 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.688 0.28 . . . . 0.0 110.747 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.753 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.0 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.0 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.949 HG22 ' CE2' ' A' ' 35' ' ' PHE . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.8 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.693 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 -178.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.0 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.8 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.787 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 34' ' ' GLU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.487 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 21' ' ' THR . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.949 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.0 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.0 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.0 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.0 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.918 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.918 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.0 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.944 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.0 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.0 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.0 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 13.0 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.992 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.2 t-160 -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.869 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.803 HD21 ' HD3' ' A' ' 70' ' ' LYS . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.803 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.829 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.0 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.0 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.0 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 9.8 m-70 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.0 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.76 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.944 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.0 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.992 HG22 ' CD2' ' A' ' 64' ' ' HIS . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.0 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.0 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.0 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.0 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' OE2' HG22 ' A' ' 21' ' ' THR . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.842 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.662 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.0 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.787 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.0 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.597 ' OG ' HG12 ' A' ' 108' ' ' VAL . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.282 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.597 HG12 ' OG ' ' A' ' 106' ' ' SER . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.0 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.639 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.733 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.0 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.499 HD21 HG11 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.107 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.0 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 112.009 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.436 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 80' ' ' ILE . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.018 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.0 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.814 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.0 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.777 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.0 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.777 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.0 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 33' ' ' LEU . 3.9 ptt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.693 0.282 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.834 ' CE2' HD13 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.0 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.018 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.626 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.0 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.0 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.0 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.572 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.013 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.98 HG12 HG13 ' A' ' 60' ' ' ILE . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.98 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.0 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.0 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.0 112.133 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.702 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.934 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.0 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.0 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.0 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 1.8 m170 -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.753 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.702 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.982 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 11' ' ' ILE . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.0 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.562 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.69 ' O ' HG21 ' A' ' 60' ' ' ILE . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.0 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.0 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.0 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 21' ' ' THR . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.0 111.755 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.0 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.0 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.83 ' O ' HD13 ' A' ' 107' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.756 HD13 ' CD2' ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.0 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.0 112.471 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.561 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.0 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.0 110.913 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.844 HG22 ' HB2' ' A' ' 112' ' ' ALA . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.0 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.0 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.755 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.478 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.04 140.43 44.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -136.2 158.09 45.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.7 pp -146.53 120.24 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.431 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.7 mt-30 -102.14 154.75 18.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.633 ' CG2' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.43 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.73 142.73 51.46 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.46 154.44 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 119.197 0.908 . . . . 0.0 110.692 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -147.41 139.19 7.68 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.796 -1.193 . . . . 0.0 114.098 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -89.05 121.27 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.717 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.38 110.31 18.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -81.5 148.61 29.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.767 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.622 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.46 -173.61 3.22 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.662 0.744 . . . . 0.0 111.888 177.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.69 -54.56 26.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.089 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 48.7 t-20 -59.59 -13.66 10.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.424 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.77 9.32 0.54 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.527 0.68 . . . . 0.0 110.482 -178.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.3 OUTLIER -108.75 144.62 36.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 176.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.063 HG23 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -105.33 128.18 59.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 1.1 t80 -61.51 97.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.67 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.33 131.36 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' HG3' ' A' ' 98' ' ' GLU . 48.5 p -70.64 111.65 6.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.595 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB2' HD13 ' A' ' 33' ' ' LEU . 1.7 tmm_? -146.62 146.96 30.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 5.7 mtm180 51.21 -86.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.561 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 82.51 36.94 0.06 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.291 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 55.35 82.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.377 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.49 88.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.44 -165.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -56.12 -57.08 13.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.4 mtt -145.41 135.4 23.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -8.98 58.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.437 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -95.11 31.13 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.959 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.41 26.31 10.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.611 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 20' ' ' ILE . 18.3 tp -68.87 57.62 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.718 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.1 tt0 -113.52 179.37 3.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.142 0.496 . . . . 0.0 111.477 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.559 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 168.17 10.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.783 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.8 Cg_endo -47.88 168.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.768 2.979 . . . . 0.0 111.737 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.8 60.5 0.73 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.659 -1.257 . . . . 0.0 114.563 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.84 108.12 0.66 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.706 -0.747 . . . . 0.0 111.664 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttt 105.16 19.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.169 0.588 . . . . 0.0 111.193 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -67.98 -36.57 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.669 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.592 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.19 -83.99 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.334 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.6 mmt 44.86 -91.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.331 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -163.81 25.82 0.2 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.928 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -94.49 -166.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.648 0.261 . . . . 0.0 110.863 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.961 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.85 159.81 30.0 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.961 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.64 -26.65 1.21 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.692 2.262 . . . . 0.0 112.27 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.936 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.6 mp0 -104.26 -48.82 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.457 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -71.24 -4.61 26.64 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.67 -45.13 14.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.997 0.427 . . . . 0.0 110.527 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.3 -33.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.085 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 47' ' ' GLU . 63.3 t -50.99 -35.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -78.15 -31.64 49.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.43 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.0 mm-40 -79.33 -35.42 41.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.626 0.727 . . . . 0.0 109.237 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.721 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -47.86 -48.61 30.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.546 -177.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -78.38 -27.63 46.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.779 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.69 -23.72 56.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.353 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mm-40 -108.04 5.4 26.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.581 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.048 HG12 HG13 ' A' ' 60' ' ' ILE . 20.3 t -134.26 -43.88 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.159 0.504 . . . . 0.0 109.663 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.74 -40.72 0.53 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.79 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.048 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -174.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 120.903 0.383 . . . . 0.0 110.826 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.83 88.99 8.69 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.973 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.87 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.7 Cg_endo -109.2 148.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.248 2.632 . . . . 0.0 114.293 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 64.9 mt-30 -74.81 80.08 2.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.753 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.71 128.87 50.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.967 -176.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.658 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 176.44 -172.83 0.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.331 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.4 m 76.94 154.78 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.775 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -117.32 113.61 22.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HB2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.16 -39.36 60.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 0.0 110.205 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.721 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.56 158.2 5.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.035 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.42 132.82 23.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.822 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.22 115.73 28.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.656 0.741 . . . . 0.0 111.908 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -114.25 108.56 17.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.754 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -142.28 137.05 30.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.027 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.65 123.23 46.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 111.596 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -94.83 163.21 22.89 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.105 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.6 Cg_exo -34.88 80.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.203 3.269 . . . . 0.0 113.396 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.7 t70 87.52 -47.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.593 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 6.6 ttp-105 -86.07 101.67 13.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.04 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.459 ' CE1' HG23 ' A' ' 81' ' ' THR . 4.1 t-80 -93.23 154.19 18.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 110.954 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -128.25 143.35 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.792 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.459 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -134.82 118.41 16.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.532 0.206 . . . . 0.0 110.765 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD23 ' CG2' ' A' ' 6' ' ' ILE . 8.0 mt -116.13 114.33 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.729 0.299 . . . . 0.0 110.986 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.452 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -107.43 122.87 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.7 0.286 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -100.63 130.25 46.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' CE2' HG11 ' A' ' 50' ' ' VAL . 74.1 m95 -106.78 120.05 40.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.887 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD23 ' HB2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -79.01 98.41 6.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.484 -177.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.753 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.3 t -73.24 146.92 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.195 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -111.94 -32.97 6.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.02 24.91 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.923 0.783 . . . . 0.0 111.841 -178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.717 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.1 p90 -150.55 126.4 10.39 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.361 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -77.94 147.89 34.77 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.965 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.76 -125.32 38.91 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 38.6 tt0 -126.42 140.26 36.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.482 0.182 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.36 128.78 10.66 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 111.285 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.579 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -132.9 -62.55 0.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.384 -0.526 . . . . 0.0 112.226 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.589 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.88 -96.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.13 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tptp 173.45 41.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.376 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HG3' HG21 ' A' ' 21' ' ' THR . 14.9 pt-20 -79.35 -50.67 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.57 -142.1 6.41 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.17 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.7 mt-30 -75.94 118.81 73.83 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.069 0.462 . . . . 0.0 111.479 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -43.42 125.91 4.9 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.087 2.525 . . . . 0.0 113.3 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -108.02 177.78 21.15 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.463 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.7 157.15 18.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.655 0.264 . . . . 0.0 110.936 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.01 106.67 1.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.727 ' CG ' HD11 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.14 147.41 44.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.945 0.402 . . . . 0.0 111.557 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.451 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -68.41 118.03 10.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.632 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.063 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -69.28 -18.03 63.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.611 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.48 -21.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.13 55.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.914 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.2 tt -62.7 150.53 40.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.809 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.19 113.28 25.66 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.23 -15.82 61.93 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -44.77 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.543 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -74.17 -13.23 60.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.651 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.68 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.72 163.22 17.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.556 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.6 Cg_endo -54.95 132.52 52.69 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.45 2.1 . . . . 0.0 112.358 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 -14.65 43.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.607 2.205 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.47 -25.36 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.531 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -109.66 3.81 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -55.4 -36.08 41.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.8 Cg_exo -44.23 -50.71 7.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.166 1.911 . . . . 0.0 114.298 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.93 -53.19 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 111.424 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.686 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.1 mm -59.71 -28.79 41.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.269 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.62 -50.94 70.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -48.02 71.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.207 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.626 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.27 -50.05 12.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.512 . . . . 0.0 110.669 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.71 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.96 -39.14 54.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.836 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -63.63 -8.39 9.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.411 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.772 0.32 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 116.64 15.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 133.23 29.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.729 HD22 H2'' ' A' ' 131' ' ' 8OG . 3.4 pp -147.32 128.63 14.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.36 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 49.2 mt-30 -101.95 157.03 17.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.231 0.539 . . . . 0.0 111.702 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 " O3'" ' A' ' 131' ' ' 8OG . 68.1 mt -146.22 140.15 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.54 124.62 38.66 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -135.08 158.87 41.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 118.6 0.636 . . . . 0.0 111.822 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.56 150.12 22.17 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.515 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.808 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.64 119.91 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.737 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -80.33 111.54 17.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.3 mmm-85 -80.12 145.23 32.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.071 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -120.27 -173.16 2.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.332 1.063 . . . . 0.0 113.202 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -56.43 -56.06 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.729 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 45.7 t30 -74.06 2.66 8.35 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.682 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 81.99 9.98 0.79 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.677 0.275 . . . . 0.0 111.31 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 3.6 pt-20 -101.03 137.18 39.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -102.81 117.35 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -175.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -65.72 94.42 0.2 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.82 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.21 153.85 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 p -70.62 111.27 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HD2' HD12 ' A' ' 33' ' ' LEU . 1.1 ttp180 -134.0 131.55 39.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.075 0.464 . . . . 0.0 111.668 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 25.6 mtm105 56.13 16.31 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.045 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.28 -163.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.701 0.286 . . . . 0.0 111.443 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' A' ' 101' ' ' PRO . . . -118.43 -37.5 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.915 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -143.78 117.08 9.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 67.33 -159.51 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.042 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 68.87 173.14 0.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.981 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.5 146.59 34.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -87.14 -22.0 25.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.429 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -93.44 31.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.78 26.25 10.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.679 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.847 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -46.7 89.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 3.5 tp10 -120.07 169.87 9.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.166 0.508 . . . . 0.0 112.082 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.65 163.19 28.79 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.278 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HG3' HD11 ' A' ' 11' ' ' ILE . 14.0 Cg_endo -55.08 168.02 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.636 2.891 . . . . 0.0 112.15 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 60.05 0.76 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.183 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.93 122.79 3.83 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.844 -0.678 . . . . 0.0 112.188 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.09 0.556 . . . . 0.0 111.983 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -70.67 -31.76 47.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.739 0.78 . . . . 0.0 109.825 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.01 -82.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.193 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mtm 42.68 -87.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.515 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.26 30.37 0.1 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -93.84 -162.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.586 0.231 . . . . 0.0 110.903 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -99.5 162.06 22.5 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -30.74 3.22 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.61 2.206 . . . . 0.0 111.964 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.4 mt-10 -104.28 -46.26 4.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.577 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -70.14 -4.85 23.32 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.9 -46.21 14.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.1 p -78.79 -31.71 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.988 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.2 t -51.06 -37.46 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.935 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -78.77 -33.85 46.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.77 -37.03 42.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.616 0.722 . . . . 0.0 109.275 178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 64' ' ' HIS . 6.7 tp -48.2 -49.36 33.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.458 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -77.31 -27.4 52.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.442 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tt0 -71.77 -25.33 61.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.461 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.5 mp0 -108.59 6.87 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.927 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -132.97 -44.46 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.072 0.463 . . . . 0.0 109.834 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.71 -39.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.881 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.911 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -82.42 -173.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.817 0.341 . . . . 0.0 111.097 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.88 89.14 8.98 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.034 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.666 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.0 Cg_endo -110.71 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 123.352 2.701 . . . . 0.0 114.554 -177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -74.83 80.51 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.83 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -127.32 131.28 50.47 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.759 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 172.49 -167.41 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER 72.58 158.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.833 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.8 tt -120.01 113.23 20.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.66 -38.08 59.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.9 tt0 -171.52 166.55 6.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.95 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.0 pttt -143.81 132.36 22.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.789 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.96 115.86 29.87 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 112.253 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -115.86 107.43 15.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.06 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 2.7 t80 -143.58 126.16 15.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.67 117.8 27.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.483 . . . . 0.0 110.92 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.712 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 23.7 m-85 -81.5 163.3 54.99 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.87 86.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.349 2.699 . . . . 0.0 111.966 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 15.3 m-20 92.51 28.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.065 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt-85 -137.51 153.16 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.72 108.28 4.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.0 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 73' ' ' TYR . 1.1 tt -123.4 136.47 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.1 118.23 16.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.221 -0.191 . . . . 0.0 110.943 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 ' ND2' ' A' ' 119' ' ' ASN . 2.9 mt -116.46 114.68 24.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.667 0.27 . . . . 0.0 110.702 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -102.65 122.91 45.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 111.132 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 4.9 m-30 -97.69 120.62 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.055 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.667 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.4 m95 -101.21 120.28 40.01 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.5 tm? -77.7 96.7 4.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.524 -0.87 . . . . 0.0 113.02 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.8 t -74.08 145.29 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.807 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 14.1 pt-20 -114.05 -30.63 6.62 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.53 165.35 23.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.077 0.853 . . . . 0.0 111.946 -178.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.737 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -149.44 128.47 12.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.449 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 145.51 36.07 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.04 -125.71 40.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.411 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG12 ' A' ' 60' ' ' ILE . 30.0 tt0 -122.6 140.0 32.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.394 0.14 . . . . 0.0 110.824 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.7 Cg_exo -76.09 128.97 11.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.926 2.418 . . . . 0.0 111.069 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.646 ' HE1' HG23 ' A' ' 60' ' ' ILE . 60.1 p-90 -134.22 -63.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.16 -100.18 0.02 OUTLIER Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.07 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 174.33 35.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.54 0.209 . . . . 0.0 111.235 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -58.84 -40.65 84.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 0.0 110.414 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.12 -33.66 6.4 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.631 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 21' ' ' THR . 28.0 tt0 -103.75 106.11 50.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 112.066 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 87.9 Cg_exo -47.42 146.17 7.65 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.004 2.469 . . . . 0.0 112.165 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.38 19.2 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.286 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 mm-40 -146.97 143.43 28.44 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.95 107.11 0.49 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.811 0.338 . . . . 0.0 110.561 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.3 mtt -119.78 163.57 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.402 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.615 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -87.44 120.91 29.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.966 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.1 -18.46 59.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.434 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -51.23 -20.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.837 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.24 58.87 0.47 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.07 150.9 36.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.36 . . . . 0.0 110.64 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.98 114.31 26.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.768 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.09 -15.35 62.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.663 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -49.05 19.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.64 -13.67 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.202 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.847 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.61 150.75 39.99 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.777 0.323 . . . . 0.0 110.569 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 34' ' ' GLU . 13.9 Cg_endo -55.99 130.02 38.07 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.048 2.499 . . . . 0.0 113.329 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 37.5 Cg_endo -65.36 -17.18 57.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.331 2.021 . . . . 0.0 111.439 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -21.25 65.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.92 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.835 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -111.57 11.8 21.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.439 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -65.59 -31.67 5.2 Favored Pre-proline 0 C--O 1.219 -0.541 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.8 Cg_exo -44.85 -43.83 14.85 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 121.952 1.768 . . . . 0.0 114.137 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.21 -54.27 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.056 0.455 . . . . 0.0 111.415 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -65.74 -26.14 38.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.707 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.17 -46.75 72.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.374 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -54.91 -53.84 50.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.607 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.6 mm? -79.06 -47.15 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.595 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.1 tttt -50.11 -39.68 43.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -62.98 -11.58 19.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 126' ' ' LEU . 1.8 mp . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.432 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.764 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.22 107.08 13.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.21 139.02 35.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.73 119.11 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 8.2 mt-30 -102.29 154.2 19.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.599 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.908 HD11 " O3'" ' A' ' 131' ' ' 8OG . 8.7 mt -144.1 140.44 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.828 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -127.21 124.92 40.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.67 155.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 118.881 0.764 . . . . 0.0 112.047 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.21 144.62 13.34 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.465 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.698 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -93.74 121.59 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.76 111.65 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.95 151.6 28.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.359 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -131.8 -173.58 3.17 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 122.573 1.177 . . . . 0.0 113.504 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.34 56.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.092 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 20.5 t-20 -71.88 -7.91 51.25 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.653 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 86.17 15.88 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.367 0.603 . . . . 0.0 110.566 -179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 5.7 pt-20 -109.12 137.48 46.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.029 HD11 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -102.44 119.34 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 122.053 0.93 . . . . 0.0 113.466 -175.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.646 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -62.25 95.77 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.405 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.029 HG23 HD11 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.59 142.47 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.925 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 80.6 p -70.5 111.24 5.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' CB ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -132.4 138.73 47.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 111.904 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 39.92 30.94 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.903 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . . . 49.98 -166.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.822 0.344 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.06 -29.94 62.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.001 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.74 -54.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.78 108.86 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -179.35 77.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.751 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.0 tpt 64.11 108.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.39 -20.76 36.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.391 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.62 31.1 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.04 26.62 10.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.497 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -65.53 62.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.825 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -108.88 176.69 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.455 0.645 . . . . 0.0 112.609 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.88 168.17 10.86 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.482 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 13.9 Cg_endo -54.48 167.71 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.474 2.783 . . . . 0.0 111.651 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.04 60.66 0.75 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.931 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -134.3 116.69 1.67 Allowed Glycine 0 C--N 1.31 -0.879 0 CA-C-N 115.101 -0.55 . . . . 0.0 112.316 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.55 -8.11 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.263 0.625 . . . . 0.0 111.539 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.828 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -40.97 -73.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.73 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -6.44 -79.72 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.423 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.1 mtm 33.24 -101.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.017 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.57 10.96 0.2 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.699 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -79.89 -159.81 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.96 0.38 . . . . 0.0 110.564 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.61 154.28 37.56 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.29 -25.31 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.448 2.099 . . . . 0.0 112.142 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.3 mt-10 -103.16 -50.85 3.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.634 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -73.63 -4.14 32.38 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -85.29 -44.42 12.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.786 0.327 . . . . 0.0 110.56 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.59 -31.09 15.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.6 t -50.88 -35.12 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.839 0.352 . . . . 0.0 110.711 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -33.2 58.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.378 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.11 -37.13 39.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.764 0.792 . . . . 0.0 109.341 178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.843 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -47.82 -49.08 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.635 -177.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 59' ' ' GLY . 5.6 tt0 -78.01 -30.5 50.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.489 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -25.34 65.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.429 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.1 mp0 -108.29 6.52 26.62 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.952 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.926 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.34 -44.42 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.18 -37.68 0.32 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.192 0.837 . . . . 0.0 115.192 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.926 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.99 -172.76 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.89 0.376 . . . . 0.0 111.07 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.65 88.84 10.01 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.134 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.4 Cg_endo -110.88 150.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 123.297 2.665 . . . . 0.0 114.38 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.67 80.3 2.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.843 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 130.29 51.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.754 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 174.78 -170.23 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 p 69.73 166.4 0.28 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.831 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -126.51 122.65 35.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.329 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.25 -37.73 57.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.2 tt0 -171.66 166.83 6.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.75 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.48 129.7 19.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -96.67 116.06 28.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.832 0.825 . . . . 0.0 112.963 -178.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' N ' HD22 ' A' ' 71' ' ' LEU . 35.9 tt0 -114.7 107.58 15.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.145 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -143.22 122.06 12.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.839 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.62 107.93 12.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.147 0.499 . . . . 0.0 111.124 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 36.0 m-85 -74.43 163.51 67.73 Favored Pre-proline 0 N--CA 1.445 -0.724 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.733 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.3 Cg_endo -40.42 85.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.982 3.121 . . . . 0.0 112.358 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' PHE . 34.6 m-20 98.03 -27.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.504 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.92 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.681 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 20.5 t-160 -146.6 110.83 5.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.839 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 4' ' ' LEU . 3.5 tt -125.11 138.09 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 118.34 17.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.515 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.4 mt -115.87 114.07 24.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.766 0.317 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.854 0.359 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.8 m-85 -99.67 122.29 42.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.177 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.811 ' CE2' HG11 ' A' ' 50' ' ' VAL . 88.2 m95 -99.61 118.5 36.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 86' ' ' LEU . 3.2 tm? -80.7 97.94 7.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.781 0.801 . . . . 0.0 113.083 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.1 t -72.25 146.23 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.83 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 66.9 tt0 -113.7 -30.61 6.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.07 165.13 25.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.786 0.721 . . . . 0.0 111.719 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.721 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.87 126.27 10.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.362 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -78.08 145.74 35.62 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.33 -130.67 51.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.2 mt-10 -119.29 136.95 24.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.38 0.134 . . . . 0.0 110.655 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -75.95 128.9 11.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.788 2.326 . . . . 0.0 111.343 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.542 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 53.4 p-90 -131.18 -63.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.662 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.21 -99.38 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.016 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.08 41.32 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.818 0.342 . . . . 0.0 110.717 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 16.7 pt-20 -71.19 -49.16 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 168.63 -127.42 1.53 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 21' ' ' THR . 5.3 mp0 -76.08 133.27 72.46 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.331 0.586 . . . . 0.0 111.829 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -43.71 146.27 1.52 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.263 2.642 . . . . 0.0 113.122 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.59 177.58 17.96 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.37 151.61 51.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.37 107.38 1.08 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.891 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -119.69 163.29 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 121.36 26.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.722 HD22 HD13 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.88 -18.39 63.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.566 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 108' ' ' VAL . 13.1 p -55.66 -13.93 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.35 52.41 0.82 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.934 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.722 HD13 HD22 ' A' ' 107' ' ' LEU . 8.6 tp -61.96 143.28 56.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.93 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 111.38 16.3 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.47 -15.68 61.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.411 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -49.03 13.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.755 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -69.78 -14.95 63.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.598 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.767 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.37 162.55 19.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.663 0.268 . . . . 0.0 110.855 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.67 129.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.554 2.17 . . . . 0.0 112.257 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.24 -15.22 47.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.462 2.108 . . . . 0.0 112.344 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.76 62.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.404 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -116.82 10.96 14.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.324 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -59.81 -35.34 28.0 Favored Pre-proline 0 C--O 1.223 -0.306 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 47.1 Cg_exo -44.28 -49.89 8.37 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.293 1.995 . . . . 0.0 114.199 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -78.17 -53.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.122 0.486 . . . . 0.0 111.414 -179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.3 mm -61.57 -28.08 43.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.199 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.6 -49.38 70.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 109.521 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -54.61 -51.77 64.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.404 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tp -78.5 -48.58 15.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.042 0.449 . . . . 0.0 111.265 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -50.51 -39.04 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.053 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -63.84 -9.54 15.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.507 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.413 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.908 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.756 0.312 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.74 137.95 44.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 158.0 44.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 78' ' ' ARG . 3.4 pp -146.44 120.51 9.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.296 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -102.34 155.94 17.91 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.553 0.692 . . . . 0.0 112.668 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.803 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.81 140.41 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.004 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.34 124.98 39.93 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.6 m -129.08 158.33 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.778 0.717 . . . . 0.0 111.88 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.36 153.74 25.14 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.166 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.781 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.14 123.47 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -81.06 111.78 18.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -79.93 150.43 30.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.78 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -126.81 -172.95 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 122.155 0.978 . . . . 0.0 113.021 -179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.14 -56.36 21.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.026 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 41.8 t30 -73.85 -5.4 40.78 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.362 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 87.11 11.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.862 0.363 . . . . 0.0 110.805 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 14.4 pt-20 -101.53 126.48 48.34 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.81 117.83 48.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.856 0.836 . . . . 0.0 113.201 -175.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.74 103.45 0.26 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.554 -179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.76 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -103.12 134.41 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.529 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.19 111.8 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.551 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 26.0 ptt85 -129.38 136.88 50.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.538 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.34 30.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.981 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 48.94 -168.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.444 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -96.54 -30.88 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.42 23.52 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.5 76.42 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.237 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.03 -70.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.7 ttt -113.55 100.03 8.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.15 -18.45 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.34 31.01 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -113.76 26.06 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.922 0.392 . . . . 0.0 111.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 20' ' ' ILE . 1.7 tt -71.73 55.98 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.106 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' THR . 0.8 OUTLIER -113.86 -171.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.28 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.659 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.69 159.81 44.84 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 121.023 0.44 . . . . 0.0 111.929 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 7.3 Cg_endo -47.67 168.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.036 3.158 . . . . 0.0 112.035 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.55 60.6 0.73 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.534 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.77 109.99 0.96 Allowed Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.68 -0.76 . . . . 0.0 112.14 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 109.93 20.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.157 0.583 . . . . 0.0 111.628 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.004 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.89 -34.2 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.684 0.754 . . . . 0.0 109.878 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -83.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.357 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.2 mmm 42.55 -92.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.549 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.59 24.75 0.11 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.058 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -88.13 -163.96 1.04 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.382 0.134 . . . . 0.0 110.681 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.958 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.77 159.87 29.92 Favored Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.958 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -27.74 1.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.692 2.261 . . . . 0.0 112.125 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mt-10 -104.31 -48.51 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.659 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -70.86 -4.69 25.59 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.14 -47.53 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.022 0.439 . . . . 0.0 110.253 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.865 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -79.77 -37.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 47' ' ' GLU . 81.3 t -51.43 -35.69 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.624 0.249 . . . . 0.0 111.235 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -78.42 -29.59 47.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 111.296 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' GLU . 40.5 mm-40 -79.03 -37.6 38.63 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.982 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -47.87 -48.56 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.811 -177.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.31 -27.94 60.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.933 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -73.78 -25.37 60.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.968 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mp0 -108.49 5.95 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.023 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.7 t -133.77 -43.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 0.0 109.833 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.39 -40.85 0.49 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.8 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.51 -174.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.792 0.329 . . . . 0.0 110.798 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.18 89.12 7.93 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.728 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.904 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.2 Cg_endo -109.64 148.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.26 2.64 . . . . 0.0 114.805 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.87 80.14 2.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.982 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -124.17 130.06 51.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.743 -176.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 176.95 -172.91 0.1 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 9.3 t 70.45 161.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.859 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.2 pp -124.22 120.48 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -32.53 60.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 109.946 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 tt0 -171.56 163.91 6.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.816 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 127.19 16.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.55 116.23 28.74 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.802 0.811 . . . . 0.0 112.395 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.614 ' N ' HD22 ' A' ' 71' ' ' LEU . 64.3 tt0 -114.83 108.33 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.305 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CE2' ' CE1' ' A' ' 75' ' ' PHE . 4.6 t80 -142.48 139.37 31.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.283 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -120.49 119.02 31.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.772 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.3 m-85 -90.19 162.77 33.9 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.133 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -33.96 80.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.368 3.379 . . . . 0.0 113.431 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.9 m-20 87.01 -48.41 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.497 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.654 ' HD3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.21 108.3 19.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.62 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.468 ' N ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 m170 -96.75 154.55 17.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 HD11 ' A' ' 4' ' ' LEU . 1.3 tt -125.58 140.33 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.01 118.47 16.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.426 0.155 . . . . 0.0 110.608 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.067 HD12 HD12 ' A' ' 71' ' ' LEU . 3.7 mt -116.68 114.42 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.68 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -103.17 122.62 45.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.277 . . . . 0.0 110.605 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.3 m-30 -99.36 128.57 45.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.41 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.873 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.8 m95 -106.06 123.75 48.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.748 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.6 tp -83.15 97.51 8.86 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.852 -177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.1 t -73.3 146.46 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.39 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 5.5 mt-10 -114.02 -29.32 7.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.37 165.6 23.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.077 0.853 . . . . 0.0 112.172 -178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -153.86 124.35 7.08 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -80.06 156.83 26.92 Favored 'General case' 0 C--N 1.335 -0.036 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.9 -137.4 43.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.04 142.45 27.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.539 0.209 . . . . 0.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.37 128.89 10.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.795 2.33 . . . . 0.0 111.17 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.0 p-90 -139.18 -63.71 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.552 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.635 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.29 -97.07 0.01 OUTLIER Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.875 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER 168.06 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.984 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 16.6 pt-20 -60.29 -43.96 95.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.603 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 136.92 -43.71 1.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.719 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.687 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 11.9 mp0 -130.32 108.43 16.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 81.1 Cg_exo -50.19 145.16 21.05 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.985 2.456 . . . . 0.0 112.228 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.48 177.3 19.32 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.077 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 11.1 mm-40 -122.68 143.06 50.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.71 105.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.9 0.381 . . . . 0.0 111.316 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.459 ' HG3' ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -121.74 163.44 19.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.266 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -74.14 127.59 33.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -73.51 -18.31 61.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.679 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.2 t -55.72 -10.6 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 49.08 0.94 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.173 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.75 129.04 39.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.953 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -115.28 101.04 8.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.219 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.59 -15.78 61.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.192 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -30.96 60.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.795 0.331 . . . . 0.0 110.594 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.32 6.27 49.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.316 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.39 164.87 18.26 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.652 0.263 . . . . 0.0 111.204 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.68 136.82 72.53 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 112.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 53.8 Cg_endo -69.18 -16.89 40.34 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.605 2.203 . . . . 0.0 112.349 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.67 95.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.192 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.693 ' OD1' HD22 ' A' ' 82' ' ' LEU . 1.6 t30 -90.97 -4.33 56.56 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.437 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.547 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.55 -33.5 18.78 Favored Pre-proline 0 C--O 1.223 -0.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.567 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 61.6 Cg_exo -45.18 -51.55 7.58 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 121.692 1.595 . . . . 0.0 114.03 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.788 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -80.06 -54.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.3 -28.49 30.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.348 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.12 -49.36 71.96 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -53.44 -49.67 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mp -78.41 -43.05 28.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.542 . . . . 0.0 110.773 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 3.7 tttm -50.46 -42.22 54.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.606 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -63.45 -9.32 12.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.398 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.419 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.0 120.57 42.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.25 134.15 30.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.76 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.682 HD12 ' O ' ' A' ' 4' ' ' LEU . 4.1 pp -147.4 122.57 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.833 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 37.4 mt-30 -101.94 156.79 17.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.293 0.568 . . . . 0.0 112.027 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.621 HD11 H2'' ' A' ' 131' ' ' 8OG . 3.7 mp -146.74 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.14 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.24 123.61 36.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 118.664 0.666 . . . . 0.0 109.353 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -132.53 154.63 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 118.769 0.713 . . . . 0.0 112.197 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.42 135.71 6.33 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.588 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.807 HG22 ' CE2' ' A' ' 35' ' ' PHE . 2.7 pt -79.74 122.72 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.805 HD12 ' CE2' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -82.21 110.16 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -81.5 147.3 29.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.152 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.634 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -127.17 -173.84 3.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.463 1.125 . . . . 0.0 113.384 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 5.1 tp10 -53.27 -53.97 43.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 112.946 -1.934 . . . . 0.0 112.064 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 47.4 t-20 -70.94 -1.79 13.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.93 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 81.65 12.23 0.69 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.882 0.372 . . . . 0.0 111.21 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -105.16 144.15 32.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.95 117.43 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.805 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.5 101.43 0.45 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.904 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.37 162.79 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.678 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.7 p -70.03 131.52 44.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 110.36 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -117.19 88.98 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 30' ' ' ALA . 0.5 OUTLIER 57.01 21.58 6.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.163 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.35 -81.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.337 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.24 -69.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.23 143.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.008 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.36 36.84 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -134.47 -167.39 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 89.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 23' ' ' ARG . . . -72.63 -16.13 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.24 28.53 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.05 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.24 26.62 10.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.626 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -64.84 63.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.808 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -110.63 -172.02 1.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.074 0.464 . . . . 0.0 111.807 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.807 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.72 162.8 30.98 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.646 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.783 ' HG3' HD11 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -49.2 168.12 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.979 3.119 . . . . 0.0 112.112 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.33 60.59 0.74 Allowed Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.547 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.44 115.75 1.89 Allowed Glycine 0 C--N 1.309 -0.968 0 CA-C-N 114.957 -0.622 . . . . 0.0 111.98 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.74 21.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.009 0.524 . . . . 0.0 111.863 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.14 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -73.47 -33.22 39.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.791 0.805 . . . . 0.0 110.126 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.93 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.893 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.16 -89.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.01 26.8 0.12 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.148 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -93.66 -163.99 1.12 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.524 0.202 . . . . 0.0 110.655 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.48 156.11 37.15 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.2 Cg_endo -43.51 -27.15 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.51 2.14 . . . . 0.0 111.978 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.972 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -104.37 -46.38 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.491 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -4.01 29.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.937 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -82.92 -49.16 9.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 0.0 110.22 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.841 HG11 ' CE2' ' A' ' 85' ' ' TRP . 3.0 p -75.65 -31.12 22.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 47' ' ' GLU . 80.8 t -50.9 -35.46 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.7 -37.47 41.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' GLU . 19.7 mm-40 -78.98 -35.12 43.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 109.441 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.868 HD11 ' NE2' ' A' ' 64' ' ' HIS . 6.2 tp -47.47 -48.58 26.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.497 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' GLY . 47.4 tt0 -76.93 -28.42 55.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.188 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.07 -24.43 62.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 mp0 -108.14 6.49 26.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.823 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.89 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.7 -44.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 109.706 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.82 -37.83 0.23 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.272 -0.876 . . . . 0.0 115.09 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.89 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -84.36 -174.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 88.62 8.45 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.974 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.605 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -112.12 152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.399 2.733 . . . . 0.0 114.428 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 50.0 mt-30 -74.66 80.65 2.03 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -127.42 130.6 49.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.581 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.39 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.741 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.41 163.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.843 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -124.63 120.14 31.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -38.04 56.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.1 tt0 -171.55 166.47 6.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.823 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 133.54 24.3 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -101.02 115.66 31.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.931 0.872 . . . . 0.0 112.691 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -115.57 107.69 15.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.113 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.636 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.2 t80 -143.09 126.94 17.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.853 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.76 107.81 12.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.053 0.454 . . . . 0.0 111.345 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 14.2 m-85 -72.99 163.59 67.31 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.58 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -48.76 84.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.503 2.802 . . . . 0.0 112.021 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.7 t70 93.55 27.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.208 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -137.62 152.4 49.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.379 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 2.2 t-80 -146.28 107.67 4.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 73' ' ' TYR . 3.5 tt -117.9 135.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.5 17.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.796 0.331 . . . . 0.0 110.818 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.772 HD13 ' OD1' ' A' ' 119' ' ' ASN . 3.7 mt -118.22 113.93 22.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.744 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CH2' ' CB ' ' A' ' 46' ' ' PRO . 12.7 m0 -103.45 122.08 44.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -96.89 121.35 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.482 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.841 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.3 m95 -97.72 112.77 24.52 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.742 ' O ' ' O ' ' A' ' 65' ' ' PHE . 61.7 tp -74.63 98.16 3.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.72 0.772 . . . . 0.0 112.815 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -75.01 146.09 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.945 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 4.7 mt-10 -112.32 -37.46 4.99 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.07 165.89 24.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.778 0.717 . . . . 0.0 112.051 -178.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.735 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.5 p90 -146.35 132.01 18.88 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.558 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.55 149.86 25.07 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.41 -125.18 33.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.451 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.5 mt-10 -127.07 138.01 31.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.387 0.137 . . . . 0.0 110.815 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -76.18 128.7 10.75 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.913 2.408 . . . . 0.0 111.362 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 56.3 p-90 -133.91 -63.95 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.379 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.48 -114.47 1.25 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.156 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 8.3 tptt 176.91 41.64 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.63 -48.24 79.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.7 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -41.05 1.47 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.521 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.603 ' O ' HG22 ' A' ' 21' ' ' THR . 86.5 mt-30 -125.26 101.49 31.4 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 112.012 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.94 146.11 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.013 2.475 . . . . 0.0 112.523 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.45 177.09 19.47 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.003 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -129.37 150.2 50.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.73 106.9 0.86 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.511 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.427 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.3 ptm -120.34 163.13 18.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.506 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.2 p -79.01 119.27 21.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.259 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.2 tm? -69.13 -18.36 63.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.516 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.8 t -55.26 -13.38 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.93 50.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.209 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD13 HD22 ' A' ' 107' ' ' LEU . 7.3 tp -62.1 130.54 45.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.725 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.29 121.17 35.17 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.71 -15.45 61.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.866 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -40.61 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.026 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -81.84 -25.91 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.235 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.0 165.25 25.09 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.563 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 22.0 Cg_endo -61.42 127.91 23.29 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.332 2.021 . . . . 0.0 112.367 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -14.89 46.86 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.453 2.102 . . . . 0.0 112.14 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.66 -18.2 65.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.405 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.772 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.1 m-80 -113.56 11.81 18.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER -56.71 -37.58 59.25 Favored Pre-proline 0 C--O 1.222 -0.343 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.834 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.0 Cg_exo -44.45 -45.43 12.79 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.183 1.922 . . . . 0.0 114.537 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -79.47 -54.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.084 0.469 . . . . 0.0 111.432 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -63.5 -26.93 41.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.798 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.45 -47.07 73.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -54.16 46.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.291 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tp -78.95 -45.9 19.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.88 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.62 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -49.78 -40.17 40.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.764 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -63.28 -10.31 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.372 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.621 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 125.07 52.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 2.6 mtmp? -137.94 153.21 49.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.728 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.77 HD23 ' CD ' ' A' ' 78' ' ' ARG . 2.8 pp -146.6 117.01 7.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.127 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 43.6 mt-30 -102.74 156.68 17.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.61 0.719 . . . . 0.0 112.851 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 88.3 mt -146.59 140.56 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.983 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.84 124.8 40.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 119' ' ' ASN . 0.7 OUTLIER -132.72 159.38 43.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.63 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.65 155.11 25.96 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.39 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -96.38 119.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.858 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -81.09 111.31 17.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 112.292 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.43 151.46 29.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.741 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 6.2 t30 -130.2 -172.61 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.168 0.985 . . . . 0.0 112.819 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.37 -57.98 10.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.436 -1.711 . . . . 0.0 112.207 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 5.2 t-20 -67.83 -6.68 22.68 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.822 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.1 t30 86.39 10.91 0.2 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.211 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -103.77 128.05 51.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.005 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -102.84 121.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.897 0.856 . . . . 0.0 112.914 -175.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.9 104.63 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.595 -178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.743 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -107.84 138.99 31.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.809 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.8 p -70.36 111.25 5.8 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -126.9 136.51 52.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ALA . 19.3 mtt180 51.73 22.94 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.627 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.36 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.633 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -149.24 71.14 1.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.844 0.354 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.56 126.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.78 -168.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 64.46 -172.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.17 101.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.332 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -87.15 -8.96 56.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.71 31.19 2.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 111.01 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.49 26.95 10.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.728 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -62.96 63.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.962 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.6 tt0 -113.23 171.05 7.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.266 0.555 . . . . 0.0 112.023 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' HD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.02 168.52 10.19 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.557 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' HD11 ' A' ' 11' ' ' ILE . 7.8 Cg_endo -47.47 168.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.21 3.274 . . . . 0.0 112.717 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.1 60.49 0.71 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.012 -1.09 . . . . 0.0 114.966 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 129.72 5.32 Favored Glycine 0 C--N 1.313 -0.743 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.769 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 ttmm 87.63 28.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.139 0.47 . . . . 0.0 111.233 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.983 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -82.19 -33.58 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.898 0.856 . . . . 0.0 109.546 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.32 -85.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.275 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.9 mtm 42.9 -89.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.569 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.07 32.81 0.1 OUTLIER Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.433 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.54 -165.68 1.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.929 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.942 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.2 162.14 21.47 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.942 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.14 -29.37 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.715 2.277 . . . . 0.0 112.344 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.5 mp0 -104.9 -46.7 4.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -4.04 32.72 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.769 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -80.14 -52.56 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.748 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.8 p -79.68 -36.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.09 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.8 t -51.03 -35.48 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.878 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -77.12 -28.69 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -78.95 -38.57 36.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.927 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.95 -48.47 32.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.236 -177.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.65 -32.54 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -70.5 -23.73 62.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.111 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -109.0 5.38 24.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 60' ' ' ILE . 17.1 t -134.37 -44.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.661 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.11 8.16 16.2 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.576 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.5 -168.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.807 0.803 . . . . 0.0 110.543 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -104.78 89.47 2.85 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.1 Cg_endo -111.4 135.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.259 2.639 . . . . 0.0 114.337 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 61.7 mt-30 -74.72 78.75 2.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.951 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -117.57 124.37 48.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.111 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 177.22 -173.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.494 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER 73.94 155.11 0.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.413 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 tt -115.99 112.66 22.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.67 -35.27 62.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -171.77 167.37 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.541 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' HD11 ' A' ' 67' ' ' LEU . 15.1 ptmm? -144.34 132.37 21.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.2 tp -97.34 115.66 28.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.569 0.699 . . . . 0.0 112.327 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -114.3 108.1 16.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.447 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.75 130.49 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.164 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' HIS . 2.7 pt-20 -115.74 121.88 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.299 0.571 . . . . 0.0 111.613 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.6 m-85 -92.25 162.54 29.9 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.166 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.446 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 4.1 Cg_exo -33.58 80.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.36 3.373 . . . . 0.0 113.407 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 75' ' ' PHE . 15.7 t70 87.62 -48.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.246 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.77 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -84.67 108.25 17.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -98.71 154.16 18.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 4' ' ' LEU . 4.0 tt -136.3 136.76 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.816 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 83' ' ' TRP . 3.2 m -134.86 129.66 34.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.731 0.3 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD12 HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -116.26 119.78 36.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.204 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.65 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -97.56 123.0 41.28 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.789 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.9 m-30 -101.65 123.68 46.04 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 54.9 m95 -108.44 126.79 53.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.026 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 53.2 tp -81.38 96.96 7.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.732 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' CD2' ' A' ' 64' ' ' HIS . 13.3 t -75.52 146.51 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.261 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.57 -26.36 7.93 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.19 165.55 24.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.598 1.09 . . . . 0.0 112.553 -178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.742 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.5 119.24 6.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.986 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' THR . 4.7 tt0 -71.79 149.2 45.54 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.914 0.387 . . . . 0.0 111.202 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.18 -130.15 46.96 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.657 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.5 tt0 -116.05 140.55 26.45 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.436 0.16 . . . . 0.0 110.637 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.706 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.89 128.95 10.34 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.864 2.376 . . . . 0.0 111.366 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 60.8 p-90 -143.87 -58.57 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.327 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 40.33 -95.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.893 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 2.7 tttt 174.67 37.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 18.5 pt-20 -61.16 -40.6 94.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.702 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 130.36 -67.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.687 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 6.9 mt-30 -103.37 117.47 60.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.34 146.36 24.82 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.166 2.577 . . . . 0.0 112.288 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.03 177.2 19.3 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -134.26 148.15 50.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 110.518 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.23 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.541 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.4 mtt -119.9 163.1 18.06 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.072 0.463 . . . . 0.0 111.72 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.61 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.41 123.23 29.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.691 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD21 HD13 ' A' ' 10' ' ' ILE . 12.1 tp -78.6 -18.21 54.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.675 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.5 p -49.64 -21.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.19 53.46 0.65 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.633 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.9 tt -62.63 150.4 40.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 0.0 110.854 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -115.58 109.98 18.55 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.576 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.34 -15.97 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.693 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -35.82 45.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.496 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -9.87 57.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.454 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.818 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.04 162.14 20.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.676 0.274 . . . . 0.0 110.87 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.54 129.31 34.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.474 2.116 . . . . 0.0 112.474 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.33 -14.75 45.8 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.669 2.246 . . . . 0.0 112.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.41 69.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 8' ' ' VAL . 1.3 m-20 -107.54 0.7 22.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -53.91 -40.17 79.24 Favored Pre-proline 0 C--O 1.222 -0.369 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.642 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.1 Cg_exo -44.58 -44.11 13.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.303 2.002 . . . . 0.0 114.27 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -79.31 -54.22 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.0 111.568 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -64.52 -27.68 43.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.35 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.05 -50.05 67.59 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.419 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -50.39 68.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.468 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.44 -49.9 12.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.576 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 4.2 tttm -50.97 -38.9 53.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.146 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -64.05 -9.17 14.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.561 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.414 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.485 ' N7 ' ' HB2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.893 0.378 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.36 114.05 21.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.18 139.47 35.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -147.63 120.76 8.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.302 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.482 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 34.9 mt-30 -102.1 156.46 17.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.094 0.473 . . . . 0.0 111.58 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.5 mp -146.17 139.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.1 140.6 52.15 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -144.33 155.61 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 119.68 1.127 . . . . 0.0 111.298 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.03 146.03 14.52 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.336 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.93 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -101.66 122.26 53.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.875 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -82.55 111.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -79.1 154.03 29.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.97 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' ND2' ' CE2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -131.12 -173.05 2.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 122.449 1.118 . . . . 0.0 113.472 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.55 -55.43 25.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.988 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 19.5 t-20 -71.19 -7.3 45.85 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.445 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 84.98 15.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.04 0.448 . . . . 0.0 110.422 -178.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 16.0 pt-20 -106.58 135.43 48.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -102.0 116.31 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -175.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -63.36 97.22 0.12 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.449 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -109.09 151.25 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 59.4 p -70.48 131.05 43.45 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -148.3 128.03 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.359 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 25' ' ' ALA . 1.5 mtt-85 42.72 28.59 0.13 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.613 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . . . 54.29 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.438 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -165.8 31.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.171 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.6 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 178.94 112.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.82 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 17.9 mmt -92.55 51.74 1.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 110.864 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.3 66.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.46 13.49 15.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.426 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.12 10.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.075 0.464 . . . . 0.0 111.195 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.1 tt -68.6 67.29 0.13 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.389 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.2 tt0 -112.8 -177.4 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.398 0.618 . . . . 0.0 112.081 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.84 168.1 10.98 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.612 -179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -48.51 167.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.544 2.83 . . . . 0.0 111.304 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.16 60.81 0.75 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 119.252 -1.451 . . . . 0.0 114.966 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.4 111.99 1.05 Allowed Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.95 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.82 22.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.978 0.511 . . . . 0.0 111.621 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.017 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -68.27 -35.9 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.933 0.873 . . . . 0.0 109.338 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.82 -83.18 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.338 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 mtm 42.29 -91.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.661 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.24 24.22 0.14 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.031 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -89.85 -165.88 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.524 0.202 . . . . 0.0 110.614 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.978 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.42 159.98 30.67 Favored Pre-proline 0 N--CA 1.456 -0.173 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.978 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.4 Cg_endo -43.66 -28.04 1.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.591 2.194 . . . . 0.0 112.21 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.976 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.25 -47.64 4.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.488 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.34 -4.29 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.88 -48.04 12.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -78.76 -35.06 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -35.39 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 0.0 110.722 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -77.98 -30.78 50.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.134 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -78.85 -37.48 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.675 0.75 . . . . 0.0 109.362 178.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.742 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.14 -48.92 33.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.501 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -26.82 53.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.26 -27.53 60.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 11.5 mp0 -108.23 6.81 27.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.71 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.95 HG12 HG13 ' A' ' 60' ' ' ILE . 60.2 t -132.83 -43.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-O 120.99 0.424 . . . . 0.0 109.895 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -40.72 0.34 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.802 -0.636 . . . . 0.0 114.266 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.95 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.48 -176.39 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.4 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.45 89.08 9.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.642 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.835 ' HG3' HG11 ' A' ' 58' ' ' VAL . 8.5 Cg_endo -110.79 151.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.351 2.7 . . . . 0.0 114.76 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 66.6 mt-30 -74.73 81.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.748 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.58 131.6 52.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.154 -176.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 175.66 -171.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.568 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.0 OUTLIER 70.77 160.87 0.22 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.315 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -124.87 122.99 38.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.76 -50.29 15.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.623 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 tt0 -161.3 137.67 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.297 0.57 . . . . 0.0 111.25 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -124.81 133.43 53.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.925 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.844 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -104.58 115.28 30.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.838 0.828 . . . . 0.0 112.081 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' CG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -115.6 108.45 16.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.753 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 80' ' ' ILE . 4.0 t80 -142.65 132.38 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.501 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -121.76 117.88 27.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 111.355 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 30.3 m-85 -82.02 163.48 52.96 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.463 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.2 Cg_endo -42.02 83.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.838 3.026 . . . . 0.0 112.53 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 23.2 t0 101.77 -27.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.515 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 1.9 ttm180 -76.94 152.99 35.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.949 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 63.5 m-70 -146.31 109.95 4.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.284 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.765 HD12 HD11 ' A' ' 4' ' ' LEU . 5.2 tt -126.25 139.97 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -132.59 118.6 19.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.714 0.293 . . . . 0.0 110.69 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.908 HD23 ' CG2' ' A' ' 122' ' ' VAL . 1.6 tp -108.45 113.66 26.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.505 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 11.4 m0 -112.04 122.47 47.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.714 0.292 . . . . 0.0 110.895 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -107.93 129.91 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.822 ' CE2' HG11 ' A' ' 50' ' ' VAL . 81.2 m95 -104.7 119.0 37.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.839 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 10' ' ' ILE . 1.7 tm? -81.89 98.17 8.4 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.419 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -71.75 146.56 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.164 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.46 -30.22 7.22 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.02 164.42 25.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.802 0.728 . . . . 0.0 111.561 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.678 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -149.81 128.85 12.66 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.49 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.82 148.26 31.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.42 -117.5 11.32 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.2 mt-10 -135.07 141.02 36.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.466 0.174 . . . . 0.0 110.898 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.0 Cg_exo -76.55 128.88 10.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.047 2.498 . . . . 0.0 111.252 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.5 p-90 -137.45 -64.71 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.88 -95.37 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.93 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.8 ttpm? 168.58 46.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.678 0.391 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 14.1 pt-20 -76.62 -48.5 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.364 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 174.56 -136.69 3.6 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.188 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' O ' HG22 ' A' ' 21' ' ' THR . 1.5 mp0 -75.86 131.44 76.36 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.227 0.537 . . . . 0.0 111.865 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -43.66 145.0 1.96 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.403 2.735 . . . . 0.0 113.307 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.7 18.97 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.555 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.48 157.05 30.22 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.745 -0.268 . . . . 0.0 110.6 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.96 106.56 1.96 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.9 ptm -120.31 163.02 18.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.568 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.8 t -76.92 128.65 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -80.17 -18.48 49.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.385 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.2 t -53.52 -16.68 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 52.81 0.75 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 111' ' ' ASN . 8.8 tt -62.17 150.43 38.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.584 0.231 . . . . 0.0 110.562 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.867 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.51 113.56 21.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.35 61.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.401 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -38.81 53.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.08 -18.74 45.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.654 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.92 159.43 30.88 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.742 0.306 . . . . 0.0 110.928 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.6 Cg_endo -58.64 137.21 78.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.661 2.241 . . . . 0.0 112.705 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.06 -14.68 38.76 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.71 2.273 . . . . 0.0 112.402 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.4 -19.24 63.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.312 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.54 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -116.48 7.43 13.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.137 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.13 -32.67 12.36 Favored Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.2 Cg_exo -44.9 -50.49 8.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.922 1.748 . . . . 0.0 113.817 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.908 ' CG2' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.01 -53.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.085 0.469 . . . . 0.0 111.458 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.2 mm -60.15 -28.45 41.56 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.106 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -51.04 67.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.317 0.58 . . . . 0.0 109.57 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -54.28 -49.37 69.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.309 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -49.76 13.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.035 0.445 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -51.09 -40.15 57.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.174 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -64.36 -8.44 13.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.726 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.429 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.575 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 147.25 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.43 155.2 50.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.765 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.824 HD11 HD12 ' A' ' 80' ' ' ILE . 3.7 pp -146.61 119.02 8.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.278 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.603 ' C ' HD12 ' A' ' 6' ' ' ILE . 46.9 mt-30 -102.21 155.66 18.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.612 0.72 . . . . 0.0 112.865 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.689 HD11 H2'' ' A' ' 131' ' ' 8OG . 4.6 mp -146.75 140.07 19.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.019 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.32 124.62 39.13 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.5 m -133.6 159.26 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.166 -0.613 . . . . 0.0 111.537 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.21 151.94 23.91 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.749 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -92.94 119.42 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -81.09 112.43 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 5.9 mmm-85 -85.04 148.29 26.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.592 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.653 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -133.48 -172.5 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.572 0.701 . . . . 0.0 111.693 178.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -49.24 -55.77 11.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.028 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.8 t-20 -62.47 -12.11 20.09 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.487 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 81.38 8.51 1.04 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.432 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.653 ' HG2' HD21 ' A' ' 13' ' ' ASN . 16.7 pt-20 -104.74 135.42 46.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.45 120.16 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -174.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.76 107.44 0.97 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.671 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.6 134.71 49.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.369 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 t -70.52 111.08 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 34.0 ptt180 -120.92 133.74 55.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.916 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 36.07 34.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.064 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 56.63 -164.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 111.118 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -97.63 29.07 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.06 -76.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.42 132.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.16 -65.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.797 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.2 mmt -133.14 92.02 2.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.648 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -62.43 -26.14 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.51 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -96.76 30.83 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.07 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 26.46 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.402 . . . . 0.0 111.658 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.1 tt -68.78 57.95 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 0.3 OUTLIER -107.15 -175.53 2.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.995 0.426 . . . . 0.0 111.714 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.2 162.76 32.09 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.637 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HG3' HD11 ' A' ' 11' ' ' ILE . 8.8 Cg_endo -49.52 168.21 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.663 2.909 . . . . 0.0 111.765 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 60.43 0.73 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.747 -1.216 . . . . 0.0 114.48 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.91 109.43 0.9 Allowed Glycine 0 C--N 1.311 -0.86 0 CA-C-N 114.672 -0.764 . . . . 0.0 111.879 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.8 tttp 112.16 19.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.183 0.593 . . . . 0.0 111.542 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.019 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -70.22 -34.16 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.765 0.793 . . . . 0.0 110.022 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.58 -81.89 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.329 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.8 mmt 41.3 -90.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.714 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.74 27.49 0.11 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.978 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -92.17 -163.94 1.11 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.503 0.192 . . . . 0.0 110.841 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.951 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.25 159.39 32.15 Favored Pre-proline 0 N--CA 1.456 -0.158 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -27.68 1.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.685 2.257 . . . . 0.0 111.915 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.939 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.1 mt-10 -104.18 -48.47 3.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.327 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -70.77 -4.49 24.17 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.85 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.9 -47.95 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.969 0.414 . . . . 0.0 110.24 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.59 -35.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.398 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.3 t -52.03 -35.89 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.252 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.4 -31.04 48.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.536 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 57' ' ' GLU . 59.4 mm-40 -79.06 -36.55 40.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.684 0.754 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.972 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -47.35 -48.05 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.966 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -27.52 61.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.353 0.597 . . . . 0.0 110.134 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -76.84 -26.06 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.183 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -108.47 5.43 25.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.559 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.2 t -134.24 -44.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.781 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.26 -42.04 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.348 -0.842 . . . . 0.0 113.849 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.909 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.67 -176.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.023 0.44 . . . . 0.0 111.083 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -110.96 89.2 9.18 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.396 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -110.54 151.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 123.233 2.622 . . . . 0.0 115.19 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.8 mt-30 -76.72 80.38 3.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.972 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -123.27 129.05 50.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.644 -176.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 172.2 -168.0 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.213 0.53 . . . . 0.0 111.368 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 86' ' ' LEU . 33.1 p 59.04 96.98 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.118 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -60.18 128.29 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.185 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -76.54 -34.32 58.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 7.0 tt0 -171.44 167.34 6.78 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.426 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 132.4 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.763 HD23 HD12 ' A' ' 82' ' ' LEU . 6.7 tp -98.48 115.41 28.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.91 0.862 . . . . 0.0 112.455 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.74 108.37 16.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.435 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.51 138.89 31.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.28 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.4 pt-20 -118.92 113.34 20.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.29 0.567 . . . . 0.0 111.724 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.7 m-85 -86.16 162.77 45.29 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.102 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 4.5 Cg_exo -33.26 80.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 124.451 3.434 . . . . 0.0 113.489 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.4 t70 87.12 -48.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.565 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 5.3 ttm-85 -88.56 107.43 18.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 2.8 t60 -95.43 154.61 17.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.908 0.385 . . . . 0.0 111.113 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 4' ' ' LEU . 1.2 tt -127.92 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.63 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.84 118.51 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.476 0.179 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.763 HD12 HD23 ' A' ' 71' ' ' LEU . 3.7 mt -115.66 114.28 24.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 110.607 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.5 m0 -99.88 123.93 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.692 0.282 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 5.2 m-30 -100.36 123.75 44.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.515 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.924 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 91.8 m95 -102.28 119.24 38.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.642 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.9 tp -81.71 97.44 7.93 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.666 0.746 . . . . 0.0 112.31 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.0 t -72.86 145.93 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.511 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -112.34 -31.69 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.89 164.91 25.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.954 0.797 . . . . 0.0 111.88 -178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -151.77 128.91 11.14 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.635 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -77.68 152.25 33.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.982 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.81 -128.32 42.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.699 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -122.41 146.05 46.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.565 0.221 . . . . 0.0 110.849 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.6 128.75 10.45 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.958 2.438 . . . . 0.0 111.506 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.6 p-90 -137.19 -61.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.059 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.626 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.24 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.139 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.67 40.26 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 23.8 pt-20 -58.13 -47.34 83.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 143.73 -42.77 1.04 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.663 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.4 mp0 -138.2 120.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 92.4 Cg_exo -48.41 146.16 10.7 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.177 2.584 . . . . 0.0 112.504 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.3 19.27 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -126.99 150.59 49.35 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -62.77 105.85 0.72 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.585 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.555 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -121.46 144.93 48.42 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.496 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 17' ' ' GLU . 1.8 t -67.5 130.69 43.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.56 HD21 HD13 ' A' ' 10' ' ' ILE . 13.5 tp -74.64 -18.03 60.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.831 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.59 -14.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.87 50.86 0.87 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.11 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.967 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.68 130.25 44.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.848 0.356 . . . . 0.0 110.217 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.967 ' N ' HD22 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.45 108.94 15.16 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.71 -15.69 61.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -31.89 64.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.596 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.605 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -92.42 -11.86 33.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.15 162.47 19.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.93 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 18.3 Cg_endo -58.89 135.56 67.66 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.712 2.275 . . . . 0.0 112.624 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.08 -14.81 38.94 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.607 2.205 . . . . 0.0 112.426 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.63 67.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.193 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.533 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.2 m-20 -109.49 4.1 21.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.165 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -57.16 -34.91 29.78 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.594 ' HB2' HD22 ' A' ' 71' ' ' LEU . 66.8 Cg_exo -44.97 -50.55 8.55 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.985 1.79 . . . . 0.0 114.345 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.72 -54.27 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.081 0.467 . . . . 0.0 110.948 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.575 HG23 HD11 ' A' ' 110' ' ' LEU . 1.1 mm -57.47 -27.77 29.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.145 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.79 -48.94 72.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -52.29 61.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.21 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.28 -46.5 20.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.982 0.42 . . . . 0.0 111.317 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 2.5 ttpt -50.17 -39.68 44.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.883 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -63.42 -10.51 17.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.504 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.454 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.689 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.821 0.343 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 122.43 46.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 79' ' ' HIS . 18.1 mtmt -139.38 152.22 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 80' ' ' ILE . 3.9 pp -146.52 123.6 11.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.421 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 33.4 mt-30 -102.89 151.33 22.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.485 0.659 . . . . 0.0 112.533 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 " O5'" ' A' ' 131' ' ' 8OG . 24.9 mm -147.09 139.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.988 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.97 144.83 50.9 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.626 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -144.49 159.26 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 118.808 0.731 . . . . 0.0 111.466 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.87 147.45 17.28 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.091 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.709 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -97.85 120.7 47.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.779 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.56 111.5 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.01 153.7 28.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.964 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -130.27 -171.65 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.234 1.016 . . . . 0.0 112.72 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -46.3 -50.26 16.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.379 -1.737 . . . . 0.0 112.66 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -84.96 -73.21 0.44 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 167.59 16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.309 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.2 mt-10 -108.91 128.26 54.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -103.61 129.19 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -173.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.5 100.74 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.036 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -105.44 131.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.76 123.72 22.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.205 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.706 ' HD3' HD22 ' A' ' 33' ' ' LEU . 57.8 ttp180 -148.17 147.63 29.66 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.026 0.441 . . . . 0.0 111.511 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 36.1 mtp180 41.96 28.68 0.1 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.185 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 46.49 28.99 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.844 0.354 . . . . 0.0 111.422 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.28 29.55 19.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.05 -68.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.72 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.219 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -49.38 127.4 15.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.159 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.6 mtt 59.31 63.52 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -64.21 -19.86 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -95.5 31.28 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 26.17 10.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.819 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD22 ' HD3' ' A' ' 22' ' ' ARG . 15.6 tp -67.94 63.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.714 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.3 tt0 -120.21 -173.87 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.48 168.15 11.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.827 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 8.5 Cg_endo -47.56 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.02 3.146 . . . . 0.0 112.096 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.51 60.89 0.7 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.757 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.96 108.09 0.66 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.838 -0.681 . . . . 0.0 112.06 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.21 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.217 0.607 . . . . 0.0 111.756 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.988 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -63.1 -34.6 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.762 0.792 . . . . 0.0 109.939 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.45 -86.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.4 mtm 47.77 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.644 0.259 . . . . 0.0 111.362 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.03 30.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.832 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.85 -165.16 1.24 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.505 0.193 . . . . 0.0 110.842 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.936 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -96.81 161.96 24.7 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.936 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.86 -27.64 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.685 2.257 . . . . 0.0 112.172 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.927 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mp0 -104.31 -49.66 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.488 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.88 -4.56 16.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.21 -46.84 15.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.11 0.481 . . . . 0.0 110.296 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.1 p -80.3 -39.05 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.308 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.2 t -50.6 -35.75 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.561 0.219 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -28.54 47.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.956 0.407 . . . . 0.0 111.065 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.16 -37.6 38.04 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.4 -49.1 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.829 -177.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -27.36 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.134 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -72.38 -26.49 61.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.801 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.6 mp0 -108.69 5.8 25.16 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.068 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.021 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -133.66 -44.07 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 110.23 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.16 -41.39 0.36 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.722 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.021 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.37 -175.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.946 0.403 . . . . 0.0 110.886 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.89 89.01 10.71 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.079 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.954 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -108.58 149.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.339 2.693 . . . . 0.0 113.895 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.62 79.63 2.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.029 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.67 128.87 50.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.534 -176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 178.36 -174.1 0.16 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 111.336 -179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 73.01 157.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.727 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.888 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -121.15 119.62 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.175 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.29 -35.87 61.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.511 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.4 tt0 -171.51 168.38 6.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -144.17 132.11 21.52 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -98.55 115.19 28.06 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.859 0.838 . . . . 0.0 111.915 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.9 108.51 16.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.586 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.34 132.57 24.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.09 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -113.27 126.66 55.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.304 0.573 . . . . 0.0 111.893 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.59 163.35 20.63 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.221 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -34.55 81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.193 3.262 . . . . 0.0 113.28 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' PHE . 6.8 t70 88.33 -48.01 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.318 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -84.71 111.32 19.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.562 ' NE2' HG23 ' A' ' 81' ' ' THR . 23.9 t60 -101.27 154.8 18.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.526 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -129.81 145.19 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.562 HG23 ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -128.06 120.8 28.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -112.14 114.68 27.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.857 0.36 . . . . 0.0 111.603 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -107.56 122.49 46.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.7 0.286 . . . . 0.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.1 m-85 -104.81 130.0 52.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 79.8 m95 -108.73 124.0 49.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.827 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 15.2 tp -83.73 98.22 9.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.378 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.029 HG22 ' ND1' ' A' ' 64' ' ' HIS . 18.5 t -73.26 146.85 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.376 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -113.08 -33.67 5.95 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -163.3 165.2 24.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.897 0.772 . . . . 0.0 111.76 -178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.726 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -148.17 129.04 14.34 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.547 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -79.01 147.15 32.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.79 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.11 -118.19 12.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.401 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.7 mt-10 -133.65 141.09 38.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.403 0.144 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.29 128.97 10.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.874 2.383 . . . . 0.0 111.421 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.621 ' NE1' HG23 ' A' ' 60' ' ' ILE . 58.2 p-90 -135.15 -63.58 0.68 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.522 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.71 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.986 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER 166.62 40.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.943 0.401 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 13.0 pt-20 -56.66 -36.09 69.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.84 -47.09 0.99 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.44 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.61 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.2 mp0 -133.96 112.41 12.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.987 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.4 143.94 3.4 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.938 2.425 . . . . 0.0 112.513 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.38 177.39 19.23 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.4 mt-10 -133.64 150.0 51.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.473 0.177 . . . . 0.0 110.525 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.35 106.93 0.43 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 110.699 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.496 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.71 147.88 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.741 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.418 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -58.45 114.51 2.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.945 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.92 -18.57 60.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.532 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -53.51 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.4 50.35 0.86 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 123' ' ' ILE . 8.6 tt -62.46 150.25 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.695 0.284 . . . . 0.0 110.739 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -114.0 104.9 12.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.817 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.28 -15.62 61.9 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -46.66 18.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.701 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.44 -33.6 69.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.59 165.59 46.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.694 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 9.9 Cg_endo -54.32 138.12 72.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.526 2.151 . . . . 0.0 112.581 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.557 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 53.9 Cg_endo -69.24 -14.97 38.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.707 2.271 . . . . 0.0 112.79 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 111.456 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.576 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -103.6 -8.11 20.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.584 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.742 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 16.1 tt0 -52.37 -36.59 34.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.577 ' HB2' HD22 ' A' ' 71' ' ' LEU . 44.5 Cg_exo -44.18 -50.71 7.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.131 1.887 . . . . 0.0 114.098 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -79.46 -54.14 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.817 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.2 mm -57.15 -28.41 29.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -51.01 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -54.25 -49.71 68.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.249 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 129' ' ' LEU . 1.2 tp -77.3 -50.05 13.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 0.0 111.014 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.806 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -51.09 -39.79 56.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.266 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -9.56 15.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.662 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.32 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.832 " H3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.84 0.352 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 79' ' ' HIS . 8.7 ttpt -109.84 139.15 45.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.5 132.8 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.741 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.879 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -147.89 128.14 13.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.474 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.556 ' C ' HD12 ' A' ' 6' ' ' ILE . 25.9 mt-30 -102.28 157.1 17.14 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.311 0.576 . . . . 0.0 111.709 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.31 140.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.716 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.82 40.45 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -135.65 158.27 39.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 118.506 0.594 . . . . 0.0 111.278 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.27 155.11 25.96 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.753 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.97 HD12 ' HG ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -93.57 117.19 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.731 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 6.3 mt -81.39 110.14 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 0.0 111.671 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.5 mmt180 -80.93 153.13 27.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.286 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t30 -124.51 -173.05 2.69 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 122.418 1.104 . . . . 0.0 113.488 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -48.0 -47.69 33.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.021 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -91.8 -65.17 1.03 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.071 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.8 p30 166.89 15.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.833 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 2.5 pm0 -102.43 118.76 37.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.807 HG21 HD11 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -101.16 122.6 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -173.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.726 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.79 105.13 0.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.214 -178.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -103.91 136.92 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.467 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.6 p -70.67 111.92 6.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.693 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.776 ' HB2' HD13 ' A' ' 33' ' ' LEU . 8.9 ttp85 -129.71 142.34 50.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 59.96 13.46 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.078 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 45.75 25.06 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 162.61 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.901 0.381 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -45.45 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.45 104.54 1.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.65 -68.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.08 63.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.847 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.31 52.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.347 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -79.97 1.56 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.452 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 26.68 9.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 22' ' ' ARG . 18.8 tp -65.48 61.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HB2' ' CD ' ' A' ' 116' ' ' PRO . 2.0 tt0 -116.66 -170.33 1.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.0 163.24 29.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.366 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -48.32 168.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.662 2.908 . . . . 0.0 111.714 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.86 60.06 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.752 -1.213 . . . . 0.0 114.385 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.96 121.34 3.18 Favored Glycine 0 C--N 1.312 -0.804 0 CA-C-N 114.653 -0.773 . . . . 0.0 111.872 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 98.55 20.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.077 0.551 . . . . 0.0 111.749 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.12 -32.06 46.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.696 0.76 . . . . 0.0 109.808 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.64 -81.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.286 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mtp 39.67 -90.24 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.719 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.99 31.36 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.944 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -85.48 -160.83 0.54 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.535 0.207 . . . . 0.0 110.848 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.94 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.53 160.49 27.92 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.94 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.94 -30.01 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.617 2.211 . . . . 0.0 111.807 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.58 -45.83 4.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.515 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.17 -4.74 27.1 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.07 -54.01 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.034 0.445 . . . . 0.0 109.94 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.6 p -80.33 -42.12 21.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.096 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 47' ' ' GLU . 75.0 t -50.91 -35.88 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.219 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -28.6 48.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.47 . . . . 0.0 110.781 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 40' ' ' ILE . 12.0 mm-40 -79.24 -38.49 35.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.038 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.823 HD11 ' NE2' ' A' ' 64' ' ' HIS . 1.8 tp -47.62 -48.12 28.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.981 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -26.94 61.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.395 0.617 . . . . 0.0 109.628 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -75.14 -23.98 57.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.886 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 5.3 mm-40 -108.42 5.5 25.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.711 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 14.2 t -134.19 -43.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.126 0.488 . . . . 0.0 109.83 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.15 -39.9 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.764 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.33 -174.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 120.838 0.351 . . . . 0.0 110.702 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.84 88.61 10.06 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.833 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.897 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.6 Cg_endo -109.34 150.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.24 2.627 . . . . 0.0 114.258 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -74.93 79.42 2.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -125.02 128.61 48.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.364 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 177.69 -173.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.001 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 71.17 159.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.749 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.3 pp -123.29 120.39 32.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.41 -33.12 60.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.6 tt0 -171.92 166.63 6.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.932 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -144.46 124.14 13.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 82' ' ' LEU . 1.7 tm? -96.68 116.28 28.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -115.36 107.32 15.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 t80 -143.58 124.46 14.29 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.102 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.64 111.06 16.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.3 m-85 -76.31 163.47 66.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.988 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.02 84.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.529 2.82 . . . . 0.0 112.155 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.5 t0 94.12 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.192 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.6 152.86 49.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.545 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' CB ' ' HA ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -146.52 108.98 4.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.673 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 73' ' ' TYR . 2.2 tt -124.56 135.78 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.02 118.13 16.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.786 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.978 HD12 HD12 ' A' ' 71' ' ' LEU . 1.6 mt -114.7 114.77 26.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.804 0.335 . . . . 0.0 110.513 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.582 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 6.2 m0 -99.06 122.72 42.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 2.0 m-85 -103.81 122.93 46.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 84.0 m95 -106.64 123.95 48.88 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.453 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.4 tp -81.81 97.18 7.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.493 -0.883 . . . . 0.0 112.669 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.004 HG22 ' CD2' ' A' ' 64' ' ' HIS . 13.9 t -74.29 146.38 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.049 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.8 mt-10 -114.02 -34.41 5.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.14 165.5 24.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.23 0.923 . . . . 0.0 112.277 -178.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.686 ' CE3' HG22 ' A' ' 11' ' ' ILE . 1.9 p90 -149.57 128.92 12.92 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.585 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.15 134.51 34.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.757 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.15 -118.81 5.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.9 mt-10 -135.11 139.73 32.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.533 0.206 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.44 130.4 11.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.961 2.441 . . . . 0.0 111.245 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.643 ' HE1' HG23 ' A' ' 60' ' ' ILE . 53.9 p-90 -136.63 -64.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 47.78 -100.98 0.03 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.587 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER 179.62 34.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.6 pt-20 -60.59 -29.41 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.452 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.23 -24.12 23.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.515 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -113.04 91.61 18.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.052 0.453 . . . . 0.0 111.826 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -47.76 135.41 22.44 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.91 2.407 . . . . 0.0 112.094 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.31 177.1 19.44 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.161 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 16.7 mt-10 -138.87 155.4 48.12 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.15 107.49 0.49 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 110.638 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.86 163.11 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.824 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 t -80.46 114.74 19.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.97 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.96 -18.22 50.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.39 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.24 -21.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.65 53.47 0.71 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.287 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' A' ' 107' ' ' LEU . 7.1 tt -62.29 150.26 39.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.729 0.299 . . . . 0.0 110.804 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.15 109.99 19.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.93 0.395 . . . . 0.0 111.903 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.649 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.25 -17.29 61.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.891 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -34.28 46.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.967 0.413 . . . . 0.0 110.318 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.86 -23.75 33.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.225 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.58 163.03 29.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.585 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 34' ' ' GLU . 10.6 Cg_endo -54.64 129.35 34.49 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.629 2.219 . . . . 0.0 112.604 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 34.5 Cg_endo -64.56 -14.9 47.06 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.539 2.159 . . . . 0.0 112.281 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -24.94 67.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.587 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.2 0.37 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.196 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -54.29 -35.11 27.08 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 47.2 Cg_exo -44.34 -48.88 9.44 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.058 1.839 . . . . 0.0 114.165 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -79.39 -54.29 11.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.3 mm -59.78 -28.38 40.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.136 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.49 -51.07 66.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.344 0.592 . . . . 0.0 109.464 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -49.65 69.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.459 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.31 -49.44 13.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.932 0.396 . . . . 0.0 111.221 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.649 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 tttm -51.02 -39.56 56.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.178 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -9.24 14.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.661 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.376 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.845 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.67 127.05 53.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.738 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.14 139.16 35.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.791 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.991 HD13 " H3'" ' A' ' 131' ' ' 8OG . 3.7 pp -147.79 122.58 9.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.764 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 20.0 mt-30 -102.43 152.37 21.19 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.244 0.545 . . . . 0.0 111.461 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.673 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mm -147.21 140.2 19.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.965 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.5 145.58 50.45 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -144.35 153.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.398 0.999 . . . . 0.0 111.017 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -150.39 145.89 14.38 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.741 -1.219 . . . . 0.0 114.311 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.671 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.3 pt -96.5 120.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -83.16 112.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.577 0.703 . . . . 0.0 111.98 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -82.18 150.92 27.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.653 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -133.21 -173.27 3.16 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.781 0.801 . . . . 0.0 111.81 178.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.55 -54.3 18.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.537 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 33.8 t-20 -61.31 -12.95 15.72 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.5 -1.227 . . . . 0.0 113.263 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 83.0 10.07 0.59 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.295 0.569 . . . . 0.0 110.907 -179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -109.6 142.8 40.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.787 HD11 HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -104.46 120.16 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.01 106.15 0.56 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.693 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.787 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -110.51 162.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 73.2 p -70.05 140.42 52.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.1 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 47.56 25.73 0.7 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 100' ' ' GLN . . . 54.84 20.47 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.663 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 45.13 29.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.699 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -114.96 -83.08 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.074 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . 171.86 40.58 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -173.56 164.69 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 tpp 57.9 43.97 20.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.66 -16.79 61.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.18 25.45 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 111.166 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -114.24 26.08 10.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 HD12 ' A' ' 20' ' ' ILE . 1.3 tt -69.32 63.11 0.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 1.1 tt0 -109.59 -179.73 3.9 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.416 0.626 . . . . 0.0 112.45 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -120.09 168.33 10.64 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.8 Cg_endo -47.59 168.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.774 2.983 . . . . 0.0 111.527 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.01 60.43 0.72 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.781 -1.2 . . . . 0.0 114.575 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.31 107.58 0.64 Allowed Glycine 0 C--N 1.31 -0.912 0 CA-C-N 114.8 -0.7 . . . . 0.0 111.95 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.6 ttmm 111.95 9.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.168 0.587 . . . . 0.0 111.494 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.965 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -57.77 -33.53 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.633 0.73 . . . . 0.0 110.41 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.5 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.099 -178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -71.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.947 0.404 . . . . 0.0 110.569 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 168.67 38.43 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.55 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -97.62 -165.19 1.22 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.794 0.331 . . . . 0.0 111.337 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.9 165.98 12.71 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.7 Cg_endo -43.94 -32.4 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.873 2.382 . . . . 0.0 112.317 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.875 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -105.0 -43.61 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -72.25 -4.69 31.02 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -80.42 -51.59 8.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 0.0 110.678 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -34.42 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.249 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.3 t -50.74 -35.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.974 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.99 -30.02 49.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.151 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -79.34 -35.02 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.0 109.331 177.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.86 -49.63 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.742 -177.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 2.7 tt0 -76.61 -40.22 50.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.806 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -64.02 -24.86 67.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -108.66 6.11 25.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 60' ' ' ILE . 76.5 t -133.7 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.049 0.452 . . . . 0.0 109.98 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.77 -41.49 0.69 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.361 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.913 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.62 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.104 0.478 . . . . 0.0 111.324 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.07 88.86 8.9 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.475 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.64 150.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.246 2.631 . . . . 0.0 114.865 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 55.5 mt-30 -74.93 80.52 2.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.76 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -124.68 130.76 53.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.74 -176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 174.23 -169.6 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.453 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 2.8 m 75.59 155.31 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.643 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -118.15 114.61 23.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.22 -41.25 58.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.275 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.34 138.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 111.951 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HB3' HD11 ' A' ' 67' ' ' LEU . 9.5 ptmt -125.16 132.93 52.97 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.767 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -105.42 116.09 31.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.836 0.827 . . . . 0.0 112.257 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -115.46 107.5 15.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.93 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.643 ' CE1' HD21 ' A' ' 71' ' ' LEU . 1.3 p90 -143.66 137.39 28.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.799 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -121.83 131.2 53.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.501 . . . . 0.0 111.429 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.707 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 8.5 m-85 -91.77 163.6 27.28 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.16 87.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.319 2.679 . . . . 0.0 111.932 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 12.3 m-20 91.36 29.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.968 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttm180 -137.59 153.72 49.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.535 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 16.8 t60 -145.98 107.85 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' CZ ' ' A' ' 73' ' ' TYR . 2.9 tt -121.71 141.48 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.16 129.83 36.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 6' ' ' ILE . 84.9 mt -126.37 113.7 17.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -110.68 122.6 48.2 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.745 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.796 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.1 m-85 -105.6 131.15 53.34 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.042 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.94 ' CE2' HG11 ' A' ' 50' ' ' VAL . 76.8 m95 -107.7 120.39 42.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.448 0.166 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 13.4 tp -80.1 98.18 7.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.553 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.76 HG13 ' CB ' ' A' ' 64' ' ' HIS . 15.4 t -72.1 146.46 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.033 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -114.1 -31.21 6.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 1.4 tpt180 -163.15 164.92 25.07 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.091 0.86 . . . . 0.0 111.878 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -150.49 128.78 12.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.441 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.73 155.64 25.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.45 -120.09 18.17 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.52 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -133.09 141.88 42.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.467 0.175 . . . . 0.0 110.763 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.54 136.88 17.83 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.05 2.5 . . . . 0.0 111.451 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.577 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.0 p-90 -147.91 -63.79 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.627 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.23 -98.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.071 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.37 41.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.57 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 14.2 pt-20 -63.15 -38.59 91.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.288 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 157.91 -78.06 0.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.316 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.81 133.96 25.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.307 0.575 . . . . 0.0 112.115 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.96 142.86 3.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.464 2.776 . . . . 0.0 113.126 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.54 177.38 19.27 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -124.86 145.22 49.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 110.723 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.625 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.83 106.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.841 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.72 155.87 33.0 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.179 0.514 . . . . 0.0 111.68 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.452 ' N ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -67.43 122.45 17.97 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.42 -18.18 63.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.671 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.9 p -54.47 -12.92 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.19 51.55 0.85 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.805 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 107' ' ' LEU . 10.8 tp -61.78 138.49 58.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.727 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.38 110.84 15.65 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -72.82 -15.44 61.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -42.89 29.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.86 -20.72 59.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.201 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.47 162.54 22.22 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 19.8 Cg_endo -58.08 135.43 68.51 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.92 -14.9 39.63 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.499 2.133 . . . . 0.0 112.369 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.42 62.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.359 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.555 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.194 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -57.79 -34.07 22.69 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HB2' HD22 ' A' ' 71' ' ' LEU . 55.4 Cg_exo -44.36 -50.09 8.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.228 1.952 . . . . 0.0 114.257 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -78.94 -53.88 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.175 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 112' ' ' ALA . 3.1 mm -58.46 -28.42 36.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.131 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -49.64 70.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.336 0.588 . . . . 0.0 109.446 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -51.62 64.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.424 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tp -78.26 -48.02 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 111.264 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.13 -37.88 36.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.861 -178.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 28.3 ttt-85 -63.47 -10.54 18.04 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.389 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.991 " H3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.82 0.343 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.0 111.02 22.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.42 158.33 44.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 80' ' ' ILE . 3.3 pp -146.86 121.09 9.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.457 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.616 ' C ' HD12 ' A' ' 6' ' ' ILE . 44.3 mt-30 -102.97 151.17 22.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.667 0.746 . . . . 0.0 112.914 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 H2'' ' A' ' 131' ' ' 8OG . 4.1 mp -147.35 140.58 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.717 -1.128 . . . . 0.0 108.181 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 147.49 48.99 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -144.47 156.05 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 118.973 0.806 . . . . 0.0 111.249 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.07 142.16 9.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.073 -1.061 . . . . 0.0 114.238 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.779 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -106.15 124.78 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.32 112.37 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.234 0.47 . . . . 0.0 111.525 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HG2' HD11 ' A' ' 18' ' ' ILE . 6.2 mmt85 -79.94 113.65 18.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.384 1.088 . . . . 0.0 113.823 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.5 t30 -76.69 172.57 12.84 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 111.896 -2.411 . . . . 0.0 114.119 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.47 -49.54 72.24 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 112.17 -2.286 . . . . 0.0 111.655 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 61.1 t30 -72.42 -13.7 61.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.441 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 1.7 t-20 95.66 18.24 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.518 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -113.89 133.7 55.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.779 HG21 HG22 ' A' ' 10' ' ' ILE . 4.7 mt -103.4 126.68 57.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.51 102.06 0.16 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.158 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.776 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -107.8 126.6 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.8 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 t -70.23 111.7 6.04 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.743 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.708 ' HG3' HD13 ' A' ' 33' ' ' LEU . 6.7 tmm_? -120.42 118.08 29.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.253 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 48.44 26.8 1.23 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.656 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 50.76 27.03 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.406 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 82.16 -46.34 0.18 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.29 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.64 130.27 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.5 -164.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.17 -173.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.4 mmt -58.06 110.21 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.33 62.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.337 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.95 31.24 2.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.017 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 26.17 8.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.285 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 20' ' ' ILE . 14.4 tp -70.77 55.83 0.18 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.172 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' THR . 1.1 tt0 -117.24 178.81 4.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.776 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.62 169.09 8.84 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.086 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.1 Cg_endo -46.11 169.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.567 2.845 . . . . 0.0 111.903 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.648 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 103.61 60.62 0.7 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.039 -1.077 . . . . 0.0 114.123 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.64 116.91 1.88 Allowed Glycine 0 C--N 1.31 -0.899 0 CA-C-N 114.594 -0.803 . . . . 0.0 111.791 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 94.23 24.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.978 0.511 . . . . 0.0 111.51 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -72.85 -33.55 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.813 0.816 . . . . 0.0 109.392 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -47.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.147 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.6 mtm 42.85 -90.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.474 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.42 28.14 0.11 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.728 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -87.84 -169.29 2.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.792 0.329 . . . . 0.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.96 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -95.49 165.2 17.2 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.245 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.96 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.8 Cg_endo -47.54 -26.9 6.85 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.652 2.235 . . . . 0.0 112.072 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.56 -47.12 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -71.98 -4.28 27.59 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.96 -53.09 7.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.309 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.1 p -79.85 -38.41 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.103 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.1 t -50.48 -35.41 12.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 110.847 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -29.09 59.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -80.15 -38.69 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.646 177.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.85 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -47.66 -48.76 28.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.861 -177.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -73.02 -51.19 19.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.334 0.588 . . . . 0.0 109.895 179.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -28.13 15.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 7.5 mm-40 -108.77 6.78 25.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 60' ' ' ILE . 88.9 t -133.48 -44.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.962 0.411 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.41 -41.94 0.65 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.876 -0.602 . . . . 0.0 114.576 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.818 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.65 -176.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.062 0.458 . . . . 0.0 111.428 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.57 88.8 11.73 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.327 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.0 Cg_endo -111.05 147.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 123.389 2.726 . . . . 0.0 113.881 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 42.1 mt-30 -74.74 79.98 2.06 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.85 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.65 130.87 53.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.145 -1.388 . . . . 0.0 110.636 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 66' ' ' SER . 0.1 OUTLIER 177.73 -172.99 0.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 3.6 m 73.98 158.52 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.731 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -119.67 120.32 36.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.1 -37.11 61.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.07 -179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.5 tt0 -171.42 161.35 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.538 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -143.46 132.28 22.69 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -99.98 114.85 28.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.849 0.833 . . . . 0.0 112.671 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -114.19 108.16 16.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.55 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.73 133.42 25.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.256 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 3.3 pt-20 -115.74 110.02 18.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.346 0.593 . . . . 0.0 111.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -84.35 163.24 48.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.219 179.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -32.91 80.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.414 3.409 . . . . 0.0 113.34 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.4 m-20 85.94 -46.84 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.513 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 12.5 ttp180 -87.22 105.84 17.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.044 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.462 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.2 m-70 -101.39 154.81 18.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 110.616 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 4' ' ' LEU . 7.3 tt -129.3 144.92 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.56 118.74 19.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.201 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.614 HD21 ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -114.16 114.16 25.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.133 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 5.9 m0 -102.6 122.97 45.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.854 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -108.93 131.37 55.09 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.913 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 76.0 m95 -110.04 127.75 55.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.363 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.8 pp -88.93 99.6 12.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.782 0.801 . . . . 0.0 112.682 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -71.24 147.59 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.558 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -115.95 -25.57 7.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 6.4 tpt180 -163.84 165.25 23.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.972 0.805 . . . . 0.0 111.268 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.95 125.49 5.74 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.704 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.72 149.43 32.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.78 -122.41 28.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.502 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.0 tt0 -131.96 142.43 45.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.592 0.234 . . . . 0.0 110.82 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -76.5 131.57 12.72 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.009 2.473 . . . . 0.0 111.36 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.3 p-90 -138.86 -63.31 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.677 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.92 -103.31 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.791 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.92 37.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 11.0 pt-20 -55.67 -36.06 66.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.29 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 151.65 -59.35 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.349 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -138.25 119.03 10.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.973 0.416 . . . . 0.0 112.079 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.99 141.87 4.18 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.019 2.479 . . . . 0.0 112.648 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.33 19.28 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.843 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 1.8 tt0 -120.5 150.1 41.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.62 107.48 0.51 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.907 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.773 ' HG2' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -120.21 151.49 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.372 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.644 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -72.56 132.18 43.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.25 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.867 HD23 HD13 ' A' ' 110' ' ' LEU . 7.3 mt -80.04 -18.71 49.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.403 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.3 p -50.5 -22.8 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.93 46.16 1.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.981 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.867 HD13 HD23 ' A' ' 107' ' ' LEU . 10.8 tp -62.52 147.08 50.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.289 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 m-20 -123.3 108.27 12.58 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.4 -17.53 61.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.527 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -36.76 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -84.35 -2.6 57.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -114.89 166.08 12.55 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.7 Cg_endo -54.41 127.91 27.9 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.382 2.055 . . . . 0.0 112.488 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 36.9 Cg_endo -65.46 -17.9 58.57 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.56 2.174 . . . . 0.0 112.414 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.72 67.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' HD21 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -107.82 -1.83 20.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.392 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -53.9 -36.69 43.6 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -44.24 -50.68 7.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.146 1.897 . . . . 0.0 114.168 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.716 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.83 -53.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 111.366 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 1.1 mm -59.18 -29.12 40.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.096 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.69 -51.31 67.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.246 0.546 . . . . 0.0 109.568 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -54.44 -48.65 71.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.364 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.3 tp -78.36 -50.08 12.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.981 0.419 . . . . 0.0 110.985 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.575 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -50.85 -38.18 47.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.203 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 19.5 ttp180 -63.44 -11.31 22.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.318 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.38 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.788 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.769 0.319 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -110.04 134.84 51.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.842 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.74 140.18 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 80' ' ' ILE . 4.0 pp -147.73 120.31 8.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -102.26 153.43 19.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.976 0.417 . . . . 0.0 111.274 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.757 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.5 mp -145.58 140.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' CB ' HG21 ' A' ' 40' ' ' ILE . . . -127.14 124.67 39.64 Favored 'General case' 0 C--O 1.215 -0.715 0 O-C-N 121.822 -0.549 . . . . 0.0 109.642 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -127.22 150.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.384 0.611 . . . . 0.0 112.08 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -143.06 141.39 10.5 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.463 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.018 HG22 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -97.46 119.77 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.914 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.6 111.82 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmm-85 -81.06 154.58 26.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.74 ' OD1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -132.65 -175.33 3.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.946 0.879 . . . . 0.0 112.446 178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -49.17 -51.31 33.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.586 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -62.42 -10.72 12.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.998 -178.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER 80.75 8.65 1.21 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.016 0.436 . . . . 0.0 111.112 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.74 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -108.87 145.28 35.57 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.018 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -104.56 116.99 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -175.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -62.51 107.73 0.99 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.265 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -119.37 154.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.934 HG22 ' O ' ' A' ' 34' ' ' GLU . 12.8 t -70.57 111.41 6.06 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.936 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -105.25 83.94 2.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 0.0 110.829 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HB1' ' A' ' 30' ' ' ALA . 2.4 mtt180 54.59 22.05 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.166 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.626 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . . . 56.83 -82.72 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -125.83 -60.79 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.78 178.15 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.55 102.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.414 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.06 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.355 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 14.5 mtp 58.75 29.95 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.979 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.541 ' HB1' ' NE ' ' A' ' 23' ' ' ARG . . . -82.81 -21.22 34.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.526 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 27.18 4.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.228 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.21 26.24 10.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.519 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -67.03 65.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.15 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.934 ' O ' HG22 ' A' ' 21' ' ' THR . 2.0 mm-40 -111.28 171.76 7.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.125 0.488 . . . . 0.0 111.754 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.727 ' CE2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.68 168.22 10.63 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.609 -179.131 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.1 Cg_endo -47.37 168.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.974 3.116 . . . . 0.0 112.683 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 60.89 0.73 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 119.939 -1.124 . . . . 0.0 114.458 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.57 111.47 0.9 Allowed Glycine 0 C--N 1.31 -0.916 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.135 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 116.86 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.341 0.656 . . . . 0.0 111.619 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.865 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.36 -69.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.283 0.564 . . . . 0.0 110.767 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -7.98 -81.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.547 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.5 mtp 40.08 -101.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.11 10.73 0.16 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.947 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HB3' ' CA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.64 -160.26 0.3 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.013 0.406 . . . . 0.0 110.689 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.892 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -95.38 158.55 34.45 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.892 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -43.93 -26.54 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 111.916 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.966 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.7 mt-10 -104.21 -50.19 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.574 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.85 -4.19 26.65 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -84.86 -43.98 13.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.726 0.298 . . . . 0.0 110.486 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.686 ' CB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -79.2 -32.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.6 t -50.84 -35.66 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 -30.82 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' GLU . 77.0 mm-40 -79.45 -37.86 35.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.51 0.671 . . . . 0.0 109.681 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -48.05 -48.9 32.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.144 -176.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.36 -26.9 63.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.348 0.594 . . . . 0.0 109.933 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 1.1 tt0 -76.91 -27.3 54.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.076 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -108.44 6.03 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.922 HG12 HG13 ' A' ' 60' ' ' ILE . 22.5 t -133.73 -44.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.097 0.475 . . . . 0.0 109.901 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.27 -41.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.753 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.922 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -176.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.965 0.412 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.3 88.72 11.09 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.813 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -109.98 158.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.429 2.753 . . . . 0.0 114.322 -177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -83.18 81.51 8.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.2 t-160 -125.84 130.75 51.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.69 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 175.04 -169.64 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.516 -179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 m 72.72 162.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.91 120.08 31.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.06 -39.15 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -171.86 166.49 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.59 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -143.81 132.28 22.2 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -96.7 116.43 29.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.075 0.941 . . . . 0.0 112.635 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.87 107.29 15.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.011 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.7 t80 -143.59 124.29 14.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.88 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.68 114.98 21.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.19 0.519 . . . . 0.0 111.101 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.705 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 24.1 m-85 -80.12 163.52 57.14 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.954 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -49.49 85.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.498 2.798 . . . . 0.0 112.01 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.8 t70 93.36 27.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.058 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.51 152.57 49.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.388 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 89.5 m-70 -146.99 113.36 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 4' ' ' LEU . 4.7 tt -127.07 135.25 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.34 118.3 17.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.52 0.2 . . . . 0.0 110.803 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.076 HD12 HD12 ' A' ' 71' ' ' LEU . 4.8 mt -114.15 113.8 25.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.706 0.289 . . . . 0.0 110.278 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 13.2 m0 -100.51 122.76 43.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.695 0.283 . . . . 0.0 111.123 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.71 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.5 m-30 -100.41 120.9 40.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.065 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 65.3 m95 -99.69 123.01 43.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.517 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 65' ' ' PHE . 45.9 tp -84.74 97.48 9.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.21 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' CD2' ' A' ' 64' ' ' HIS . 20.2 t -71.77 146.04 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.251 -1.341 . . . . 0.0 112.184 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.2 mt-10 -108.32 -39.53 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.51 165.4 26.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.087 0.858 . . . . 0.0 112.166 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.745 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.0 p90 -146.13 130.68 17.81 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -84.16 157.45 21.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.2 -120.11 21.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 27.7 mt-10 -134.63 145.22 54.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.575 0.226 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.88 128.71 10.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.939 2.426 . . . . 0.0 111.291 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.8 p-90 -142.67 -64.8 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.795 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.648 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 38.47 -98.97 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.989 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 3.1 tttt 168.15 64.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.328 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -92.12 -49.35 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.219 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.7 -104.46 0.22 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.279 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.626 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -94.22 113.65 61.3 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.088 0.47 . . . . 0.0 112.001 -179.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.97 146.23 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.995 2.463 . . . . 0.0 112.535 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 177.08 19.43 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.707 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 66.8 mm-40 -119.74 153.88 34.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.671 0.272 . . . . 0.0 110.623 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.98 107.07 0.48 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.0 ppp? -119.65 143.23 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.664 ' HB2' HG12 ' A' ' 108' ' ' VAL . 14.5 p -58.64 116.49 3.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.273 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.829 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.7 tm? -69.61 -18.52 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.9 p -53.3 -16.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.1 46.22 1.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.92 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.921 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.01 138.12 58.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.596 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.48 124.32 42.59 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.87 -15.66 61.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -49.2 13.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.192 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -68.45 -20.01 64.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.355 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.67 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.63 164.04 16.97 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' CG ' ' CG ' ' A' ' 34' ' ' GLU . 18.7 Cg_endo -60.75 139.93 88.04 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.481 2.12 . . . . 0.0 112.866 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 -14.71 37.94 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.781 2.321 . . . . 0.0 112.657 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -15.67 53.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.555 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.797 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.16 11.87 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -50.03 -47.01 82.07 Favored Pre-proline 0 C--O 1.221 -0.403 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 90.0 Cg_exo -45.2 -37.51 13.53 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.408 2.072 . . . . 0.0 114.249 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 71' ' ' LEU . 9.0 t -78.23 -52.74 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.3 mm -73.6 -27.56 23.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.07 -50.37 66.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.752 ' HE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -54.64 -49.09 71.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.558 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 125' ' ' LYS . 3.3 mm? -78.53 -49.86 12.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.64 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.3 ttpp -50.48 -35.71 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.987 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -63.15 -12.01 24.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.523 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.645 H2'' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.872 0.368 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -95.34 102.77 14.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.94 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -79.24 158.45 27.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.2 pp -146.2 118.31 8.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.318 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 30.8 mt-30 -102.26 153.05 20.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.654 0.74 . . . . 0.0 112.976 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.412 HG12 " O3'" ' A' ' 131' ' ' 8OG . 3.3 mp -147.05 139.73 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.62 138.98 53.51 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -144.33 159.28 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 119.059 0.845 . . . . 0.0 111.314 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.34 150.16 22.05 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.738 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.728 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -94.7 122.45 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.88 111.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -81.06 151.5 28.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.287 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 90' ' ' TRP . 4.5 p-10 -130.93 -172.84 2.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.44 1.114 . . . . 0.0 113.251 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.78 -55.36 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.782 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' ASN . 12.5 t30 -72.73 -7.06 48.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.804 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 2.3 t30 86.12 15.06 0.13 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 15' ' ' ASN . 15.8 pt-20 -105.69 132.85 51.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.927 HD11 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.28 117.64 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 122.125 0.964 . . . . 0.0 113.113 -175.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -64.5 97.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.183 -1.372 . . . . 0.0 112.058 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.927 HG23 HD11 ' A' ' 18' ' ' ILE . 3.2 pt -104.13 143.29 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 15.5 p -70.09 111.63 5.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HG3' HD12 ' A' ' 33' ' ' LEU . 18.9 ttt180 -133.33 124.88 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.95 0.405 . . . . 0.0 111.56 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' ALA . 7.6 mtt180 60.86 14.11 4.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.763 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 45.99 -89.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -140.99 -52.74 0.47 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.847 0.356 . . . . 0.0 110.93 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.1 129.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.29 39.91 21.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.154 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -131.28 -176.47 4.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 mtm -51.14 94.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . . . -86.47 -27.12 24.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.46 17.23 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.23 25.75 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.01 0.433 . . . . 0.0 111.455 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -51.15 94.98 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.746 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -128.43 169.24 14.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' HD2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 168.88 9.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.275 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.3 Cg_endo -47.15 167.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.461 2.774 . . . . 0.0 111.563 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.2 60.17 0.75 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.433 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -133.42 116.36 1.7 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 114.869 -0.666 . . . . 0.0 111.814 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.8 ttmm 98.97 20.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.121 0.568 . . . . 0.0 111.309 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -69.84 -34.59 61.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.807 0.813 . . . . 0.0 109.667 179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.623 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -49.27 -87.97 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.051 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 41.43 -88.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.649 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -165.71 27.34 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -93.51 -171.32 2.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.612 0.244 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.933 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.76 161.05 26.32 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.933 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.93 -27.01 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.608 2.205 . . . . 0.0 112.328 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.956 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -104.14 -49.87 3.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -4.03 23.56 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.857 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.55 -47.31 13.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.598 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.9 -34.22 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.213 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 47' ' ' GLU . 64.6 t -50.55 -35.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.716 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -75.97 -30.03 58.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.032 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -79.35 -37.2 38.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.618 0.723 . . . . 0.0 109.652 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -48.36 -48.98 36.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.016 -177.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -37.39 46.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.306 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 53' ' ' GLU . 4.3 mm-40 -108.32 5.72 25.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 42.9 t -133.99 -44.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 110.501 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 74.27 -41.47 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.376 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.8 -167.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.653 0.263 . . . . 0.0 111.118 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 61' ' ' THR . 4.2 t -110.37 89.38 8.57 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.284 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.867 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -109.14 139.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.116 2.544 . . . . 0.0 115.055 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.84 79.12 2.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -116.94 124.23 48.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.642 -176.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 176.75 -172.48 0.09 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.13 0.49 . . . . 0.0 111.111 -179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 7.6 t 72.71 159.22 0.21 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.382 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 70' ' ' LYS . 3.0 tt -116.85 112.09 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.0 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -74.93 -36.1 62.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 109.769 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 9.1 tt0 -171.66 157.62 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.487 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.92 132.4 22.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -97.59 114.7 26.67 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.679 0.752 . . . . 0.0 112.036 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -114.63 108.31 16.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.51 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -142.66 131.48 22.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.946 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' HIS . 3.0 pt-20 -113.55 140.01 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.572 0.701 . . . . 0.0 111.86 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -99.76 165.17 15.14 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.923 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.6 Cg_endo -38.04 -25.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.684 2.923 . . . . 0.0 113.75 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 p30 -155.05 -39.1 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.002 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp-105 -101.26 93.58 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 74' ' ' GLU . 2.2 t60 -85.29 154.83 21.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.738 0.304 . . . . 0.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 4.8 tt -128.75 144.38 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 HG23 ' CE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -131.63 118.49 20.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -112.67 113.7 25.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.724 0.297 . . . . 0.0 111.044 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.0 m0 -105.73 122.44 46.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 111.021 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -103.23 128.1 50.33 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 73.5 m95 -108.45 125.2 51.5 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.58 ' O ' ' O ' ' A' ' 65' ' ' PHE . 30.8 tp -80.07 97.47 6.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.613 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.4 t -74.2 146.54 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.25 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 12' ' ' ARG . 64.6 tt0 -113.32 -31.96 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.7 166.25 22.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.015 1.28 . . . . 0.0 112.895 -178.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.733 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -150.8 129.57 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.982 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.1 tt0 -78.04 150.21 33.86 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.369 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.95 -122.35 22.66 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.826 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -119.64 141.73 31.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.481 0.181 . . . . 0.0 110.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 60' ' ' ILE . 23.3 Cg_endo -78.28 128.73 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.374 2.05 . . . . 0.0 111.001 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.607 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 27.1 p-90 -134.92 -63.65 0.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.256 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.19 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.807 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mttm 165.22 42.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.413 . . . . 0.0 110.48 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 12.9 pt-20 -67.74 -48.15 67.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.261 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 169.79 -127.25 1.46 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.288 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 3.3 mp0 -76.09 130.78 77.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.811 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -43.76 142.8 3.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.281 2.654 . . . . 0.0 113.016 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.42 177.28 19.32 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.744 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -127.07 147.88 50.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 110.742 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -60.72 106.5 0.57 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.752 0.31 . . . . 0.0 110.483 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.0 ppp? -120.57 155.52 33.51 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.285 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 p -73.65 130.64 40.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.791 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -75.56 -18.45 59.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.639 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.13 -13.22 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.27 51.54 0.84 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.042 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD13 HD22 ' A' ' 107' ' ' LEU . 9.9 tp -62.16 143.61 56.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -123.52 108.83 13.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.747 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' A' ' 127' ' ' LYS . . . -72.46 -15.65 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -37.05 78.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.704 0.287 . . . . 0.0 110.757 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -15.19 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.276 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.38 163.84 18.34 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 -179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 27.9 Cg_endo -63.25 135.11 48.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.764 2.309 . . . . 0.0 113.106 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.15 -16.75 40.37 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.564 2.176 . . . . 0.0 112.11 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -29.54 70.85 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.558 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -101.54 2.08 38.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -58.63 -32.73 13.77 Favored Pre-proline 0 C--O 1.221 -0.402 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.741 ' HB2' HD22 ' A' ' 71' ' ' LEU . 74.1 Cg_exo -45.73 -50.82 9.03 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 121.758 1.638 . . . . 0.0 113.881 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.63 -54.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.195 0.521 . . . . 0.0 110.563 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -56.86 -28.35 28.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.354 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.87 -48.48 72.91 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -53.12 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.126 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 126' ' ' LEU . 3.5 mm? -78.41 -48.17 16.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.901 0.381 . . . . 0.0 111.611 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.588 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 5.0 tttm -50.74 -41.83 56.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.093 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -9.25 13.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.746 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.35 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.412 " O3'" HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.831 0.348 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -102.88 117.11 33.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 79' ' ' HIS . 9.3 ptpt -140.4 134.48 30.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 6' ' ' ILE . 1.5 pp -147.5 128.16 14.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.349 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 46.6 mt-30 -102.1 156.52 17.5 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.18 0.514 . . . . 0.0 112.01 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.93 HD11 HD12 ' A' ' 4' ' ' LEU . 5.2 mp -146.35 139.84 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.02 124.52 39.55 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -124.24 149.85 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.265 0.555 . . . . 0.0 111.984 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.31 139.16 8.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.348 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.33 119.09 43.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.781 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -86.3 111.02 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -82.45 155.59 24.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.301 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.672 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.36 -172.89 3.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.796 0.808 . . . . 0.0 112.81 179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.53 -56.49 8.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.191 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -62.51 -7.32 4.4 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.158 -1.383 . . . . 0.0 112.899 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 79.87 7.29 1.72 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 110.957 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' C ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -100.76 140.29 35.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.57 115.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -174.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.97 107.3 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.054 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.85 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.86 142.91 27.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.9 p -70.61 111.77 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -129.11 146.91 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.073 -179.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.629 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.8 ptp85 35.98 -106.82 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.997 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 159.43 47.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.937 0.398 . . . . 0.0 110.376 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 72.5 24.83 2.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.74 141.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.62 -158.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.73 -61.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.097 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 16.8 mtm -96.95 37.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -8.87 27.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.39 22.36 2.19 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.26 25.96 10.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.022 0.439 . . . . 0.0 111.527 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.85 HD21 HD12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -71.62 62.39 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.644 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' CE1' ' A' ' 35' ' ' PHE . 20.2 tp10 -106.57 169.38 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.208 0.528 . . . . 0.0 112.037 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.52 162.43 32.46 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.87 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.781 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.8 Cg_endo -50.61 168.56 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.14 3.226 . . . . 0.0 112.415 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.94 60.79 0.72 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.934 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.9 114.78 1.38 Allowed Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.938 -0.631 . . . . 0.0 112.295 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 104.67 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 0.0 112.001 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.053 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -74.5 -33.89 34.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.795 0.807 . . . . 0.0 109.777 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.52 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.462 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 mmt 43.19 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.63 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.78 23.59 0.1 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.196 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.43 -163.17 0.96 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.456 0.17 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.955 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.88 159.31 30.61 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.955 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.21 -28.56 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.373 2.049 . . . . 0.0 112.293 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.937 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.7 mt-10 -103.05 -49.67 3.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -4.31 20.6 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.76 -45.14 16.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.278 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.2 p -79.24 -35.41 17.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.445 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 47' ' ' GLU . 37.9 t -50.87 -35.84 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.249 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -30.22 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.01 0.433 . . . . 0.0 111.04 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.0 tp10 -78.94 -36.19 42.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.69 0.757 . . . . 0.0 109.244 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.4 tp -48.01 -49.06 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.772 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -27.68 64.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.945 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -24.91 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.223 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 9.1 mm-40 -108.28 5.15 25.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.712 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG12 HG13 ' A' ' 60' ' ' ILE . 14.9 t -134.46 -43.96 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.191 0.519 . . . . 0.0 109.764 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.86 -41.98 0.57 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.501 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.043 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -175.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.017 0.437 . . . . 0.0 111.436 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 89.2 10.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.539 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.918 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.67 152.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.237 2.625 . . . . 0.0 115.278 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -74.93 81.07 2.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.977 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.87 132.6 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.108 -176.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 174.84 -170.17 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.827 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 m 69.76 163.07 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -125.62 121.38 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.04 -35.81 59.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.258 0.551 . . . . 0.0 109.686 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 6.7 tt0 -171.52 165.35 6.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 132.47 22.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -98.94 115.28 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.772 0.796 . . . . 0.0 112.227 -179.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -115.63 107.49 15.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.054 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.614 ' O ' HG22 ' A' ' 80' ' ' ILE . 7.1 t80 -143.44 121.1 11.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.867 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -121.6 107.82 12.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.472 . . . . 0.0 111.205 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 33.6 m-85 -74.61 163.63 66.95 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.48 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.6 Cg_endo -39.74 84.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.905 3.07 . . . . 0.0 112.487 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.8 m-20 97.83 -25.64 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.71 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.94 152.33 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.763 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -146.48 108.68 4.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.908 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 73' ' ' TYR . 8.0 tt -122.96 135.6 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.74 118.13 16.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.577 0.227 . . . . 0.0 110.928 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.846 HD12 HD23 ' A' ' 71' ' ' LEU . 5.1 mt -115.81 114.06 24.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.743 0.306 . . . . 0.0 110.504 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.56 122.66 45.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.991 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -99.87 122.29 42.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.034 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.753 ' CE2' HG11 ' A' ' 50' ' ' VAL . 71.7 m95 -101.02 120.94 40.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.288 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 65' ' ' PHE . 16.7 tp -82.87 96.93 8.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.787 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.8 t -72.38 145.87 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.055 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -111.73 -32.7 6.56 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 11.4 ttt180 -162.87 165.18 25.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.732 0.697 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.7 p90 -148.19 131.94 16.96 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.616 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.23 149.5 29.0 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.37 -117.02 9.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.5 mt-10 -135.04 140.67 35.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.455 0.169 . . . . 0.0 110.778 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.1 Cg_exo -76.72 132.28 13.05 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.982 2.455 . . . . 0.0 111.444 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.1 p-90 -141.08 -64.41 0.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.664 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.5 -96.98 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.931 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 mttp 167.8 63.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.988 0.423 . . . . 0.0 110.431 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.93 -27.83 18.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.396 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.85 -120.57 1.58 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.575 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 21' ' ' THR . 11.8 mp0 -75.8 126.87 86.6 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.231 0.539 . . . . 0.0 112.223 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.79 146.34 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.289 2.659 . . . . 0.0 112.956 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.28 177.36 19.03 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.83 157.21 44.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.561 0.22 . . . . 0.0 110.926 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.611 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.74 106.26 0.95 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.89 150.55 40.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.665 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -64.94 130.3 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.042 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.667 ' CD1' HD13 ' A' ' 110' ' ' LEU . 9.2 tp -79.94 -18.28 50.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.659 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.6 t -60.33 -8.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.43 50.28 0.89 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.668 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 107' ' ' LEU . 6.7 tp -61.53 125.23 23.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.135 -0.532 . . . . 0.0 110.694 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -123.17 113.07 18.47 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.84 -27.86 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -30.92 67.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.413 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -2.61 41.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.671 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.48 161.28 30.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.779 0.323 . . . . 0.0 111.186 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.94 135.03 68.37 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.72 2.28 . . . . 0.0 112.558 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.22 -15.57 39.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.369 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -20.1 64.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.495 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.5 m-80 -116.82 8.29 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -60.11 -36.23 35.84 Favored Pre-proline 0 C--O 1.221 -0.407 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.77 ' HB2' HD22 ' A' ' 71' ' ' LEU . 72.3 Cg_exo -44.78 -45.83 13.24 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.214 1.943 . . . . 0.0 114.239 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -78.98 -54.04 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.185 0.517 . . . . 0.0 111.277 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -62.19 -26.84 41.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.131 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.94 -48.5 70.19 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.384 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.86 -53.29 57.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.515 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.79 -47.23 17.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.395 . . . . 0.0 111.579 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.577 ' CE ' ' HB3' ' A' ' 112' ' ' ALA . 6.1 tttm -49.74 -37.2 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.845 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -10.8 18.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.434 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.725 ' C8 ' HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.876 0.37 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -74.01 113.32 11.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.27 134.96 31.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.801 HD13 " C2'" ' A' ' 131' ' ' 8OG . 4.1 pp -147.71 123.07 10.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 48.5 mt-30 -102.26 156.51 17.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.295 0.569 . . . . 0.0 111.621 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.884 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.7 mp -146.48 140.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.116 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -126.88 124.98 40.81 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -131.89 158.68 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.697 0.68 . . . . 0.0 111.736 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -151.56 150.7 22.66 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.76 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -93.88 118.72 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.701 HD12 ' CE2' ' A' ' 19' ' ' PHE . 5.0 mt -79.73 110.2 15.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 111.669 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 88' ' ' GLU . 8.9 mmm-85 -79.36 149.77 31.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.306 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.517 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 43.6 t30 -111.86 173.35 6.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 122.194 0.997 . . . . 0.0 113.027 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 2.6 tm-20 -44.49 -39.13 4.59 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.152 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -98.25 -62.01 1.3 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.927 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 168.56 11.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.449 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 12.7 pm0 -100.79 120.86 40.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.99 HD13 ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.91 119.64 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.416 1.103 . . . . 0.0 113.857 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' CE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.48 97.98 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.031 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.871 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -99.73 143.04 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.25 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.799 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -70.54 112.23 6.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.1 ttm105 -134.02 150.53 51.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.828 0.347 . . . . 0.0 111.502 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 35.05 -102.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.778 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.19 46.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 70.24 16.29 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.568 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -146.98 -86.55 0.1 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.855 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . 177.68 38.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.72 129.87 54.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.976 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mtm 67.93 47.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -17.34 62.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.399 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -73.11 -6.38 45.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.37 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 26.7 5.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 22' ' ' ARG . 29.1 tp -67.31 59.42 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.037 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 3.0 tt0 -111.24 177.45 4.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.02 0.438 . . . . 0.0 111.366 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.88 168.98 9.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 5.0 Cg_endo -47.05 167.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.557 2.838 . . . . 0.0 112.031 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.21 60.14 0.75 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.766 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.96 125.98 3.9 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.114 -0.543 . . . . 0.0 112.262 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 89.14 22.42 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.748 0.419 . . . . 0.0 111.924 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.116 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.6 -33.07 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.816 0.817 . . . . 0.0 109.517 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.73 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.28 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmm 41.97 -89.55 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.555 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.68 31.1 0.09 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.812 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -89.07 -162.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.537 0.208 . . . . 0.0 110.889 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -101.01 163.28 18.28 Favored Pre-proline 0 N--CA 1.455 -0.192 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.953 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -44.0 -30.0 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.762 2.308 . . . . 0.0 112.283 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.9 mp0 -104.78 -45.92 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -71.81 -4.53 28.42 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.756 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -79.36 -51.13 9.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.317 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.879 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -79.84 -38.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.1 t -51.79 -35.94 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpp85 -76.99 -27.58 54.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.989 0.423 . . . . 0.0 110.403 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.55 -35.37 46.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -48.55 -48.95 38.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.458 -178.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.61 -27.31 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.958 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.11 -26.69 53.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.197 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 1.3 mp0 -108.51 3.53 23.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.702 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.903 HG11 ' HG3' ' A' ' 62' ' ' PRO . 31.6 t -134.41 -43.82 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.98 -40.46 0.43 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.298 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.78 -171.97 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 120.748 0.308 . . . . 0.0 110.787 -179.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.483 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -113.99 88.39 14.47 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.903 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.5 Cg_endo -107.64 149.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 123.135 2.556 . . . . 0.0 114.198 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 88.5 mt-30 -74.63 79.02 2.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.015 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.4 t-160 -125.41 127.83 47.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.545 -176.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 176.51 -171.93 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 47.0 t 66.34 164.23 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.817 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -126.69 123.72 38.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.05 -39.2 56.05 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.174 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.802 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.6 tt0 -171.38 138.65 1.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.433 0.635 . . . . 0.0 111.835 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 83' ' ' TRP . 7.5 tttt -120.99 132.49 54.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.808 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -103.46 116.06 31.69 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.815 0.817 . . . . 0.0 112.255 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -115.25 107.7 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.321 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -143.23 129.35 19.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.823 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -121.54 120.03 33.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.909 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 21.7 m-85 -83.93 163.43 48.65 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -49.57 86.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.647 2.898 . . . . 0.0 112.022 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-20 91.84 27.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.166 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.31 152.83 50.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.213 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 68.7 m80 -147.13 109.04 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.612 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -121.78 139.26 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.99 118.27 16.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.127 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD23 ' HB ' ' A' ' 6' ' ' ILE . 22.1 mt -115.93 114.14 24.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.588 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.681 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 m0 -106.79 122.44 46.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.389 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-30 -102.3 128.69 48.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.007 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.879 ' CE2' HG11 ' A' ' 50' ' ' VAL . 85.5 m95 -105.69 122.18 45.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.597 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 10.9 tp -80.15 97.21 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.633 -0.827 . . . . 0.0 112.552 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.015 HG22 ' CD2' ' A' ' 64' ' ' HIS . 15.1 t -74.76 145.95 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.195 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 2.5 tt0 -113.06 -35.05 5.52 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.75 166.06 22.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 112.139 -178.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 6.5 p90 -141.42 145.79 35.75 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.669 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 141.06 28.95 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.623 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.0 -108.58 1.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.045 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 28.0 tt0 -135.13 140.81 35.85 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.48 0.181 . . . . 0.0 110.978 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.15 129.0 10.98 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.84 2.36 . . . . 0.0 110.841 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -134.78 -66.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.651 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.44 -99.54 0.01 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.916 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 174.77 38.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 0.0 110.47 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.799 ' OE2' HG22 ' A' ' 21' ' ' THR . 23.2 pt-20 -60.3 -43.79 95.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.018 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.39 -108.47 0.45 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.188 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.9 mp0 -75.84 117.46 63.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 0.0 111.67 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -43.61 146.12 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.862 2.374 . . . . 0.0 112.504 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.02 177.44 18.68 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.691 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 6.4 mm-40 -136.2 150.78 49.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.714 0.292 . . . . 0.0 110.647 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.502 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.78 106.88 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.849 0.357 . . . . 0.0 110.511 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.871 ' SD ' HD11 ' A' ' 20' ' ' ILE . 2.1 ppp? -120.74 163.41 18.16 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.254 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -81.03 114.81 20.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.314 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.34 -17.57 63.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.845 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.5 t -45.84 -21.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.16 51.85 0.72 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.188 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' N ' ' A' ' 111' ' ' ASN . 9.1 tt -62.65 150.34 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.807 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.3 m-20 -119.1 113.31 20.73 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.43 -18.41 61.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.505 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -34.98 45.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.347 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -82.4 -16.83 47.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.342 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.12 164.14 16.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 34' ' ' GLU . 11.0 Cg_endo -54.67 135.3 66.53 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.385 2.057 . . . . 0.0 112.489 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 47.5 Cg_endo -68.25 -14.82 41.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.593 2.196 . . . . 0.0 112.636 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.65 -26.78 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.577 ' ND2' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -109.19 -0.42 19.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.35 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -54.1 -35.4 29.64 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' HD2' ' C ' ' A' ' 119' ' ' ASN . 50.7 Cg_exo -44.06 -49.92 8.04 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.17 1.913 . . . . 0.0 114.358 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.808 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -79.1 -53.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 111.6 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 112' ' ' ALA . 1.4 mm -60.4 -28.84 43.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.306 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -56.04 -51.24 68.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.238 0.542 . . . . 0.0 109.665 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -54.39 -48.29 71.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.337 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -49.63 13.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 110.777 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.765 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -50.73 -37.52 42.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.988 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -63.84 -9.62 15.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.516 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.403 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.801 " C2'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.09 130.12 55.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.975 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -137.09 158.12 45.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.737 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.613 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.39 116.7 7.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.494 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 19.8 mt-30 -102.02 156.87 17.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.648 0.737 . . . . 0.0 112.678 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.3 mp -146.83 140.03 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.067 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.0 124.28 39.05 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 118.744 0.702 . . . . 0.0 109.465 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.3 m -129.53 153.25 38.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.668 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.96 138.72 7.94 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.797 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.15 119.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.892 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -87.82 111.49 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 8.5 mmm-85 -81.37 152.0 27.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -132.79 -173.13 3.1 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.596 0.713 . . . . 0.0 112.06 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.09 -55.74 11.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.667 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -59.2 -10.23 2.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.823 -178.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 81.24 8.63 1.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.151 0.5 . . . . 0.0 110.843 -179.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' C ' ' A' ' 105' ' ' MET . 0.8 OUTLIER -108.72 146.73 33.05 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.951 HD11 HG23 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -104.61 121.27 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -174.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 7.1 t80 -62.1 95.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.489 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.13 154.79 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.3 p -75.79 111.88 11.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.32 141.42 50.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.002 0.429 . . . . 0.0 111.583 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 60.08 12.93 3.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.35 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB1' ' CE1' ' A' ' 28' ' ' HIS . . . 63.37 -66.65 0.1 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.773 0.32 . . . . 0.0 111.62 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.841 ' HB3' ' HB2' ' A' ' 101' ' ' PRO . . . 75.05 29.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.682 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.21 -73.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.51 36.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.582 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.747 ' CE1' ' HB1' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -137.42 -176.33 4.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.954 0.406 . . . . 0.0 111.111 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.56 155.71 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.16 -8.78 56.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.496 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -85.55 31.47 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.282 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.2 26.96 9.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.756 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -59.58 66.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.936 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -115.56 169.37 9.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.728 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -120.09 166.53 14.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.774 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.5 Cg_endo -47.71 169.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.055 3.17 . . . . 0.0 112.322 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.34 60.57 0.7 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.306 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -134.33 123.6 3.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.123 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 97.21 25.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.938 0.495 . . . . 0.0 112.158 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.067 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -76.71 -33.15 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.819 0.819 . . . . 0.0 109.814 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.0 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.408 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 48.61 -82.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.443 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 29.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.778 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -94.34 -164.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.499 0.19 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.935 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.67 160.6 27.53 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.935 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.79 -28.88 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.497 2.131 . . . . 0.0 112.031 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.946 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -104.4 -48.56 3.8 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -71.33 -4.22 24.89 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -81.29 -45.84 15.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.3 p -79.07 -32.68 15.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.387 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.5 t -51.96 -35.93 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.196 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -78.6 -33.24 47.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.766 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 57' ' ' GLU . 6.8 mm-40 -79.25 -36.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.572 0.701 . . . . 0.0 109.563 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.594 ' O ' HG23 ' A' ' 58' ' ' VAL . 9.9 tp -47.62 -48.38 28.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.829 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -27.16 58.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LYS . 3.4 tt0 -76.12 -24.96 54.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.117 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -108.41 6.43 26.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.861 -178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.961 HG12 HG13 ' A' ' 60' ' ' ILE . 36.7 t -133.51 -43.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.617 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 67.93 -39.42 0.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.042 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.961 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.68 -176.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.93 0.395 . . . . 0.0 111.02 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.43 88.85 11.52 Favored Pre-proline 0 N--CA 1.441 -0.909 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.845 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.4 Cg_endo -110.42 160.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.251 2.634 . . . . 0.0 114.548 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -85.11 81.7 8.74 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 175.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -127.27 130.24 49.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.195 -176.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.673 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 174.15 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.477 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 t 74.92 158.22 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.748 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 70' ' ' LYS . 4.3 tt -119.09 114.15 22.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.759 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.74 -39.36 57.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.7 tt0 -171.48 162.62 6.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.761 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.841 ' HD2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.6 133.28 23.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.813 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 tp -96.62 114.86 26.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.716 0.77 . . . . 0.0 111.756 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.98 108.58 16.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.753 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -142.36 136.97 30.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.056 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 79' ' ' HIS . 2.7 pt-20 -121.16 114.13 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.335 0.588 . . . . 0.0 111.6 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -88.73 163.38 35.67 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.06 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -32.77 79.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.341 3.361 . . . . 0.0 113.479 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 75' ' ' PHE . 13.1 t0 86.34 -47.2 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.623 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 2.6 tpp180 -87.61 103.27 15.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.056 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' CG ' ' CB ' ' A' ' 74' ' ' GLU . 1.4 m-70 -98.9 154.2 18.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 111.256 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.613 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -125.05 141.72 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.615 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -134.68 118.42 17.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.587 0.232 . . . . 0.0 110.674 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.81 HD13 ' ND2' ' A' ' 119' ' ' ASN . 2.7 mt -116.86 114.47 23.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.68 0.276 . . . . 0.0 111.126 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.5 m0 -103.4 122.86 45.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.211 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.6 m-30 -98.48 123.45 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.174 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.789 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.9 m95 -101.19 117.94 35.99 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.707 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.673 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -77.55 97.78 5.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.573 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.892 HG11 HG23 ' A' ' 11' ' ' ILE . 11.4 t -74.43 145.77 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-N 114.546 -1.207 . . . . 0.0 112.43 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 2.0 mt-10 -109.71 -39.36 5.14 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.98 165.9 24.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.004 0.82 . . . . 0.0 112.139 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.643 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.5 p90 -145.38 131.06 18.93 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.46 115.74 20.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.29 -118.91 5.32 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.371 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.8 mt-10 -135.17 137.83 27.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.386 0.136 . . . . 0.0 110.996 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.22 132.0 13.44 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.053 2.502 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.671 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.1 p-90 -138.84 -62.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.38 -105.99 0.16 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.845 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -165.64 20.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.587 0.232 . . . . 0.0 111.286 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -59.64 -26.98 65.95 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.172 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.98 37.44 92.7 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.923 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 47.0 mt-30 -140.84 99.1 6.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.461 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.841 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 71.0 Cg_exo -43.58 131.53 7.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.134 2.556 . . . . 0.0 112.901 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 21' ' ' THR . . . -134.58 177.4 19.26 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.253 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.418 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -58.98 106.43 0.42 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.74 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.4 ppp? -120.1 149.93 41.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.921 0.391 . . . . 0.0 111.38 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.772 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.6 p -73.04 117.0 14.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.84 -18.53 65.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.772 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.9 p -56.25 -12.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 52.42 0.82 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -61.78 131.86 51.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.022 0.439 . . . . 0.0 110.252 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.994 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -115.87 111.32 20.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.157 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.47 -15.77 61.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.781 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -45.77 20.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.515 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.01 -17.64 61.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.55 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -100.87 162.32 21.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.666 0.27 . . . . 0.0 111.005 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 127.94 28.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.53 2.153 . . . . 0.0 112.447 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.22 -16.55 55.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.37 2.047 . . . . 0.0 112.079 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -17.92 62.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.338 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.81 ' ND2' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -116.51 11.93 14.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.238 -179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -61.36 -34.21 16.35 Favored Pre-proline 0 C--O 1.22 -0.484 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.813 ' HB2' HD22 ' A' ' 71' ' ' LEU . 68.3 Cg_exo -44.79 -47.85 11.24 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.12 1.88 . . . . 0.0 114.32 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -79.11 -54.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.501 . . . . 0.0 111.174 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.694 ' CG2' HD11 ' A' ' 110' ' ' LEU . 1.4 mm -61.24 -26.34 39.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.23 -46.36 72.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -53.32 55.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.986 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 tp -78.7 -43.69 25.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.313 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -50.2 -42.14 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.763 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -63.22 -10.21 14.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.527 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -110.07 129.88 55.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 158.0 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.594 HD11 HD12 ' A' ' 80' ' ' ILE . 3.4 pp -146.72 119.88 8.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.316 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 45.1 mt-30 -102.52 147.98 26.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.644 0.735 . . . . 0.0 112.855 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.718 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -147.68 132.45 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.06 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.66 125.13 42.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 119.065 0.848 . . . . 0.0 109.616 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.639 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -121.57 162.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.22 0.533 . . . . 0.0 112.091 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -148.13 148.86 20.74 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.674 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.833 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -102.55 120.01 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.915 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -80.12 115.91 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -77.58 151.98 34.19 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.543 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 46.6 t30 -120.11 174.07 6.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.352 1.072 . . . . 0.0 113.075 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 3.8 tm-20 -44.49 -44.25 8.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.974 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -85.56 -70.27 0.6 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.948 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.46 17.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.986 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' C ' ' A' ' 105' ' ' MET . 1.0 OUTLIER -111.91 132.63 54.61 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.915 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -102.59 121.07 53.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -60.94 100.21 0.11 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.791 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.08 137.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 t -69.98 111.26 5.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.866 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 ttp-105 -124.7 126.71 46.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.472 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ALA . 5.0 mtp85 43.75 26.7 0.14 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.849 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' CD ' ' A' ' 100' ' ' GLN . . . 47.1 28.48 0.94 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.726 0.298 . . . . 0.0 111.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.96 27.03 12.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.03 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -165.47 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.76 95.53 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.141 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -144.46 -78.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -139.18 101.94 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.713 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . . . -67.63 -12.7 61.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.789 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.56 25.22 5.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.643 0.259 . . . . 0.0 111.171 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -114.17 25.86 10.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.4 tt -75.38 60.38 1.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.23 -174.05 2.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.128 0.489 . . . . 0.0 112.137 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.833 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -120.23 166.39 15.35 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.086 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 9.9 Cg_endo -51.62 167.88 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.863 3.042 . . . . 0.0 111.94 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.01 60.88 0.75 Allowed Glycine 0 C--N 1.338 0.648 0 C-N-CA 119.503 -1.332 . . . . 0.0 115.244 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.65 110.06 0.93 Allowed Glycine 0 C--N 1.309 -0.954 0 CA-C-N 115.178 -0.511 . . . . 0.0 112.332 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.94 10.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.22 0.608 . . . . 0.0 112.052 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.06 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -57.29 -32.87 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.644 0.735 . . . . 0.0 110.262 179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.616 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.01 -85.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.2 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.2 mmm 38.49 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.312 0.383 . . . . 0.0 111.699 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.05 32.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.2 mp0 -97.27 -167.56 1.56 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.5 0.19 . . . . 0.0 110.917 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.967 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 160.62 28.33 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.967 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.72 -27.1 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.608 2.205 . . . . 0.0 112.065 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.965 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.0 mt-10 -104.38 -50.66 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.707 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -69.15 -4.86 19.12 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 40' ' ' ILE . . . -84.51 -42.06 15.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.231 0.539 . . . . 0.0 110.164 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.714 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -79.73 -39.28 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.518 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.8 t -52.15 -36.46 20.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -76.93 -27.95 55.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 110.792 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -79.25 -37.78 37.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.908 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -48.06 -48.65 33.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.98 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -74.76 -26.88 60.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.503 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.37 -30.01 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.114 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.1 mp0 -108.86 6.01 25.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.913 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 41.1 t -133.8 -43.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.84 -42.68 0.75 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.824 -0.626 . . . . 0.0 113.835 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.5 -175.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -111.36 88.94 9.58 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.043 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.908 ' HG3' HG11 ' A' ' 58' ' ' VAL . 15.1 Cg_endo -106.98 147.41 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.419 2.746 . . . . 0.0 114.053 -177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.908 ' NE2' HD11 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -119.24 127.43 53.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.355 -176.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 175.9 -172.25 0.08 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.438 0.637 . . . . 0.0 111.71 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.33 97.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.204 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.981 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.3 pp -56.22 122.64 12.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HB2' HD13 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.8 -36.07 59.85 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.233 0.54 . . . . 0.0 109.649 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.5 tt0 -171.68 161.29 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 132.02 22.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -96.43 115.9 28.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.973 0.892 . . . . 0.0 112.289 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.606 ' N ' HD22 ' A' ' 71' ' ' LEU . 40.7 tt0 -114.08 108.22 16.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.612 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -142.78 127.85 18.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.226 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -112.33 121.0 43.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.297 0.57 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -92.04 163.31 27.87 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.183 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 2.6 Cg_exo -34.77 81.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.185 3.256 . . . . 0.0 113.224 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.8 m-20 87.28 -47.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.361 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -85.72 107.6 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.96 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -98.78 154.93 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -130.97 140.33 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.01 120.2 21.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.322 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.973 HD12 HD12 ' A' ' 71' ' ' LEU . 16.0 mt -117.84 113.45 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.6 m0 -103.05 122.55 44.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 0.0 111.264 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.7 m-30 -102.32 131.04 49.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.022 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.981 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.0 m95 -110.4 130.16 55.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 68' ' ' PHE . 10.5 tp -89.33 97.65 11.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.338 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.857 HG22 ' CG ' ' A' ' 64' ' ' HIS . 30.0 t -71.8 147.18 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.231 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 4.0 mm-40 -112.18 -27.03 8.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -164.67 165.69 20.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.319 0.963 . . . . 0.0 112.212 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.03 122.85 8.08 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.69 158.67 29.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.33 -116.72 5.46 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.524 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mt-10 -134.57 142.78 43.95 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.489 0.185 . . . . 0.0 110.717 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 2.9 Cg_exo -76.41 128.87 10.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.948 2.432 . . . . 0.0 111.299 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -139.4 -62.74 0.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.485 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.74 -106.53 0.07 OUTLIER Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.012 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 44.2 tptt 176.25 37.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.0 110.637 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.88 -40.23 75.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.97 -58.43 0.4 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.186 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.681 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 89.3 mt-30 -140.14 121.92 9.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.218 0.532 . . . . 0.0 112.068 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -43.96 146.18 1.77 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.205 2.603 . . . . 0.0 112.808 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.23 19.33 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.725 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . 3.9 mt-10 -123.07 147.3 46.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.582 0.229 . . . . 0.0 110.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 107.34 0.5 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.495 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.427 ' SD ' HD12 ' A' ' 20' ' ' ILE . 6.3 ptm -120.13 149.42 42.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.729 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -65.28 114.49 4.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -67.3 -18.32 65.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.697 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.3 -17.35 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.78 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.713 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.41 150.51 39.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.21 100.07 9.03 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.804 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . . . -72.28 -15.88 61.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.279 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -35.87 42.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.62 6.13 42.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.884 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -118.99 165.67 16.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.764 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.42 127.96 28.1 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.055 . . . . 0.0 112.371 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 120' ' ' GLU . 31.2 Cg_endo -63.69 -16.95 57.8 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.579 2.186 . . . . 0.0 112.453 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.609 HD21 HG11 ' A' ' 8' ' ' VAL . 1.4 t30 -104.64 -2.42 25.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.422 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.569 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -57.64 -34.27 24.28 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.2 Cg_exo -44.69 -50.7 8.05 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.851 1.701 . . . . 0.0 113.64 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.55 -53.1 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.359 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 112' ' ' ALA . 2.4 mm -59.17 -28.67 39.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.31 -51.14 67.69 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -48.26 71.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.234 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.3 -50.12 12.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.065 0.459 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.804 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -51.59 -40.01 59.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -64.78 -7.65 11.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.847 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.502 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.439 H2'' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.13 102.8 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.26 138.23 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.747 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.753 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.6 pp -147.46 123.95 11.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 14.7 mt-30 -102.26 158.75 15.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.222 0.534 . . . . 0.0 111.679 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.9 mp -146.25 139.34 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -127.68 124.97 39.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m -133.06 154.78 40.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 119.043 0.838 . . . . 0.0 111.433 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 35' ' ' PHE . . . -145.8 137.57 7.04 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.618 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.949 HG22 ' CE2' ' A' ' 35' ' ' PHE . 5.2 pt -83.64 118.82 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.8 ' C ' HG12 ' A' ' 18' ' ' ILE . 1.6 tt -85.9 109.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.14 152.52 26.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.217 -178.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.693 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -132.24 -173.24 3.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.249 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -51.1 -57.01 9.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.803 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -59.09 -9.7 2.18 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 -178.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER 83.2 7.72 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.057 0.456 . . . . 0.0 110.882 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -102.46 144.66 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.8 HG12 ' C ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 116.38 47.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -62.07 106.08 0.67 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.187 -179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.787 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -117.61 159.11 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.607 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 34' ' ' GLU . 8.3 p -70.51 154.17 42.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.22 95.61 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.487 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 63.83 9.78 4.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.008 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 63.28 11.13 5.17 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 43.26 30.22 0.28 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.99 13.21 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.88 98.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.288 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -175.2 -68.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 tpp -118.11 87.43 2.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.25 -20.02 64.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.27 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.52 31.2 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -113.78 26.16 10.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.713 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.8 tt -65.07 63.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.61 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 21' ' ' THR . 7.9 tp10 -108.34 177.19 4.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 112.13 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.949 ' CE2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.61 168.32 10.39 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.879 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 3.8 Cg_endo -47.2 167.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.486 2.791 . . . . 0.0 111.706 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 101.9 60.5 0.76 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.689 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -132.2 118.64 2.31 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 115.021 -0.589 . . . . 0.0 111.992 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.4 ttmm 95.28 23.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.991 0.517 . . . . 0.0 111.624 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -71.23 -33.64 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.875 0.845 . . . . 0.0 109.504 178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.549 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.374 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 31.5 mmt 41.6 -91.55 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.673 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.86 27.17 0.13 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.755 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -87.33 -165.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.705 -0.247 . . . . 0.0 110.94 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.918 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -98.41 163.98 18.04 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.918 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.3 Cg_endo -46.92 -30.64 9.95 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.521 2.147 . . . . 0.0 111.979 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.73 -44.02 4.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.112 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HG3' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -73.6 -3.62 29.08 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -80.8 -53.55 6.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 110.587 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.944 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.4 p -78.42 -33.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.186 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.9 t -51.19 -35.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.681 0.277 . . . . 0.0 110.365 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.18 -31.26 60.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.79 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -78.58 -31.67 47.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.8 OUTLIER -49.05 -49.52 40.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -28.53 48.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.0 -27.58 54.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.711 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' GLU . 1.2 mm-40 -108.22 5.04 25.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.556 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 62' ' ' PRO . 28.1 t -134.56 -43.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.151 0.5 . . . . 0.0 109.949 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.16 -41.15 0.47 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.157 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.73 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.64 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 88.89 3.55 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.5 Cg_endo -110.64 152.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.056 2.504 . . . . 0.0 114.872 -176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 89' ' ' ARG . 13.0 mt-30 -74.77 79.36 2.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.992 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.2 t-160 -126.41 128.21 46.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.869 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 173.21 -167.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.396 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 70.66 161.87 0.23 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.803 HD21 ' HD3' ' A' ' 70' ' ' LYS . 1.9 tt -121.43 115.93 23.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -75.64 -41.12 55.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 5.6 tt0 -171.22 160.54 6.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.803 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.19 133.34 24.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.829 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.1 tp -98.09 115.77 28.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.614 0.721 . . . . 0.0 111.958 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -115.23 108.09 16.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.503 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.657 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.5 t80 -143.0 124.53 14.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.599 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.69 108.77 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.149 0.5 . . . . 0.0 111.298 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.651 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 26.1 m-85 -74.79 163.45 68.12 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.597 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.1 Cg_endo -40.99 85.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.934 3.089 . . . . 0.0 112.414 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 37.1 m-20 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.494 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -76.95 152.52 35.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.693 179.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 9.8 m-70 -146.74 109.49 4.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.851 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 73' ' ' TYR . 5.7 tt -119.58 137.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.68 118.43 17.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.743 0.306 . . . . 0.0 110.842 -179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' LEU . 4.1 mt -116.51 114.72 24.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.76 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 1.6 m0 -107.17 122.46 46.56 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.845 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.9 m-30 -100.12 124.22 45.26 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.944 ' CE2' HG11 ' A' ' 50' ' ' VAL . 80.1 m95 -100.65 118.19 36.28 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.575 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.6 tm? -78.03 97.34 5.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.534 -0.866 . . . . 0.0 113.019 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.992 HG22 ' CD2' ' A' ' 64' ' ' HIS . 18.8 t -74.03 145.46 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.82 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -115.08 -31.19 6.12 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.32 165.72 23.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.175 0.898 . . . . 0.0 111.845 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.8 p90 -146.56 143.31 28.79 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.737 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -80.67 145.04 31.83 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.559 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.99 -109.1 0.25 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.685 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.7 tt0 -127.45 137.52 30.87 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.585 0.231 . . . . 0.0 110.805 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.0 Cg_exo -76.51 151.32 32.83 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.81 2.34 . . . . 0.0 110.712 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.9 p-90 -154.56 -66.44 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.715 -0.794 . . . . 0.0 113.124 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -95.34 0.01 OUTLIER Glycine 0 CA--C 1.518 0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.825 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.62 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.882 0.372 . . . . 0.0 110.389 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' OE2' HG22 ' A' ' 21' ' ' THR . 13.4 pt-20 -55.81 -37.8 69.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 133.29 -57.86 0.7 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.842 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.662 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -115.42 103.58 54.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -43.98 137.21 7.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.964 2.442 . . . . 0.0 112.759 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.59 177.36 19.29 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.999 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -125.93 157.38 37.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -59.48 106.76 0.49 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.276 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.787 ' SD ' HD11 ' A' ' 20' ' ' ILE . 3.6 ppp? -120.25 144.8 47.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.017 0.437 . . . . 0.0 111.664 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.597 ' OG ' HG12 ' A' ' 108' ' ' VAL . 8.4 t -68.26 118.07 10.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.282 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.5 tm? -69.12 -17.99 63.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.695 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.597 HG12 ' OG ' ' A' ' 106' ' ' SER . 13.1 p -48.45 -20.05 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.9 55.64 0.56 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.75 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.522 ' HB2' HD22 ' A' ' 107' ' ' LEU . 9.7 tt -62.34 150.47 39.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.314 . . . . 0.0 110.865 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -118.17 113.32 21.38 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -15.63 61.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -35.32 49.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.375 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.639 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -82.6 -19.07 39.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.132 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.733 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -97.77 162.63 21.7 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.831 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.62 127.91 28.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.568 2.179 . . . . 0.0 112.724 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.93 -18.99 58.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 111.983 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.85 -21.66 66.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.499 HD21 HG11 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -111.87 5.45 18.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.107 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -56.66 -40.81 87.64 Favored Pre-proline 0 C--O 1.219 -0.518 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.9 Cg_exo -44.57 -39.53 13.12 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.254 1.969 . . . . 0.0 114.329 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.5 t -78.92 -53.52 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.076 0.465 . . . . 0.0 112.009 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -71.08 -26.71 27.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.47 -179.586 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -53.44 -48.45 68.77 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -54.79 -51.64 65.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.471 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 129' ' ' LEU . 4.5 mm? -78.51 -49.22 13.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.037 0.446 . . . . 0.0 111.224 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -50.46 -37.07 36.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.015 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -63.61 -10.62 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.436 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.653 " C2'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.0 117.62 34.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -140.12 158.32 44.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.444 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.705 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.5 pp -147.11 122.17 10.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.458 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 15.8 mt-30 -102.6 147.02 27.3 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 60.6 mt -147.97 129.51 6.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.987 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.018 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.8 124.9 43.09 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.205 0.911 . . . . 0.0 110.083 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.814 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.4 m -144.98 138.14 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 85' ' ' TRP . . . -148.71 135.43 5.44 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.881 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD13 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -69.09 143.97 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 117.71 0.755 . . . . 0.0 111.763 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -87.37 123.23 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.677 -179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.777 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -79.29 156.9 27.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.865 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 27.9 t-20 -120.35 174.15 6.7 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.337 1.065 . . . . 0.0 113.524 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.7 tt0 -43.09 -38.91 2.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.127 -1.851 . . . . 0.0 112.733 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -96.6 -63.22 1.16 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.886 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p30 166.89 14.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.22 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 104' ' ' TRP . 4.8 pm0 -100.25 123.35 44.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.001 0.429 . . . . 0.0 110.197 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.777 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -99.9 114.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.498 1.142 . . . . 0.0 112.971 -173.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.35 123.89 19.05 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.995 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' CG2' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -129.14 123.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 t -70.31 111.53 5.97 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.533 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 33' ' ' LEU . 3.9 ptt180 -121.95 117.56 26.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.01 28.41 0.62 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.339 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 100' ' ' GLN . . . 50.52 -167.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 111.23 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.89 -30.51 11.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.054 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.08 42.83 2.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.1 140.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.268 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.49 -75.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.32 102.42 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.29 -24.2 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.432 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.63 27.99 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.142 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.16 25.9 10.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.483 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 33' ' ' LEU . 3.1 tt -71.01 59.65 0.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.92 179.06 4.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.834 ' CE2' HD13 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.05 168.46 10.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.083 -178.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 6.9 Cg_endo -47.49 167.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.944 3.096 . . . . 0.0 112.293 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.27 60.52 0.75 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.66 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -137.95 110.98 0.78 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.118 -0.541 . . . . 0.0 111.957 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.3 tttp 115.59 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.289 0.635 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.018 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -60.58 -32.8 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.363 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.626 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.21 -85.21 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.161 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.7 mmm 35.6 -87.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.258 0.349 . . . . 0.0 111.688 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.46 30.43 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.615 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -94.01 -171.71 2.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 0.0 111.008 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -97.74 165.02 16.28 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.4 Cg_endo -45.42 -27.77 3.51 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.591 2.194 . . . . 0.0 112.099 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mp0 -104.03 -50.23 3.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.54 -4.61 15.79 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -81.38 -48.46 11.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 0.0 110.422 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.572 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.5 p -80.2 -41.19 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 47' ' ' GLU . 90.5 t -50.71 -35.93 14.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.308 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -27.77 47.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 111.239 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' GLU . 14.3 mm-40 -79.06 -35.54 42.37 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.013 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -47.87 -48.35 31.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.325 -177.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -74.67 -26.71 60.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.368 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tt0 -76.96 -29.36 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -109.1 5.85 24.4 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.98 HG12 HG13 ' A' ' 60' ' ' ILE . 15.9 t -133.89 -43.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.937 0.399 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 66.29 5.11 26.46 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.98 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.98 -168.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 117.843 0.821 . . . . 0.0 110.876 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -106.58 89.7 4.36 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.685 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 25.2 Cg_endo -111.04 134.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.668 2.912 . . . . 0.0 114.381 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.83 79.1 2.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.013 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.22 125.34 54.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.841 -176.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.93 -172.22 0.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.618 0.723 . . . . 0.0 112.133 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 64.6 94.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.164 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -51.05 119.24 3.79 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.466 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -74.85 -38.14 62.06 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.702 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -171.91 138.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.541 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.3 pttt -124.07 132.12 53.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.934 ' HB2' HG13 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -98.02 115.89 29.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.884 0.849 . . . . 0.0 112.47 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.5 107.66 16.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.628 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -143.16 127.93 18.22 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.269 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 2.3 pt-20 -108.94 112.45 24.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.317 0.579 . . . . 0.0 111.358 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 77' ' ' ASP . 5.0 m-85 -82.6 162.66 55.01 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 3.8 Cg_exo -33.61 81.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.53 3.487 . . . . 0.0 113.332 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.7 m-20 86.99 -48.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.345 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 4.5 ttm105 -87.87 113.36 23.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.696 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 1.8 m170 -101.55 154.97 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.753 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 4' ' ' LEU . 2.6 tt -132.19 136.06 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.55 121.52 28.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.648 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 3.9 mt -120.81 112.65 19.09 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.693 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 13.3 m0 -103.89 121.57 43.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.702 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.6 m-30 -105.73 140.96 37.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.032 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.982 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.6 m95 -120.29 135.16 55.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.202 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 68' ' ' PHE . 1.7 pp -90.19 99.54 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.758 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 11' ' ' ILE . 22.7 t -70.48 146.62 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 114.17 -1.377 . . . . 0.0 112.28 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 1.5 mt-10 -118.17 -14.16 9.89 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -163.87 162.88 23.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.496 1.044 . . . . 0.0 112.447 -179.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.562 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -157.72 120.42 3.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.515 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.69 ' O ' HG21 ' A' ' 60' ' ' ILE . 5.3 tt0 -70.13 145.39 51.6 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.892 0.377 . . . . 0.0 111.055 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.47 -118.25 8.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.721 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 mt-10 -126.62 142.07 42.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -77.29 135.49 15.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.966 2.444 . . . . 0.0 111.417 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 53.5 p-90 -148.34 -60.07 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.356 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.25 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.862 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 171.14 39.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.349 . . . . 0.0 110.305 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 21' ' ' THR . 1.4 pp20? -72.49 -45.56 58.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.59 -85.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.061 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' CB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -136.73 135.12 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.403 0.621 . . . . 0.0 111.755 -179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -43.85 142.98 3.24 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.322 2.681 . . . . 0.0 113.05 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.3 19.29 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.645 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.38 157.35 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.552 0.215 . . . . 0.0 110.602 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.551 ' HB2' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.44 105.84 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.209 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.401 ' O ' ' N ' ' A' ' 18' ' ' ILE . 27.4 ptm -121.25 163.07 19.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.579 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 114.56 8.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.167 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.83 ' O ' HD13 ' A' ' 107' ' ' LEU . 2.2 tm? -60.16 -18.24 46.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.815 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 108' ' ' VAL . 19.9 t -54.01 -11.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.64 48.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.717 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.756 HD13 ' CD2' ' A' ' 107' ' ' LEU . 6.3 tp -61.8 146.5 49.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.976 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -123.37 101.49 7.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.844 ' HB2' HG22 ' A' ' 123' ' ' ILE . . . -72.63 -18.63 61.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.329 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -42.23 26.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -79.15 -0.27 31.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.952 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -118.43 165.44 16.53 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.486 0.184 . . . . 0.0 110.618 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 9.7 Cg_endo -54.39 132.53 51.38 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.454 2.102 . . . . 0.0 112.623 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 52.9 Cg_endo -68.81 -20.54 39.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.644 2.229 . . . . 0.0 112.471 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.19 63.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.01 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.561 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -111.47 0.6 16.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.085 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -59.49 -31.78 10.57 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.5 Cg_exo -44.24 -50.88 7.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.859 1.706 . . . . 0.0 113.779 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -78.44 -52.92 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.068 0.461 . . . . 0.0 110.913 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.844 HG22 ' HB2' ' A' ' 112' ' ' ALA . 5.3 mm -57.61 -28.96 33.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.22 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.76 -51.41 69.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.258 0.551 . . . . 0.0 109.688 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -47.34 73.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.303 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -78.58 -49.92 12.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.885 0.374 . . . . 0.0 110.779 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.755 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -50.54 -35.84 31.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.05 -178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -63.32 -10.93 18.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.478 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.705 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_